
<html lang="en"     class="pb-page"  data-request-id="79ce6872-9a3e-4419-895a-9b65df33c98a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2018.61.issue-18;article:article:10.1021/acs.jmedchem.8b00690;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Introduction of a Methyl Group Curbs Metabolism of Pyrido[3,4-d]pyrimidine Monopolar Spindle 1 (MPS1) Inhibitors and Enables the Discovery of the Phase 1 Clinical Candidate N2-(2-Ethoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl)-6-methyl-N8-neopentylpyrido[3,4-d]pyrimidine-2,8-diamine (BOS172722)" /></meta><meta name="dc.Creator" content="Hannah&#xA;L.  Woodward" /></meta><meta name="dc.Creator" content="Paolo  Innocenti" /></meta><meta name="dc.Creator" content="Kwai-Ming J.  Cheung" /></meta><meta name="dc.Creator" content="Angela  Hayes" /></meta><meta name="dc.Creator" content="Jennie  Roberts" /></meta><meta name="dc.Creator" content="Alan T.  Henley" /></meta><meta name="dc.Creator" content="Amir  Faisal" /></meta><meta name="dc.Creator" content="Grace Wing-Yan  Mak" /></meta><meta name="dc.Creator" content="Gary  Box" /></meta><meta name="dc.Creator" content="Isaac M.  Westwood" /></meta><meta name="dc.Creator" content="Nora  Cronin" /></meta><meta name="dc.Creator" content="Michael  Carter" /></meta><meta name="dc.Creator" content="Melanie  Valenti" /></meta><meta name="dc.Creator" content="Alexis  De Haven Brandon" /></meta><meta name="dc.Creator" content="Lisa  O’Fee" /></meta><meta name="dc.Creator" content="Harry  Saville" /></meta><meta name="dc.Creator" content="Jessica  Schmitt" /></meta><meta name="dc.Creator" content="Rosemary  Burke" /></meta><meta name="dc.Creator" content="Fabio  Broccatelli" /></meta><meta name="dc.Creator" content="Rob L. M.  van Montfort" /></meta><meta name="dc.Creator" content="Florence I.  Raynaud" /></meta><meta name="dc.Creator" content="Suzanne A.  Eccles" /></meta><meta name="dc.Creator" content="Spiros  Linardopoulos" /></meta><meta name="dc.Creator" content="Julian  Blagg" /></meta><meta name="dc.Creator" content="Swen  Hoelder" /></meta><meta name="dc.Description" content="Monopolar spindle 1 (MPS1) occupies a central role in mitosis and is one of the main components of the spindle assembly checkpoint. The MPS1 kinase is an attractive cancer target, and herein, we re..." /></meta><meta name="Description" content="Monopolar spindle 1 (MPS1) occupies a central role in mitosis and is one of the main components of the spindle assembly checkpoint. The MPS1 kinase is an attractive cancer target, and herein, we re..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 10, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00690" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00690" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00690" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00690" /></link>
        
    
    

<title>Introduction of a Methyl Group Curbs Metabolism of Pyrido[3,4-d]pyrimidine Monopolar Spindle 1 (MPS1) Inhibitors and Enables the Discovery of the Phase 1 Clinical Candidate N2-(2-Ethoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl)-6-methyl-N8-neopentylpyrido[3,4-d]pyrimidine-2,8-diamine (BOS172722) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00690" /></meta><meta property="og:title" content="Introduction of a Methyl Group Curbs Metabolism of Pyrido[3,4-d]pyrimidine Monopolar Spindle 1 (MPS1) Inhibitors and Enables the Discovery of the Phase 1 Clinical Candidate N2-(2-Ethoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl)-6-methyl-N8-neopentylpyrido[3,4-d]pyrimidine-2,8-diamine (BOS172722)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0019.jpeg" /></meta><meta property="og:description" content="Monopolar spindle 1 (MPS1) occupies a central role in mitosis and is one of the main components of the spindle assembly checkpoint. The MPS1 kinase is an attractive cancer target, and herein, we report the discovery of the clinical candidate BOS172722. The starting point for our work was a series of pyrido[3,4-d]pyrimidine inhibitors that demonstrated excellent potency and kinase selectivity but suffered from rapid turnover in human liver microsomes (HLM). Optimizing HLM stability proved challenging since it was not possible to identify a consistent site of metabolism and lowering lipophilicity proved unsuccessful. Key to overcoming this problem was the finding that introduction of a methyl group at the 6-position of the pyrido[3,4-d]pyrimidine core significantly improved HLM stability. Met ID studies suggested that the methyl group suppressed metabolism at the distant aniline portion of the molecule, likely by blocking the preferred pharmacophore through which P450 recognized the compound. This work ultimately led to the discovery of BOS172722 as a Phase 1 clinical candidate." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00690"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00690">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00690&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00690&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00690&amp;href=/doi/10.1021/acs.jmedchem.8b00690" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 8226-8240</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00671" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00727" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Introduction of a Methyl Group Curbs Metabolism of Pyrido[3,4-<i>d</i>]pyrimidine Monopolar Spindle 1 (MPS1) Inhibitors and Enables the Discovery of the Phase 1 Clinical Candidate <i>N</i><sup>2</sup>-(2-Ethoxy-4-(4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)phenyl)-6-methyl-<i>N</i><sup>8</sup>-neopentylpyrido[3,4-<i>d</i>]pyrimidine-2,8-diamine (BOS172722)</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Hannah L. Woodward</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hannah L. Woodward</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hannah%0AL.++Woodward">Hannah L. Woodward</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paolo Innocenti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paolo Innocenti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paolo++Innocenti">Paolo Innocenti</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kwai-Ming J. Cheung</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kwai-Ming J. Cheung</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kwai-Ming+J.++Cheung">Kwai-Ming J. Cheung</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Angela Hayes</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Angela Hayes</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Angela++Hayes">Angela Hayes</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jennie Roberts</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jennie Roberts</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jennie++Roberts">Jennie Roberts</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alan T. Henley</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alan T. Henley</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alan+T.++Henley">Alan T. Henley</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Amir Faisal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Amir Faisal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Amir++Faisal">Amir Faisal</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Grace Wing-Yan Mak</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Grace Wing-Yan Mak</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Grace+Wing-Yan++Mak">Grace Wing-Yan Mak</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gary Box</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gary Box</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gary++Box">Gary Box</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Isaac M. Westwood</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Isaac M. Westwood</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div><div class="loa-info-affiliations-info">Division of Structural Biology, The Institute of Cancer Research, London SW3 6JB, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Isaac+M.++Westwood">Isaac M. Westwood</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nora Cronin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nora Cronin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Structural Biology, The Institute of Cancer Research, London SW3 6JB, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nora++Cronin">Nora Cronin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael Carter</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Carter</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Carter">Michael Carter</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Melanie Valenti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Melanie Valenti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Melanie++Valenti">Melanie Valenti</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alexis De Haven Brandon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alexis De Haven Brandon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alexis++De+Haven+Brandon">Alexis De Haven Brandon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lisa O’Fee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lisa O’Fee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lisa++O%E2%80%99Fee">Lisa O’Fee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Harry Saville</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Harry Saville</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Harry++Saville">Harry Saville</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jessica Schmitt</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jessica Schmitt</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jessica++Schmitt">Jessica Schmitt</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rosemary Burke</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rosemary Burke</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rosemary++Burke">Rosemary Burke</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fabio Broccatelli</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fabio Broccatelli</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fabio++Broccatelli">Fabio Broccatelli</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rob L. M. van Montfort</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rob L. M. van Montfort</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div><div class="loa-info-affiliations-info">Division of Structural Biology, The Institute of Cancer Research, London SW3 6JB, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rob+L.+M.++van+Montfort">Rob L. M. van Montfort</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Florence I. Raynaud</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Florence I. Raynaud</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Florence+I.++Raynaud">Florence I. Raynaud</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Suzanne A. Eccles</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Suzanne A. Eccles</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Suzanne+A.++Eccles">Suzanne A. Eccles</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Spiros Linardopoulos</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Spiros Linardopoulos</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div><div class="loa-info-affiliations-info">The Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London SW3 6JB, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Spiros++Linardopoulos">Spiros Linardopoulos</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Julian Blagg</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Julian Blagg</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Julian++Blagg">Julian Blagg</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7409-0323" title="Orcid link">http://orcid.org/0000-0002-7409-0323</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Swen Hoelder</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Swen Hoelder</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</div></div><span class="conrtib-corresp"><strong>*</strong>Tel: +44 (0)20 8722 4353. E-mail: <a href="/cdn-cgi/l/email-protection#4e3d392b206026212b222a2b3c0e272d3c602f2d603b25"><span class="__cf_email__" data-cfemail="5625213338783e39333a323324163f352478373578233d">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Swen++Hoelder">Swen Hoelder</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8636-1488" title="Orcid link">http://orcid.org/0000-0001-8636-1488</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00690&amp;href=/doi/10.1021%2Facs.jmedchem.8b00690" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 8226–8240</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 10, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 May 2018</li><li><span class="item_label"><b>Published</b> online</span>10 September 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 September 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00690" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00690</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00690"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3823</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">11</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00690" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Introduction of a Methyl Group Curbs Metabolism of Pyrido[3,4-d]pyrimidine Monopolar Spindle 1 (MPS1) Inhibitors and Enables the Discovery of the Phase 1 Clinical Candidate N2-(2-Ethoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl)-6-methyl-N8-neopentylpyrido[3,4-d]pyrimidine-2,8-diamine (BOS172722)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Hannah\nL.&quot;,&quot;last_name&quot;:&quot;Woodward&quot;},{&quot;first_name&quot;:&quot;Paolo&quot;,&quot;last_name&quot;:&quot;Innocenti&quot;},{&quot;first_name&quot;:&quot;Kwai-Ming&quot;,&quot;last_name&quot;:&quot;J. Cheung&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;Hayes&quot;},{&quot;first_name&quot;:&quot;Jennie&quot;,&quot;last_name&quot;:&quot;Roberts&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;T. Henley&quot;},{&quot;first_name&quot;:&quot;Amir&quot;,&quot;last_name&quot;:&quot;Faisal&quot;},{&quot;first_name&quot;:&quot;Grace&quot;,&quot;last_name&quot;:&quot;Wing-Yan Mak&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;Box&quot;},{&quot;first_name&quot;:&quot;Isaac&quot;,&quot;last_name&quot;:&quot;M. Westwood&quot;},{&quot;first_name&quot;:&quot;Nora&quot;,&quot;last_name&quot;:&quot;Cronin&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Carter&quot;},{&quot;first_name&quot;:&quot;Melanie&quot;,&quot;last_name&quot;:&quot;Valenti&quot;},{&quot;first_name&quot;:&quot;Alexis&quot;,&quot;last_name&quot;:&quot;De Haven Brandon&quot;},{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;O’Fee&quot;},{&quot;first_name&quot;:&quot;Harry&quot;,&quot;last_name&quot;:&quot;Saville&quot;},{&quot;first_name&quot;:&quot;Jessica&quot;,&quot;last_name&quot;:&quot;Schmitt&quot;},{&quot;first_name&quot;:&quot;Rosemary&quot;,&quot;last_name&quot;:&quot;Burke&quot;},{&quot;first_name&quot;:&quot;Fabio&quot;,&quot;last_name&quot;:&quot;Broccatelli&quot;},{&quot;first_name&quot;:&quot;Rob&quot;,&quot;last_name&quot;:&quot;L. M. van Montfort&quot;},{&quot;first_name&quot;:&quot;Florence&quot;,&quot;last_name&quot;:&quot;I. Raynaud&quot;},{&quot;first_name&quot;:&quot;Suzanne&quot;,&quot;last_name&quot;:&quot;A. Eccles&quot;},{&quot;first_name&quot;:&quot;Spiros&quot;,&quot;last_name&quot;:&quot;Linardopoulos&quot;},{&quot;first_name&quot;:&quot;Julian&quot;,&quot;last_name&quot;:&quot;Blagg&quot;},{&quot;first_name&quot;:&quot;Swen&quot;,&quot;last_name&quot;:&quot;Hoelder&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;8226-8240&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00690&quot;},&quot;abstract&quot;:&quot;Monopolar spindle 1 (MPS1) occupies a central role in mitosis and is one of the main components of the spindle assembly checkpoint. The MPS1 kinase is an attractive cancer target, and herein, we report the discovery of the clinical candidate BOS172722. The starting point for our work was a series of pyrido[3,4-d]pyrimidine inhibitors that demonstrated excellent potency and kinase selectivity but suffered from rapid turnover in human liver microsomes (HLM). Optimizing HLM stability proved challenging since it was not possible to identify a consistent site of metabolism and lowering lipophilicity proved unsuccessful. Key to overcoming this problem was the finding that introduction of a methyl group at the 6-position of the pyrido[3,4-d]pyrimidine core significantly improved HLM stability. Met ID studies suggested that the methyl group suppressed metabolism at the distant aniline portion of the molecule, likely by blocking the preferred pharmacophore through which P450 recognized the compound. This work ultimate&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00690&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00690" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00690&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00690" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00690&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00690" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00690&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00690&amp;href=/doi/10.1021/acs.jmedchem.8b00690" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00690" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00690" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00690%26sid%3Dliteratum%253Aachs%26pmid%3D30199249%26genre%3Darticle%26aulast%3DWoodward%26date%3D2018%26atitle%3DIntroduction%2Bof%2Ba%2BMethyl%2BGroup%2BCurbs%2BMetabolism%2Bof%2BPyrido%255B3%252C4-d%255Dpyrimidine%2BMonopolar%2BSpindle%2B1%2B%2528MPS1%2529%2BInhibitors%2Band%2BEnables%2Bthe%2BDiscovery%2Bof%2Bthe%2BPhase%2B1%2BClinical%2BCandidate%2BN2-%25282-Ethoxy-4-%25284-methyl-4H-1%252C2%252C4-triazol-3-yl%2529phenyl%2529-6-methyl-N8-neopentylpyrido%255B3%252C4-d%255Dpyrimidine-2%252C8-diamine%2B%2528BOS172722%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D18%26spage%3D8226%26epage%3D8240%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/jmcmar.2018.61.issue-18/20180927/jmcmar.2018.61.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00690&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Monopolar spindle 1 (MPS1) occupies a central role in mitosis and is one of the main components of the spindle assembly checkpoint. The MPS1 kinase is an attractive cancer target, and herein, we report the discovery of the clinical candidate BOS172722. The starting point for our work was a series of pyrido[3,4-<i>d</i>]pyrimidine inhibitors that demonstrated excellent potency and kinase selectivity but suffered from rapid turnover in human liver microsomes (HLM). Optimizing HLM stability proved challenging since it was not possible to identify a consistent site of metabolism and lowering lipophilicity proved unsuccessful. Key to overcoming this problem was the finding that introduction of a methyl group at the 6-position of the pyrido[3,4-<i>d</i>]pyrimidine core significantly improved HLM stability. Met ID studies suggested that the methyl group suppressed metabolism at the distant aniline portion of the molecule, likely by blocking the preferred pharmacophore through which P450 recognized the compound. This work ultimately led to the discovery of BOS172722 as a Phase 1 clinical candidate.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68042" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68042" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">MPS1 (monopolar spindle 1, also known as TTK) is a dual-specificity kinase that occupies a central role in mitosis. MPS1 is one of the main components of the spindle assembly checkpoint (SAC)<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1−4)</a> and ensures cells do not progress from metaphase to anaphase until the kinetochores are properly attached to the microtubules and under the appropriate tension at the metaphase plate.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> Cancer cells heavily rely on MPS1 to cope with aneuploidy resulting from aberrant numbers of chromosomes.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5−8)</a> The kinase has been found to be upregulated in a large number of tumor types<a onclick="showRef(event, 'ref6 ref7 ref9 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref9 ref10 ref11 ref12 ref13">(6,7,9−13)</a> strongly suggesting MPS1 inhibition as a therapeutic approach for the treatment of cancer. As a result, MPS1 inhibitors have been pursued by a number of organizations, and accordingly, at least four compounds have reached Phase 1 clinical trials: BAY1161909 (<b>1</b>),<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> BAY1217389 (<b>2</b>),<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> CFI-402257 (<b>3</b>),<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and S 81694 (structure undisclosed). We recently reported advanced inhibitors including CCT251455 (<b>4</b>)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and a series of pyrido[3,4-<i>d</i>]pyrimidines (34h (<b>5</b>))<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Published MPS1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00690&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While the single agent efficacy of MPS1 inhibitors has been described to be limited,<a onclick="showRef(event, 'ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21">(18−21)</a> a number of recent reports have documented that inhibition of MPS1 is particularly effective when used in combination with other drugs, for example, tubulin-targeting agents or CDK4/6 inhibitors.<a onclick="showRef(event, 'ref22 ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25 ref26">(22−26)</a> We were particularly intrigued by the use of MPS1 inhibitors in combination with paclitaxel for triple negative breast cancer. Paclitaxel is often used for this aggressive and highly proliferative cancer but, on its own, does frequently not lead to durable responses, particularly in the metastatic setting.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Triple negative breast cancer thus remains a high medical need, and new effective therapeutic regimens are needed.</div><div class="NLM_p">The work presented here builds upon a series of pyrido[3,4-<i>d</i>]pyrimidines that we recently disclosed.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Advanced compounds in this series showed excellent potency in biochemical and cellular assays, exemplified by <b>5</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>); which was effective in inhibiting MPS1 <i>in vivo</i>.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> However, this series in general, and <b>5</b> in particular, suffered from key liabilities that prevented further development, specifically high turnover in human microsomes as well as excessive lipophilicity.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. MPS1 inhibitor <b>5</b>. “P-MPS1” indicates an electrochemiluminescence mesoscale discovery (MSD)-based cellular assay that measured autophosphorylation of ectopically expressed MPS1 in HCT116 cells. Solubility conditions: HPLC, 1% DMSO, 10 mM PBS, pH 7.4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00690&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Herein, we describe our optimization of the pyrido[3,4-<i>d</i>]pyrimidine series<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> culminating in the discovery of a Phase 1 clinical candidate compound.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30026" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30026" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Des methyl pyrido[3,4-<i>d</i>]pyrimidine compounds were made using the route shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Two complementary approaches could be used to gain access to the des methyl compounds. First, the amine was introduced into <b>7</b> by displacement of the chloride, followed by <i>m</i>-CPBA oxidation to give sulfone <b>9</b>. Displacement of the sulfone with the appropriate formamide under NaH/THF conditions gave rise to the desired des methyl pyrido[3,4-<i>d</i>]pyrimidine compounds (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Alternatively, the steps could be reversed, carrying out the <i>m</i>-CPBA oxidation as the first step to afford sulfone <b>18</b>. Displacement with the appropriate formamide could then be carried out as previously, before introducing the amine at the final step, through reaction of the chloro-intermediate <b>20</b> with neopentylamine in NMP at elevated temperatures.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00690&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) amine, NMP, 100–130 °C; (ii) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C–r.t.; (iii) ArNHCHO <b>10</b>–<b>13</b> or <b>19</b>, NaH, THF, 0 °C–r.t.</p></p></figure><div class="NLM_p">Compounds in the 6-methyl pyrido[3,4-<i>d</i>]pyrimidine series were prepared from the key intermediate 8-chloro-2-(methylthio)pyrido[3,4-<i>d</i>]pyrimidine <b>22</b>, the synthesis of which we have previously reported.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Treatment of this intermediate with an amine at elevated temperature in NMP gave rise to sulfides <b>23</b>–<b>25</b>. Oxidation of these compounds with <i>m</i>-CPBA afforded sulfones <b>26</b>–<b>28</b>, which were ideally set up to undergo selective displacement. The aniline moiety was introduced using the corresponding formamide with either NaH in THF or cesium carbonate in DMSO, affording the desired 6-methyl pyrido[3,4-<i>d</i>]pyrimidines <b>34</b>–<b>42</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0008.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00690&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) amine, NMP, 100–130 °C; (ii) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C–r.t.; (iii) ArNHCHO <b>12</b>, <b>13</b>, or <b>29</b>–<b>33</b>, NaH, THF, 0 °C–r.t.; (iv) ArNHCHO, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 120 °C.</p></p></figure><div class="NLM_p">Again the order of steps could be reversed with the oxidation with <i>m</i>-CPBA being carried out first to give sulfone <b>43</b>, which could then undergo the same coupling with the appropriate formamide as previously described using NaH in THF. Displacement of the chloro intermediate <b>44</b> was then carried out with amines at elevated temperatures in NMP (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0009.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00690&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C–r.t.; (ii) ArNHCHO <b>29</b>, NaH, THF, 0 °C–r.t.; (iii) amine, NMP, 100–130 °C.</p></p></figure><div class="NLM_p last">All amines used were commercially available, and the formamides were synthesized from the corresponding anilines by refluxing in formic acid. The anilines were prepared by standard transformations (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00690/suppl_file/jm8b00690_si_002.pdf" class="ext-link">Supporting Information</a> for procedures).</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28243" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28243" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We routinely tested our compounds in a caliper-based MPS1 kinase assay at 1 mM ATP. As described in our preceding publication,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> this relatively high ATP concentration was necessary due to the high potency of advanced compounds (<i>K</i><sub>i</sub>s < 1 nM) that was beyond the dynamic range of the assay at lower ATP concentrations. Furthermore, we progressed compounds of sufficient potency to an MSD-based cellular assay that measured autophosphorylation of ectopically expressed MPS1 in HCT116 cells.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> In addition, we routinely determined selectivity against CDK2, a cell cycle kinase with a high homology to MPS1 in terms of the ATP binding domain. Since the CDK2 assay was run at much lower ATP concentrations, we converted the IC<sub>50</sub> values from the MPS1 assay (at 1 mM ATP) and those from the CDK2 assay (at 10 μM ATP) into <i>K</i><sub>i</sub> values and used these calculated <i>K</i><sub>i</sub>s to assess the selectivity ratio.</div><div class="NLM_p">Our key goal for the optimization of the pyrido[3,4-<i>d</i>]-pyrimidines series was to significantly improve the low human liver microsomal stability observed for compound <b>5</b> and other compounds in this series. Extensive attempts to identify major metabolites showed multiple oxidations and dealkylation products but failed to identify a consistent site of metabolism. Furthermore, we had not observed a correlation between stability in human microsomes and lipophilicity indicating that lowering LogP was not a promising approach. We thus suspected that rapid turnover was driven by recognition of a specific pharmacophore within our series and decided to systematically derivatize the molecule to discover modifications that would block this recognition and increase the metabolic stability.</div><div class="NLM_p">We started by altering the five-membered ring heterocycle of <b>5</b> maintaining a neopentyl substituent in the 8-position of the pyrido[3,4-<i>d</i>]pyrimidine core. These compounds are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. Methylated and dimethylated pyrazole containing compounds (<b>21</b>, <b>14</b>, and <b>15</b>) showed only relatively modest activity in the high ATP assay, as well as in the cellular assay. The imidazole substituted compound (<b>16</b>) demonstrated excellent levels of biochemical activity, as well as showing promising levels of selectivity over CDK2 and cellular activity. Finally, triazole containing <b>17</b>, while exhibiting nanomolar potency for CDK2, stood out in terms of its single digit nanomolar potency in the cellular assay and represents one of the most potent MPS1 inhibitors known to us. In fact, the potency of this compound was beyond the lower range of our biochemical assay even at 1 mM ATP. The reason why replacing the pyrazole moiety in <b>21</b> with imidazole (<b>15</b>) and particularly triazole (<b>16</b>) significantly boosted biochemical activity remained unclear, and crystal structures (<i>vide infra</i>) did not provide any additional insights.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biochemical and Cellular Data for Aniline Modifications on Neopentyl-Substituted Core<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0010.gif" alt="" id="GRAPHIC-d7e811-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0011.gif" alt="" id="gr10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Results are in nM unless otherwise stated and are mean for <i>n</i> ≥ 3, or mean values of two independent determinations or samples run <i>n</i> = 1. For SD (for <i>n</i> ≥ 3) and individual determinations (<i>n</i> = 2), see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00690/suppl_file/jm8b00690_si_001.csv" class="ext-link">Table S1</a>. “P-MPS1” indicates an electrochemiluminescence mesoscale discovery (MSD)-based cellular assay that measured autophosphorylation of ectopically expressed MPS1 in HCT116 cells. <i>K</i><sub>i</sub>s were calculated from the IC<sub>50</sub>s using the Cheng–Prusoff equation.</p></div></div><div></div></div><div class="NLM_p">We tested the human liver microsome (HLM) stability of compounds <b>16</b> and <b>17</b>, but both still underwent extensive metabolism showing Cl<sub>int</sub> values of 79 and 92 μL/min/mg protein, respectively. Nevertheless, the comparably low molecular weight (418) and lipophilicity (3.6) made <b>17</b> an excellent starting point for further investigation, and we decided to improve CDK2 selectivity and HLM stability.</div><div class="NLM_p">In order to develop hypotheses on how to reduce CDK2 activity, we superimposed X-ray structures of our compounds<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> with published CDK2 structures (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a></div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Top: Superimposed crystal structure of MPS1 (green) bound to a pyrido[3,4-<i>d</i>]pyrimidine core (carbon atoms colored green), extracted from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EH0">5EH0</a>, onto the structure of CDK2 (blue), extracted from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1H08">1H08</a> (ligand hidden for clarity), showing the different gatekeeper residues present in MPS1 and CDK2. Bottom: 6-position methyl group on pyrido[3,4-<i>d</i>]pyrimidine core.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00690&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Fourteen residues are different within the ATP binding pockets of MPS1 and CDK2, including the gatekeeper residue, which is Met602 in MPS1 and a bulkier phenylalanine (Phe80) in CDK2 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). We hypothesized that introducing a methyl group at the 6-position of the pyrido[3,4-<i>d</i>]pyrimidine core would be less tolerated in CDK2 than in MPS1, due to a clash with the CDK2 Phe80 gatekeeper residue.</div><div class="NLM_p">We thus set out to prepare a series of methyl substituted compounds. The significant investigations required to access pyrido[3,4-<i>d</i>]pyrimidines with substitution in this position were disclosed by us recently.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p"><a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> shows the biochemical and cellular results for two initial proof-of-concept compounds made as matched pairs to the corresponding unsubstituted compounds (<b>16</b> and <b>17</b>). Both compounds show potent biochemical inhibition of MPS1 and lower but still acceptable levels of inhibition in cells. As hypothesized, both 6-methylated compounds (<b>34</b> and <b>35</b>) demonstrated a significant improvement in selectivity for MPS1 over CDK2 (<i>K</i><sub>i</sub> ratio is between 500 and 7600). Even more importantly and somewhat unexpectedly, we observed a large improvement in HLM metabolism for the 6-methylated compounds. Compounds <b>34</b> and <b>35</b> represented by far the most stable compounds we had observed and thus a breakthrough in terms of optimizing the up to this point persisting HLM liability. We thus decided to focus on the methylated amino-pyrido[3,4-<i>d</i>]pyrimidine core.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Biochemical and Cellular Data for Two Matched Pairs of Compounds Containing H or Me at the 6-Position of the Pyrido[3,4-<i>d</i>]pyrimidine Core<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0012.gif" alt="" id="gr11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Results are in nM unless otherwise stated and are mean for <i>n</i> ≥ 3, or mean values of two independent determinations or samples run <i>n</i> = 1. For SD (for <i>n</i> ≥ 3) and individual determinations (<i>n</i> = 2), see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00690/suppl_file/jm8b00690_si_002.pdf" class="ext-link">Table S2</a>. “P-MPS1” indicates an electrochemiluminescence mesoscale discovery (MSD)-based cellular assay that measured autophosphorylation of ectopically expressed MPS1 in HCT116 cells. <i>K</i><sub>i</sub>s were calculated from the IC<sub>50</sub>s using the Cheng–Prusoff equation.</p></div></div><div></div></div><div class="NLM_p">To understand why these compounds showed greatly improved stability, we identified the metabolites for the matched pair <b>17</b> and <b>35</b>. Interestingly, these experiments showed that the introduction of the methyl group completely changed the nature of the main metabolites in HLM (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Incubation of compound <b>17</b> with HLM primarily led to metabolites in which the triazole and aniline moieties were oxidized (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). In sharp contrast, treatment of <b>35</b> with HLM led to oxidation on the neopentyl chain followed by loss of the entire chain (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Importantly, the metabolic hotspots are not only different for these compounds but, in both cases, also distant from the position of the newly introduced methyl group of <b>35</b>. This observation thus suggests that the reduction of HLM metabolism is not due to blocking of a metabolically labile position (a commonly applied strategy, particularly using fluorine atoms) but instead to blocking of the pharmacophore through which <b>17</b> is recognized and bound. This hypothesis is consistent with the nature of P450 enzymes where substrate recognition and catalytic sites are spatially separated.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Results of a Met ID study showing oxidation products for the match pair of compounds <b>17</b> and <b>35</b> after treatment with HLM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00690&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>35</b> thus represented a significant step forward, and we explored whether HLM stability, CDK2 selectivity, cellular potency, and solubility could be further optimized. <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> summarizes modifications of the methoxy group and the triazole ring substituents. Based on existing SAR, we hypothesized that introducing an ethoxy group in place of the methoxy group of <b>35</b> improves selectivity further. The corresponding ethoxy compound (<b>36</b>) showed similar levels of biochemical potency (IC<sub>50</sub> 11 vs 13 nM), albeit with a slight drop in cellular potency (P-MPS1 IC<sub>50</sub> 63 vs 30 nM). As hypothesized, this transformation resulted in an improved selectivity window over CDK2 (<i>K</i><sub>i</sub> ratio 500 (<b>35</b>) vs 46 (<b>36</b>)) and significantly improved stability in HLM.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Biochemical and Cellular Data for Triazole Modifications Based on <b>35</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0013.gif" alt="" id="GRAPHIC-d7e1065-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0014.gif" alt="" id="gr12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Results are in nM unless otherwise stated and are mean for <i>n</i> ≥ 3, or mean values of two independent determinations or samples run <i>n</i> = 1. For SD (for <i>n</i> ≥ 3) and individual determinations (<i>n</i> = 2), see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00690/suppl_file/jm8b00690_si_002.pdf" class="ext-link">Table S3</a>. “P-MPS1” indicates an electrochemiluminescence mesoscale discovery (MSD)-based cellular assay that measured autophosphorylation of ectopically expressed MPS1 in HCT116 cells.</p></div></div><div></div></div><div class="NLM_p">Introduction of a methyl group onto the triazole ring (<b>37</b>) resulted in very similar levels of potency to <b>35</b> both in the biochemical and cellular assays (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), albeit with an increase in lipophilicity (ALogP = 4.49 vs 3.88). The bicyclic triazole derivatives <b>38</b> and <b>39</b> were also potent biochemical inhibitors but showed significantly weaker inhibition in cells. Interestingly, this matched pair (<b>38</b> and <b>39</b>) also demonstrated a similar increase in selectivity between methoxy and ethoxy derivatives. Finally, adding a basic dimethylamino group to improve solubility (<b>40</b>) resulted in loss of cellular potency (P-MPS1 IC<sub>50</sub> 230 nM) possibly due to a decrease in cellular permeability of the more polar dimethylamine tail group, though the solubility (77.6 μM [HPLC method, 1% DMSO, 10 mM PBS, pH 7.4]) of this compound was greatly improved in comparison to <b>35</b>.</div><div class="NLM_p">From this investigation, <b>36</b> emerged as an attractive compound, and we tested if the overall properties could be further optimized by modification of the neopentyl amine.</div><div class="NLM_p"><a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> shows a representative set of amine substitutions at the 8-position of the pyrido[3,4-<i>d</i>]pyrimidine core. Compound <b>45</b> bears the same branched primary amine used in our previously reported MPS1 inhibitor <b>5</b>.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Compound <b>45</b> demonstrated good activity against MPS1 in the biochemical and cellular assays (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) but exhibits poor solubility (2.2 μM), a possible consequence of the increased ALogP (4.61). The introduction of secondary amines including pyrrolidine (<b>46</b>) and substituted azetidines (<b>47</b>, <b>48</b>, and <b>42</b>) exhibited varied activity against MPS1. Pyrrolidine containing <b>46</b> displayed a significant decrease in the biochemical and cellular potency observed. Compound <b>47</b> exhibited excellent activity (P-MPS1 IC<sub>50</sub> 37 nM) and good levels of selectivity over CDK2 coupled with an increased solubility of 31.5 μM, possibly due to the decreased ALogP of 3.85. However, movement of the gem dimethyl group one carbon round the ring into the α-position (<b>48</b>) resulted in loss of all MPS1 activity (P-MPS1 IC<sub>50</sub> 3.8 μM). Cyano-substituted azetidine compound (<b>42</b>) also showed acceptable levels of potency (P-MPS1 IC<sub>50</sub> 110 nM) and selectivity over CDK2 (CDK2 IC<sub>50</sub> 2.70 μM), combined with a much lower AlogP of 3.25. However, this reduced ALogP did not translate into increased solubility, with <b>42</b> only showing a solubility of 6.8 μM. Introduction of a polar spirocyclic amine (<b>41</b>) resulted in a dramatic drop in lipophilicity (AlogP = 3.08), which, as expected, translated into an increase in solubility (56.2 μM).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Biochemical and Cellular Data for Amine Modifications Based on <b>36</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0015.gif" alt="" id="GRAPHIC-d7e1204-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0016.gif" alt="" id="gr13" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Results are in nM unless otherwise stated and are mean for <i>n</i> ≥ 3, or mean values of two independent determinations or samples run <i>n</i> = 1. For SD (for <i>n</i> ≥ 3) and individual determinations (<i>n</i> = 2), see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00690/suppl_file/jm8b00690_si_002.pdf" class="ext-link">Table S4</a>. “P-MPS1” indicates an electrochemiluminescence mesoscale discovery (MSD)-based cellular assay that measured autophosphorylation of ectopically expressed MPS1 in HCT116 cells.</p></div></div><div></div></div><div class="NLM_p">To understand the observed MPS1 SAR (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>), we solved the crystal structure of compound <b>36</b> bound to MPS1 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). As expected, the binding mode of <b>36</b> was nearly identical to that of the previously described pyrido[3,4-<i>d</i>]pyrimidine inhibitors.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The pyrido[3,4-<i>d</i>]pyrimidine scaffold of <b>36</b> binds to the hinge region, the 6-methyl group important for CDK2 selectivity and for the reduction in HLM metabolism, is located close to the side chain of the gatekeeper residue Met602, and the ethoxy moiety also important for selectivity binds in the selectivity pocket above the hinge. Somewhat surprisingly, the triazole moiety was not engaged in a hydrogen bond, and thus the X-ray structure did not explain why replacing the pyrazole of <b>21</b> with triazole (<b>17</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) led to a significant increase in activity (<i>vide supra</i>). Together with previously reported structures of CCT251455 (<b>4</b>) and (<b>5</b>), the X-ray structure of <b>36</b> allowed us to rationalize the SAR summarized in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. As previously described for compound <b>5</b>, the neopentyl chain binds to a hydrophobic pocket that is created by a reordering of the MPS1 activation loop into an inactive conformation (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B).<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> The shape of the neopentyl chain represents an excellent match to this pocket resulting in several hydrophobic contacts explaining why this moiety is critical for activity. The two azetidine derivatives <b>47</b> and <b>48</b> exemplify the importance of the correct shape of the amine substituent for potent inhibition. The 3,3-dimethylazetidine substituent of derivative <b>47</b> can be regarded as a constrained mimetic of the neopentyl chain that can likely engage in similar hydrophobic contacts, and <b>47</b> maintains potent inhibition. The 2,2-dimethylazetidine moiety of <b>48</b>, however, differs significantly in its overall shape from the neopentyl chain leading to less favorable interactions and a 40-fold higher IC<sub>50</sub>.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Crystal structure of <b>36</b> bound to MPS1 (pdb code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6H3K">6H3K</a>). Compound <b>36</b> is shown with carbon atoms in yellow. Selected amino acids are shown in sea green and are labeled. Key hydrogen bonds are indicated as black dotted lines. (B) Close up of the neopentyl binding pocket. The neopentyl substituent is enveloped by residues Met671 and Pro673 from the activation loop. Protein surface is displayed as a transparent blue surface. The compound surface is shown in transparent yellow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00690&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To investigate which of the potent and selective compounds in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> can be progressed further, we tested the stability in liver microsomes. Gratifyingly, all compounds tested showed satisfactory stability (Cl<sub>int</sub> < 45 μL/min/mg protein in mouse and Cl<sub>int</sub> < 26 μL/min/mg protein in human) (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). This represented a vast improvement over the human intrinsic clearance values seen for compound <b>5</b> (Cl<sub>int</sub> 151.2 μL/min/mg protein), the starting point of our investigation.</div><div class="NLM_p">With a number of active, selective, and soluble compounds in hand, we decided to investigate the mouse and rat pharmacokinetics (PK) of a selection of compounds (<b>36</b>, <b>45</b>, <b>47</b>, and <b>41</b>) at 5 mg/kg administered both intravenous (iv) and orally (po) (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The resulting data showed moderate clearance for all compounds in both mouse (8.4–22.6 mL/min/kg) and rat (6.00–10.1 mL/min/kg). All compounds with the exception of <b>41</b> showed high oral bioavailability in both species (63–92%) with moderate volumes of distribution (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). The plasma protein binding for all four of these compounds was high (>98%), the lowest unsurprisingly shown by that presenting the lowest AlogP (<b>41</b>). This corresponded to a higher blood clearance and shorter half-life (0.66 h) for <b>41</b> compared to <b>36</b> (2.68 h).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Mouse and Rat Blood Pharmacokinetics of <b>36</b>, <b>41</b>, <b>45</b>, and <b>47</b> at 5 mg/kg iv and po, unless Otherwise Stated<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0017.gif" alt="" id="gr14" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">2.5 mg/kg (iv).</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">1 mg/kg (iv).</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Compounds were administered iv and po (Mouse, 0.1 mL/10 g in 10% DMSO, 5% Tween 20 in saline; Rat, 0.05 mL/10 g in 10% DMSO, 5% Tween 20 in saline).</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">AUC<sub>last</sub> 6 h for mouse, 24 h for rat, unless otherwise stated.</p></div><div class="footnote" id="t5fn5"><sup><sup>e</sup></sup><p class="last">AUC<sub>last</sub> 6 h.</p></div></div><div></div></div><div class="NLM_p">We thus decided to progress both <b>36</b> and <b>41</b> to a single dose pharmacokinetic/pharmacodynamic (PK/PD) experiment in DLD1 xenografts to investigate if the <i>in vitro</i> and PK profiles translated into sustained inhibition of MPS1 <i>in vivo</i> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). We recently disclosed<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> a xenograft model to assess modulation of MPS1 activity <i>in vivo</i>. Briefly, this model (Dox-DLD1) measures the level of MPS1 autophosphorylation in DLD1 cancer cells and, importantly, overcomes the issue of low MPS1 levels through doxycycline inducible expression of the kinase. We tested both compounds at 25 mg/kg and in addition compound <b>36</b> at 50 mg/kg. The data are summarized in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>. At 25 mg/kg, both compounds led to a pronounced reduction of MPS1 autophosphorylation after 6 h. Consistent with its longer half-life, only <b>36</b> showed significant inhibition at 24 h. As expected, the 50 mg/kg dose of <b>36</b> resulted in an increased suppression of MPS1 autophosphorylation at 6 and 24 h. The comparison of the plasma levels determined in the PK/PD study (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) after blood to plasma correction with the compound levels determined in the PK study described above and performed at lower doses (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) was consistent with linear PK.</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Bar charts show the ratio of phosphylated-MPS1/total-MPS1 levels (gray) in the Dox-DLD1 model after treatment with <b>36</b> (left) and <b>41</b> (right) at specified doses and time points. The plasma levels at the respective time points are given in the table below the bar chart.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00690&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The robust modulation of the PD biomarkers observed for <b>36</b> prompted us to focus on this compound since a long duration of action is desirable for cell cycle targets. At 1 mg/kg iv and 5 mg/kg po, <b>36</b> showed complete bioavailability (100%), low clearance (1.2 mL/min/kg), a moderate volume of distribution (1.1 L/kg), and a 12 h half-life (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>) in a dog PK study.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Dog Blood Pharmacokinetics not Dogblood <b>36</b> at 1 mg/kg iv and 5 mg/kg po<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0018.gif" alt="" id="gr15" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">The compound was administered as the dichloride salt in saline containing 10% DMSO.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">AUC<sub>last</sub> 48 h.</p></div></div><div></div></div><div class="NLM_p">We were intrigued by the high bioavailability of <b>36</b>, particularly given its poor solubility. Interestingly, p<i>K</i><sub>a</sub> values for <b>36</b> were determined as 6.22 and 2.63. This suggests that, while the compound primarily exists as the free base at physiological pH, it is protonated in the acidic environment of the stomach, likely accelerating the dissolution and enabling high bioavailability despite modest solubility at physiological pH. This is an attractive feature of the pyrido [3,4-<i>d</i>]pyrimidine scaffold since it avoids the well-recognized risk associated with drugs carrying a positive charge at physiological pH, namely, hERG inhibition, efflux, and detrimental effects on passive permeation while still allowing high bioavailability and salt formation. To shed light on the question of which atom represents the weakly basic center, we performed a calculation using MoKa.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> This calculation predicted that the nitrogen atom of the pyridine ring is by far the most basic atom.</div><div class="NLM_p">To complete the <i>in vitro</i> profiling, <b>36</b> was tested in a wide panel of more than 400 kinases (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00690/suppl_file/jm8b00690_si_002.pdf" class="ext-link">Supporting Information</a>, Tables S5–S8). As we had seen with our previous MPS1 inhibitor <b>5</b>,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> only a small number of other kinases were inhibited by <b>36</b>, in particular JNK1, JNK2, JNK3, and LRRK2 at >80% at 1 μM. Follow up IC<sub>50</sub> values were obtained (JNK1 IC<sub>50</sub> = 92 nM, JNK2 IC<sub>50</sub> = 76 nM, JNK3 IC<sub>50</sub> = 242 nM, and LRRK2 IC<sub>50</sub> = 48 nM) showing that <b>36</b> is selective for MPS1 over these other kinases. Furthermore, <b>36</b> also showed a clean CYP and hERG profile (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00690/suppl_file/jm8b00690_si_002.pdf" class="ext-link">Supporting Information</a>, Tables S9 and S10).</div><div class="NLM_p last">Following extensive <i>in vivo</i> testing, particularly in combination with paclitaxel, the results of which will be published in due course (manuscript in preparation), we nominated <b>36</b> as our candidate. The synthesis of <b>36</b> has been scaled up into the kilogram range, and the drug is currently undergoing Phase 1 clinical trials.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40051" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40051" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We describe herein the discovery of our MPS1 inhibitor <b>36</b> (BOS172722). The starting point for the work described here was a series of previously reported pyrido[3,4-<i>d</i>]pyrimidine inhibitors. These earlier compounds already showed promising <i>in vitro</i> potency and selectivity but suffered from a number of liabilities, particularly high lipophilicity and rapid metabolism in HLM. Optimizing HLM metabolism proved challenging since commonly used approaches, such as identification of metabolites and lowering lipophilicity, did not help. Key to overcoming this problem was the serendipitous finding that introduction of a methyl group at the 6-position of the pyrido[3,4-<i>d</i>]pyrimidine core significantly improved HLM stability. Met ID studies suggested that the methyl group suppressed metabolism at the distant aniline portion of the molecule, likely by blocking the preferred pharmacophore through which P450 recognized the compound. Compound <b>17</b> is thus an interesting example where metabolism is not primarily driven by hydrophobicity or the presence of a particular metabolic hotspot but by recognition of a specific pharmacophore distant from the site of metabolism. These results underscore the importance of systematic chemical modification to solve high metabolic turnover.</div><div class="NLM_p">Further optimization led to a set of compounds with promising <i>in vitro</i> profile, and we progressed a number of selected compounds to PK and subsequently PK/PD experiments. Compound <b>36</b> emerged as our candidate showing excellent PK in mouse, rat, and dog. Data showing robust efficacy of <b>36</b> in combination with paclitaxel in <i>in vivo</i> models will be published shortly.</div><div class="NLM_p">Interestingly, <b>36</b> showed very good bioavailability in all three species despite very modest solubility at physiological pH. We attribute this observation to the weakly basic character of <b>36</b> (p<i>K</i><sub>a</sub> = 6.22) and other compounds in this series, which is likely accelerating their dissolution in the acidic environment of the stomach.</div><div class="NLM_p last">The synthesis of <b>36</b> has been scaled to the kilogram range, and the compound is currently in Phase 1 clinical trials.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53522" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53522" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> General Chemistry Information</h3><div class="NLM_p">Starting materials, reagents, and solvents for reactions were reagent grade and used as purchased. Chromatography solvents were HPLC grade and were used without further purification. Thin layer chromatography (TLC) analysis was performed using silica gel 60 F-254 thin layer plates. Flash column chromatography was carried out using columns prepacked with 40–63 μm silica. Microwave-assisted reactions were carried out using a Biotage Initiator microwave system. LCMS and HRMS analyses were performed on a HPLC system with diode array detector operating at 254 nm, fitted with a reverse-phase 50 × 4.6 mm column at a temperature of 22 °C, connected to a time of flight (ToF) mass spectrometer (ESI). The following solvent system, at a flow rate of 2 mL/min, was used: solvent A, methanol; solvent B, 0.1% formic acid in water. Gradient elution was as follows: 1:9 (A:B) to 9:1 (A:B) over 2.5 min, 9:1 (A:B) for 1 min then reversion back to 1:9 (A:B) over 0.3 min, 1:9 (A:B) for 0.2 min. <sup>1</sup>H NMR spectra were recorded on a Bruker Avance 500 MHz spectrometer using an internal deuterium lock. NMR data is given as follows: chemical shift (δ) in ppm, multiplicity, coupling constants (<i>J</i>) given in Hz, and integration. The purity of final compounds was determined by HPLC as described above and is ≥95% unless specified otherwise.</div><div class="NLM_p last">Compounds 8-chloro-2-(methylthio)pyrido[3,4-<i>d</i>]pyrimidine<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a><b>7</b>, 2-(methylthio)-<i>N</i>-neopentylpyrido[3,4-<i>d</i>]pyrimidin-8-amine<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a><b>8</b>, 2-(methylsulfonyl)-<i>N</i>-neopentylpyrido[3,4-<i>d</i>]pyrimidin-8-amine<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a><b>9</b>, 8-chloro-2-(methylsulfonyl)pyrido[3,4-<i>d</i>]pyrimidine<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a><b>18</b>, <i>N</i>-(2-methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)formamide<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a><b>19</b>, 8-chloro-<i>N</i>-(2-methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)pyrido[3,4-<i>d</i>]pyrimidin-2-amine<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a><b>20</b>, <i>N</i><sup>2</sup>-(2-methoxy-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)-<i>N</i><sup>8</sup>-neopentylpyrido[3,4-<i>d</i>]pyrimidine-2,8-diamine<a onclick="showRef(event, 'ref17 ref28'); return false;" href="javascript:void(0);" class="ref ref17 ref28">(17,28)</a><b>21</b>, 8-chloro-6-methyl-2-(methythio)pyrido[3,4-<i>d</i>]pyrimidine<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a><b>22</b>, 6-methyl-2-(methylthio)-<i>N</i>-neopentylpyrido[3,4-<i>d</i>]pyrimidin-8-amine<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a><b>23</b>, and 6-methyl-2-(methylsulfonyl)-<i>N</i>-neopentylpyrido[3,4-<i>d</i>]pyrimidin-8-amine<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a><b>26</b> were synthesized by previously reported methods.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Preparation of Compounds in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a></h3><div id="sec6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> General Procedure for NaH Mediated Displacement on <b>9</b> (Compounds <b>14–17</b>)</h4><div class="NLM_p">To a cooled (0 °C) solution of appropriate formamide (1 equiv) in THF (3 mL) was added sodium hydride (60% dispersion in oil, 1.6 equiv). The reaction mixture was stirred at r.t. for 10 min. The reaction mixture was cooled to 0 °C, and appropriate sulfone (1.2 equiv) was added. The reaction mixture was stirred for 18 h, while slowly warming to r.t. aq NaOH (1 M, 1 mL) and MeOH (1 mL) were added, and the reaction mixture was stirred at r.t. for 1 h. The reaction mixture was concentrated <i>in vacuo</i>, and the residue was diluted with EtOAc and water. The aqueous layer was re-extracted with EtOAc and CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with water and brine, dried (MgSO<sub>4</sub>), and concentrated <i>in vacuo</i>. The residue was purified by flash column chromatography (0–10% MeOH in EtOAc or CH<sub>2</sub>Cl<sub>2</sub>) and, if necessary, followed by SCX-2 cartridge (MeOH, 1 M NH<sub>3</sub> in MeOH) to afford the title compounds.</div><div id="sec6_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i16" class="anchor-spacer"></div><h5 class="article-section__title" id="_i16"> <i>N</i><sup>2</sup>-(4-(1,3-Dimethyl-1<i>H</i>-pyrazol-4-yl)-2-methoxyphenyl)-<i>N</i><sup>8</sup>-neopentylpyrido[3,4-<i>d</i>]pyrimidine-2,8-diamine <b>14</b></h5><div class="NLM_p last">Using <i>N</i>-(4-(1,3-dimethyl-1<i>H</i>-pyrazol-4-yl)-2-methoxyphenyl)formamide <b>10</b> and 2-(methylsulfonyl)-<i>N</i>-neopentylpyrido[3,4-<i>d</i>]pyrimidin-8-amine <b>9</b>.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Yield = 21%. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>30</sub>N<sub>7</sub>O (M + H) 432.2506, found 432.2502; <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 9.07 (s, 1H), 8.42 (d, <i>J</i> = 8.0 Hz, 1H), 7.73 (s, 1H), 7.71 (d, <i>J</i> = 6.0 Hz, 1H), 7.10 (d, <i>J</i> = 1.5 Hz, 1H), 7.03 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 6.85 (d, <i>J</i> = 6.0 Hz, 1H), 4.00 (s, 3H), 3.88 (s, 3H), 3.40 (s, 2H), 2.40 (s, 3H), 1.09 (s, 9H).</div></div><div id="sec6_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i17" class="anchor-spacer"></div><h5 class="article-section__title" id="_i17"> <i>N</i><sup>2</sup>-(4-(1,5-Dimethyl-1<i>H</i>-pyrazol-4-yl)-2-methoxyphenyl)-<i>N</i><sup>8</sup>-neopentylpyrido[3,4-<i>d</i>]pyrimidine-2,8-diamine <b>15</b></h5><div class="NLM_p last">Using <i>N</i>-(4-(1,5-dimethyl-1<i>H</i>-pyrazol-4-yl)-2-methoxyphenyl)formamide <b>11</b> and 2-(methylsulfonyl)-<i>N</i>-neopentylpyrido[3,4-<i>d</i>]pyrimidin-8-amine <b>9</b>.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Yield = 8%. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>30</sub>N<sub>7</sub>O (M + H) 432.2506, found 432.2504; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.02 (s, 1H), 8.51 (br s, 1H), 8.05 (m, 1H), 7.84 (m, 1H), 7.58 (s, 1H), 6.99 (dd, <i>J</i> = 8.2, 1.8 Hz, 1H), 6.96 (d, <i>J</i> = 1.8 Hz, 1H), 6.80 (br s, 1H), 3.99 (s, 3H), 3.88 (s, 3H), 3.64 (br s, 2H), 2.42 (s, 3H), 1.14 (s, 9H).</div></div><div id="sec6_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i18" class="anchor-spacer"></div><h5 class="article-section__title" id="_i18"> <i>N</i><sup>2</sup>-(4-(1,2-Dimethyl-1<i>H</i>-imidazol-5-yl)-2-methoxyphenyl)-<i>N</i><sup>8</sup>-neopentylpyrido[3,4-<i>d</i>]pyrimidine-2,8-diamine <b>16</b></h5><div class="NLM_p last">Using <i>N-</i>(4-(1,2-dimethyl-1<i>H</i>-imidazol-5-yl)-2-methoxyphenyl)formamide <b>12</b> and 2-(methylsulfonyl)-<i>N</i>-neopentylpyrido[3,4-<i>d</i>]pyrimidin-8-amine <b>9</b>.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Yield = 21%. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>30</sub>N<sub>7</sub>O (M + H) 432.2506, found 432.2504; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.04 (s, 1H), 8.76 (d, <i>J</i> = 8.0 Hz, 1H), 8.12 (s, 1H), 7.94 (d, <i>J</i> = 6.0 Hz, 1H), 7.21 (s, 1H), 6.99 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 6.91 (d, <i>J</i> = 2.0 Hz, 1H), 6.79 (d, <i>J</i> = 6.0 Hz, 1H), 6.58 (br s, 1H), 4.02 (s, 3H), 3.67 (s, 3H), 3.50 (d, <i>J</i> = 6.0 Hz, 2H), 2.82 (s, 3H), 1.12 (s, 9H).</div></div><div id="sec6_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i19" class="anchor-spacer"></div><h5 class="article-section__title" id="_i19"> <i>N</i><sup>2</sup>-(2-Methoxy-4-(4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)phenyl)-<i>N</i><sup>8</sup>-neopentylpyrido[3,4-<i>d</i>]pyrimidine-2,8-diamine <b>17</b></h5><div class="NLM_p last">Using <i>N</i>-(2-methoxy-4-(4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)phenyl)formamide <b>13</b> and 2-(methylsulfonyl)-<i>N</i>-neopentylpyrido[3,4-<i>d</i>]pyrimidin-8-amine <b>9</b>.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Yield = 12%. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>27</sub>N<sub>8</sub>O (M + H) 419.2302, found 419.2288; <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 9.15 (s, 1H), 8.74 (d, <i>J</i> = 8.5 Hz, 1H), 8.57 (s, 1H), 7.77 (d, <i>J</i> = 6.0 Hz, 1H), 7.43 (d, <i>J</i> = 1.5 Hz, 1H), 7.35 (dd, <i>J</i> = 8.5, 1.5 Hz, 1H), 6.90 (d, <i>J</i> = 6.0 Hz, 1H), 4.07 (s, 3H), 3.87 (s, 3H), 3.44 (s, 2H), 1.10 (s, 9H).</div></div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Preparation of Compounds in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a></h3><div id="sec7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> General Procedure for Amine Displacement on <b>22</b></h4><div class="NLM_p">To a solution of 8-chloro-6-methyl-2-(methythio)pyrido[3,4-<i>d</i>]pyrimidine <b>22</b> (1 equiv) in NMP (20 mL) was added appropriate amine (2 equiv) and triethylamine (5 equiv). The reaction mixture was heated to 100 °C for 36 h. The reaction mixture was diluted with EtOAc and water, dried (MgSO<sub>4</sub>), and concentrated <i>in vacuo</i>. The residue was purified by flash column chromatography (0–50% EtOAc in cyclohexane) to afford the title compounds.</div><div id="sec7_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> 2-(6-Methyl-2-(methylthio)pyrido[3,4-<i>d</i>]pyrimidin-8-yl)-7-oxa-2-azaspiro[3.5]nonane <b>24</b></h5><div class="NLM_p last">Using 7-oxa-2-azaspiro[3.5]nonane. Yield = 40%. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>21</sub>N<sub>4</sub>OS (M + H) 317.1431, found 317.1422; <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 9.00 (s, 1H), 6.76 (app s, 1H), 4.33 (br s, 4H), 3.71 (app t, <i>J</i> = 5.0 Hz, 4H), 2.65 (s, 3H), 2.44 (d, <i>J</i> = 0.5 Hz, 3H), 1.90 (app t, <i>J</i> = 5.0 Hz, 4H).</div></div><div id="sec7_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> 3-Methyl-1-(6-methyl-2-(methylthio)pyrido[3,4-<i>d</i>]pyrimidin-8-yl)azetidine-3-carbonitrile <b>25</b></h5><div class="NLM_p last">Using 3-methylazetidine-3-carbonitrile hydrochloride. Yield = 66%. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>16</sub>N<sub>5</sub>S (M + H) 268.1121, found 268.1119; <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 9.05 (s, 1H), 6.89 (app s, 1H), 4.83 (br d, <i>J</i> = 7.5 Hz, 2H), 4.48 (br d, <i>J</i> = 7.5 Hz, 2H), 2.64 (s, 3H), 2.47 (d, <i>J</i> = 0.5 Hz, 3H), 1.78 (s, 3H).</div></div></div><div id="sec7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> General Procedure for <i>m</i>-CPBA Oxidation on <b>23–25</b></h4><div class="NLM_p">To a cooled (0 °C) solution of appropriate sulfide (1 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added <i>m</i>-CPBA (3 equiv). The reaction mixture was stirred for 18 h, while slowly warming to r.t. In some instances, further <i>m</i>-CPBA was needed to achieve full conversion. The reaction mixture was quenched with water and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with aq. sat. NaHCO<sub>3</sub>, dried (MgSO<sub>4</sub>), and concentrated <i>in vacuo</i>. The residue was purified by flash column chromatography (0–10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>).</div><div id="sec7_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> 2-(6-Methyl-2-(methylsulfonyl)pyrido[3,4-<i>d</i>]pyrimidin-8-yl)-7-oxa-2-azaspiro[3.5]nonane <b>27</b></h5><div class="NLM_p last">Using 2-(6-methyl-2-(methylthio)pyrido[3,4-<i>d</i>]pyrimidin-8-yl)-7-oxa-2-azaspiro[3.5]nonane <b>24</b>. Yield = 28%. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>21</sub>N<sub>4</sub>O<sub>3</sub>S (M + H) 349.1329, found 349.1318; <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 9.38 (s, 1H), 6.94 (s, 1H), 4.29 (br s, 4H), 3.73 (app t, <i>J</i> = 5.5 Hz, 4H), 3.43 (s, 3H), 2.53 (s, 3H), 1.92 (app t, <i>J</i> = 5.5 Hz, 4H).</div></div><div id="sec7_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> 3-Methyl-1-(6-methyl-2-(methylsulfonyl)pyrido[3,4-<i>d</i>]pyrimidin-8-yl)azetidine-3-carbonitrile <b>28</b></h5><div class="NLM_p last">Using 3-methyl-1-(6-methyl-2-(methylthio)pyrido[3,4-<i>d</i>]pyrimidin-8-yl)azetidine-3-carbonitrile <b>25</b>. Yield = 77%. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>16</sub>N<sub>5</sub>O<sub>2</sub>S (M + H) 318.1019, found 318.1009; <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 9.46 (s, 1H), 7.08 (s, 1H), 4.54 (br s, 4H), 3.44 (s, 3H), 2.56 (s, 3H), 1.80 (s, 3H).</div></div><div id="sec7_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> <i>N</i><sup>2</sup>-(4-(1,2-Dimethyl-1<i>H</i>-imidazol-5-yl)-2-methoxyphenyl)-6-methyl-<i>N</i><sup>8</sup>-neopentylpyrido[3,4-<i>d</i>]pyrimidine-2,8-diamine <b>34</b></h5><div class="NLM_p last">To a cooled (0 °C) solution of <i>N</i>-(4-(1,2-dimethyl-1<i>H</i>-imidazol-5-yl)-2-methoxyphenyl)formamide <b>12</b> (17 mg, 0.069 mmol) in THF (3 mL) was added sodium hydride (2.7 mg, 0.11 mmol, 60% dispersion in oil). The reaction mixture was stirred at r.t. for 10 min. The reaction mixture was cooled to 0 °C, and 6-methyl-2-(methylsulfonyl)-<i>N</i>-neopentylpyrido[3,4-<i>d</i>]pyrimidin-8-amine <b>26</b><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (25.6 mg, 0.083 mmol) was added. The reaction mixture was stirred for 18 h, while slowly warming to r.t. aq NaOH (1 M, 1 mL) and MeOH (1 mL) were added, and the reaction mixture was stirred at r.t. for 1 h. The reaction mixture was concentrated <i>in vacuo</i>, and the residue diluted with EtOAc and water. The aqueous layer was re-extracted with EtOAc and CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with water and brine, dried (MgSO<sub>4</sub>), and concentrated <i>in vacuo</i>. The residue was purified by flash column chromatography (0–10% MeOH in EtOAc) and followed by SCX-2 cartridge (MeOH, 1 M NH<sub>3</sub> in MeOH) to afford the title compound (3.3 mg, 11%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>32</sub>N<sub>7</sub>O (M + H) 446.2663, found 446.2648; <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 9.02 (s, 1H), 8.57 (d, <i>J</i> = 8.5 Hz, 1H), 7.09 (d, <i>J</i> = 2.0 Hz, 1H), 7.02 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H), 6.88 (s, 1H), 6.70 (d, <i>J</i> = 1.0 Hz, 1H), 4.02 (s, 3H), 3.61 (s, 3H), 3.45 (s, 2H), 2.45 (s, 3H), 2.44 (d, <i>J</i> = 1.0 Hz, 3H), 1.09 (s, 9H).</div></div></div><div id="sec7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> General Procedure for Cesium Carbonate Mediated Substitution on <b>26</b>, <b>27</b>, or <b>28</b></h4><div class="NLM_p">To a solution of the appropriate sulfone (1 equiv) in DMSO (20 mg sulfone/mL) was added appropriate formamide (1.2 equiv) and cesium carbonate (2 equiv). The reaction mixture was heated to 120 °C in a closed cap vial for 18 h. The reaction mixture was diluted with EtOAc and water. The aqueous layer was re-extracted with EtOAc, and the combined organic layers were dried (MgSO<sub>4</sub>) and concentrated <i>in vacuo</i>. The residue was purified by flash column chromatography (0–10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) and if necessary followed by SCX-2 cartridge (MeOH, 1 M NH<sub>3</sub> in MeOH) to afford the title compounds.</div><div id="sec7_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> <i>N</i><sup>2</sup>-(2-Methoxy-4-(4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)phenyl)-6-methyl-<i>N</i><sup>8</sup>-neopentylpyrido[3,4-<i>d</i>]pyrimidine-2,8-diamine <b>35</b></h5><div class="NLM_p last">Using 6-methyl-2-(methylsulfonyl)-<i>N</i>-neopentylpyrido[3,4-<i>d</i>]pyrimidin-8-amine <b>26</b> and <i>N</i>-(2-methoxy-4-(4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)phenyl)formamide <b>13</b>. Yield = 48%. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>29</sub>N<sub>8</sub>O (M + H) 433.2459, found 433.2447; <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 9.05 (s, 1H), 8.75 (d, <i>J</i> = 8.5 Hz, 1H), 8.56 (s, 1H), 7.42 (d, <i>J</i> = 2.0 Hz, 1H), 7.34 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H), 6.71 (d, <i>J</i> = 1.0 Hz, 1H), 4.07 (s, 3H), 3.87 (s, 3H), 3.48 (s, 2H), 2.44 (app s, 3H), 1.10 (s, 9H).</div></div><div id="sec7_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> <i>N</i><sup>2</sup>-(2-Ethoxy-4-(4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)phenyl)-6-methyl-<i>N</i><sup>8</sup>-neopentylpyrido[3,4-<i>d</i>]pyrimidine-2,8-diamine <b>36</b></h5><div class="NLM_p last">Using 6-methyl-2-(methylsulfonyl)-<i>N</i>-neopentylpyrido[3,4-<i>d</i>]pyrimidin-8-amine <b>26</b> and <i>N</i>-(2-ethoxy-4-(4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)phenyl)formamide <b>29</b>. Yield = 70%. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>31</sub>N<sub>8</sub>O (M + H) 447.2615, found 447.2629; <sup>1</sup>H NMR (500 MHz, acetone-<i>d</i><sub>6</sub>) δ 9.11 (s, 1H), 8.80 (d, <i>J</i> = 8.5 Hz, 1H), 8.37 (s, 1H), 8.21 (br s, 1H), 7.46 (d, <i>J</i> = 2.0 Hz, 1H), 7.40 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H), 6.74 (d, <i>J</i> = 0.5 Hz, 1H), 4.35 (q, <i>J</i> = 7.0 Hz, 2H), 3.90 (s, 3H), 3.51 (s, 2H), 2.41 (d, <i>J</i> = 0.5 Hz, 3H), 1.55 (t, <i>J</i> = 7.0 Hz, 3H), 1.08 (s, 9H).</div></div><div id="sec7_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> <i>N</i><sup>2</sup>-(4-(4,5-Dimethyl-4<i>H</i>-1,2,4-triazol-3-yl)-2-ethoxyphenyl)-6-methyl-<i>N</i><sup>8</sup>-neopentylpyrido[3,4-<i>d</i>]pyrimidine-2,8-diamine <b>37</b></h5><div class="NLM_p last">Using 6-methyl-2-(methylsulfonyl)-<i>N</i>-neopentylpyrido[3,4-<i>d</i>]pyrimidin-8-amine <b>26</b><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and <i>N</i>-(2-ethoxy-4-(4,5-dimethyl-4<i>H</i>-1,2,4-triazol-3-yl)phenyl)formamide <b>30</b>. Yield = 56%. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>33</sub>N<sub>8</sub>O (M + H) 461.2772, found 461.2756; <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 9.06 (s, 1H), 8.75 (d, <i>J</i> = 8.5 Hz, 1H), 7.34 (d, <i>J</i> = 1.9 Hz, 1H), 7.28 (dd, <i>J</i> = 8.5, 1.9 Hz, 1H), 6.72 (s, 1H), 4.30 (q, <i>J</i> = 7.2 Hz, 2H), 3.71 (s, 3H), 3.48 (s, 2H), 2.53 (s, 3H), 2.45 (s, 3H), 1.56 (t, <i>J</i> = 7.2 Hz, 3H), 1.10 (s, 9H).</div></div><div id="sec7_3_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> <i>N</i><sup>2</sup>-(4-(6,7-Dihydro-5<i>H</i>-pyrrolo[2,1-<i>c</i>][1,2,4]triazol-3-yl)-2-methoxyphenyl)-6-methyl-<i>N</i><sup>8</sup>-neopentylpyrido[3,4-<i>d</i>]pyrimidine-2,8-diamine <b>38</b></h5><div class="NLM_p last">Using 6-methyl-2-(methylsulfonyl)-<i>N</i>-neopentylpyrido[3,4-<i>d</i>]pyrimidin-8-amine <b>26</b><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and <i>N</i>-(4-(6,7-dihydro-5<i>H</i>-pyrrolo[2,1-<i>c</i>][1,2,4]triazol-3-yl)-2-methoxyphenyl)formamide <b>31</b>. Purified by SCX-2 cartridge (MeOH, 1 M NH<sub>3</sub> in MeOH) followed by purification by HPLC. Yield = 31%. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>31</sub>N<sub>8</sub>O (M + H) 459.2615, found 459.2571; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.92 (s, 1H), 8.71 (d, <i>J</i> = 8.3 Hz, 1H), 8.07 (s, 1H), 7.66 (d, <i>J</i> = 1.9 Hz, 1H), 7.26 (br d, <i>J</i> = 1.9 Hz, 1H), 6.59 (d, <i>J</i> = 0.9 Hz, 1H), 6.53 (br t, <i>J</i> = 5.9 Hz, 1H), 4.24 (t, <i>J</i> = 6.9 Hz, 2H), 4.04 (s, 3H), 3.49 (d, <i>J</i> = 5.9 Hz, 2H), 3.06 (dd, <i>J</i> = 8.3, 6.9 Hz, 2H), 2.95–2.80 (m, 2H), 2.48 (d, <i>J</i> = 0.9 Hz, 3H), 1.11 (s, 9H).</div></div><div id="sec7_3_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> <i>N</i><sup>2</sup>-(4-(6,7-Dihydro-5<i>H</i>-pyrrolo[2,1-<i>c</i>][1,2,4]triazol-3-yl)-2-ethoxyphenyl)-6-methyl-<i>N</i><sup>8</sup>-neopentylpyrido[3,4-<i>d</i>]pyrimidine-2,8-diamine <b>39</b></h5><div class="NLM_p last">Using 6-methyl-2-(methylsulfonyl)-<i>N</i>-neopentylpyrido[3,4-<i>d</i>]pyrimidin-8-amine <b>26</b><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and <i>N</i>-(4-(6,7-dihydro-5<i>H</i>-pyrrolo[2,1-<i>c</i>][1,2,4]triazol-3-yl)-2-ethoxyphenyl)formamide <b>32</b>. Yield = 35%. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>33</sub>N<sub>8</sub>O (M+H) 473.2777, found 473.2769; <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 9.00 (s, 1H), 8.67 (d, <i>J</i> = 8.5 Hz, 1H), 7.51 (d, <i>J</i> = 1.8 Hz, 1H), 7.39 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 6.67 (s, 1H), 4.35–4.28 (m, 4H), 3.47 (s, 2H), 3.04–3.01 (m, 2H), 2.91–2.87 (m, 2H), 2.43 (s, 3H), 1.57 (t, <i>J</i> = 6.9 Hz, 3H), 1.10 (s, 9H).</div></div><div id="sec7_3_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> <i>N</i><sup>2</sup>-(4-(5-(2-(Dimethylamino)ethyl)-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)-2-ethoxyphenyl)-6-methyl-<i>N</i><sup>8</sup>-neopentylpyrido[3,4-<i>d</i>]pyrimidine-2,8-diamine <b>40</b></h5><div class="NLM_p last">Using 6-methyl-2-(methylsulfonyl)-<i>N</i>-neopentylpyrido[3,4-<i>d</i>]pyrimidin-8-amine <b>26</b><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and <i>N</i>-(4-(5-(2-(dimethylamino)ethyl)-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)-2-ethoxyphenyl)formamide <b>33</b>. Purified by reverse phase flash column chromatography (0–100% water in MeOH, followed by 0–30% 2 M methanolic ammonia in CH<sub>2</sub>Cl<sub>2</sub>). Yield = 18%. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>40</sub>N<sub>9</sub>O (M + H) 518.3356, found 518.3370; <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 9.05 (s, 1H), 8.75 (d, <i>J</i> = 8.5 Hz, 1H), 7.34 (d, <i>J</i> = 1.8 Hz, 1H), 7.28 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 6.71 (s, 1H), 4.30 (q, <i>J</i> = 7.0 Hz, 2H), 3.73 (s, 3H), 3.47 (s, 2H), 3.09 (app t, <i>J</i> = 7.5 Hz, 2H), 2.91 (app t, <i>J</i> = 7.5 Hz, 2H), 2.44 (s, 3H), 2.42 (s, 6H), 1.56 (t, <i>J</i> = 7.0 Hz, 3H), 1.09 (s, 9H).</div></div><div id="sec7_3_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> <i>N</i>-(2-Ethoxy-4-(4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)phenyl)-6-methyl-8-(7-oxa-2-azaspiro[3.5]nonan-2-yl)pyrido[3,4-<i>d</i>]pyrimidin-2-amine <b>41</b></h5><div class="NLM_p last">Using 2-(6-methyl-2-(methylsulfonyl)pyrido[3,4-<i>d</i>]pyrimidin-8-yl)-7-oxa-2-azaspiro[3.5]nonane <b>27</b> and <i>N</i>-(2-ethoxy-4-(4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)phenyl)formamide <b>29</b>. Yield = 46%. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>31</sub>N<sub>8</sub>O<sub>2</sub> (M + H) 487.2564, found 487.2511; <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 9.06 (s, 1H), 8.57 (d, <i>J</i> = 8.5 Hz, 1H), 8.56 (s, 1H), 7.39 (d, <i>J</i> = 2.0 Hz, 1H), 7.36 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H), 6.78 (s, 1H), 4.31–4.27 (m, 6H), 3.87 (s, 3H), 3.69 (app t, <i>J</i> = 5.5 Hz, 4H), 2.44 (s, 3H), 1.89 (app t, <i>J</i> = 5.5 Hz, 4H), 1.54 (t, <i>J</i> = 7.0 Hz, 3H).</div></div><div id="sec7_3_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 1-(2-((2-Ethoxy-4-(4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)phenyl)amino)-6-methylpyrido[3,4-<i>d</i>]pyrimidin-8-yl)-3-methylazetidine-3-carbonitrile <b>42</b></h5><div class="NLM_p last">Using 3-methyl-1-(6-methyl-2-(methylsulfonyl)pyrido[3,4-<i>d</i>]pyrimidin-8-yl)azetidine-3-carbonitrile <b>28</b> and <i>N</i>-(2-ethoxy-4-(4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)phenyl)formamide <b>29</b>. Yield = 38%. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>26</sub>N<sub>9</sub>O (M + H) 456.2255, found 456.2180; <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 9.10 (s, 1H), 8.56 (s, 1H), 8.46 (d, <i>J</i> = 8.5 Hz, 1H), 7.40 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H), 7.39 (d, <i>J</i> = 2.0 Hz, 1H), 6.91 (s, 1H), 4.75 (d, <i>J</i> = 9.0 Hz, 2H), 4.39 (d, <i>J</i> = 9.0 Hz, 2H), 4.28 (q, <i>J</i> = 7.0 Hz, 2H), 3.88 (s, 3H), 2.47 (s, 3H), 1.75 (s, 3H), 1.53 (t, <i>J</i> = 7.0 Hz, 3H).</div></div></div></div><div id="sec8" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Preparation of Compounds in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a></h3><div id="sec8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 8-Chloro-6-methyl-2-(methylsulfonyl)pyrido[3,4-<i>d</i>]pyrimidine <b>43</b></h4><div class="NLM_p">A suspension of 8-chloro-6-methyl-2-(methylthio)pyrido[3,4-<i>d</i>]pyrimidine <b>22</b> (1.13 g, 5.01 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) was treated with <i>m</i>-CPBA (77% w/w, 2.60 g, 11.57 mmol) at 0 °C. The reaction mixture was stirred for 18 h, while slowly warming to r.t. The reaction was quenched with water and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with aq. sat. NaHCO<sub>3</sub>, dried (MgSO<sub>4</sub>), and concentrated <i>in vacuo</i>. The residue was purified by flash column chromatography (0–70% EtOAc in cyclohexane) to afford the title compound (972 mg, 75%). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>9</sub>H<sub>9</sub>ClN<sub>3</sub>O<sub>2</sub>S (M + H) 258.0099, found 258.0092; <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 9.82 (s, 1H), 7.96 (d, <i>J</i> = 0.5 Hz, 1H), 3.54 (s, 3H), 2.78 (d, <i>J</i> = 0.5 Hz, 3H).</div><div id="sec8_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> 8-Chloro-<i>N</i>-(2-ethoxy-4-(4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)phenyl)-6-methylpyrido[3,4-<i>d</i>]pyrimidin-2-amine <b>44</b></h5><div class="NLM_p last">To a solution of <i>N</i>-(2-ethoxy-4-(4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)phenyl)formamide <b>29</b> (1.88 g, 7.63 mmol) in THF (70 mL) was added NaH (60% w/w, 500 mg, 12.50 mmol) at 0 °C. The reaction mixture was stirred at r.t. for 30 min. The mixture was cooled to 0 °C, and 8-chloro-6-methyl-2-(methylsulfonyl)pyrido[3,4-<i>d</i>]pyrimidine <b>43</b> (2.50 g, 9.70 mmol) was added. The reaction mixture was stirred for 18 h, while slowly warming to r.t. aq. NaOH (2 M, 25 mL) and MeOH (25 mL) were added, and the resulting mixture stirred at r.t. for 1 h. The reaction mixture was concentrated <i>in vacuo</i>, and the residue was diluted with CH<sub>2</sub>Cl<sub>2</sub> and water. The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub>, and the combined organic layers were dried (MgSO<sub>4</sub>) and concentrated <i>in vacuo</i>. The residue was purified by flash column chromatography (0–6% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to afford the title compound (3.24 g, quant). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>ClN<sub>7</sub>O (M + H) 396.1339, found 396.1335; <sup>1</sup>H NMR (500 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 9.46 (s, 1H), 8.85 (d, <i>J</i> = 8.3 Hz, 1H), 8.79 (s, 1H), 8.56 (s, 1H), 7.74 (d, <i>J</i> = 1.0 Hz, 1H), 7.49–7.36 (m, 2H), 4.25 (q, <i>J</i> = 7.0 Hz, 2H), 3.80 (s, 3H), 2.58 (s, 3H), 1.43 (t, <i>J</i> = 7.0 Hz, 3H).</div></div></div><div id="sec8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> General Procedure for Amine Displacement on 44 (Compounds <b>45–48</b>)</h4><div class="NLM_p">To a solution of the appropriate chloro compound (1 equiv) in NMP (3 mL) was added the appropriate amine or salt thereof (2–5 equiv) and triethylamine (5 equiv). The reaction mixture was heated to 100 °C in a closed cap vial for 18 h. The reaction mixture was diluted with EtOAc and water. The organic layer was washed with brine, dried (MgSO<sub>4</sub>), and concentrated <i>in vacuo</i>. The residue was purified by flash column chromatography (eluting with the appropriate solvent system) and, if necessary, followed by SCX-2 cartridge (MeOH, 1 M NH<sub>3</sub> in MeOH).</div><div id="sec8_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> (<i>S</i>)-<i>N</i><sup>8</sup>-(3,3-Dimethylbutan-2-yl)-<i>N</i><sup>2</sup>-(2-ethoxy-4-(4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)phenyl)-6-methylpyrido[3,4-<i>d</i>]pyrimidine-2,8-diamine <b>45</b></h5><div class="NLM_p last">Using 8-chloro-<i>N</i>-(2-ethoxy-4-(4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)phenyl)-6-methylpyrido[3,4-<i>d</i>]pyrimidin-2-amine <b>44</b> and (<i>S</i>)-3,3-dimethylbutan-2-amine at 130 °C for 2 days. Yield = 52%. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>33</sub>N<sub>8</sub>O (M + H) 461.2777, found 461.2777; <sup>1</sup>H NMR (500 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 9.15 (s, 1H), 8.57 (s, 1H), 8.43 (d, <i>J</i> = 8.3 Hz, 1H), 7.41 (d, <i>J</i> = 1.9 Hz, 1H), 7.31 (dd, <i>J</i> = 8.2, 1.9 Hz, 1H), 6.72 (d, <i>J</i> = 1.0 Hz, 1H), 6.43 (d, <i>J</i> = 9.5 Hz, 1H), 4.23 (q, <i>J</i> = 6.9 Hz, 2H), 4.13 (dq, <i>J</i> = 9.4, 6.6 Hz, 1H), 3.78 (s, 3H), 2.38 (s, 3H), 1.41 (t, <i>J</i> = 6.9 Hz, 3H), 1.16 (d, <i>J</i> = 6.6 Hz, 3H), 1.00 (s, 9H).</div></div><div id="sec8_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> <i>N</i>-(2-Ethoxy-4-(4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)phenyl)-6-methyl-8-(pyrrolidin-1-yl)pyrido[3,4-<i>d</i>]pyrimidin-2-amine <b>46</b></h5><div class="NLM_p last">Using 8-chloro-<i>N</i>-(2-ethoxy-4-(4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)phenyl)-6-methylpyrido[3,4-<i>d</i>]pyrimidin-2-amine <b>44</b> and pyrrolidine at 130 °C. Yield = 70%. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>27</sub>N<sub>8</sub>O (M + H) 431.2308, found 431.2315; <sup>1</sup>H NMR (500 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 9.13 (s, 1H), 8.56 (s, 1H), 8.34 (s, 1H), 8.23 (d, <i>J</i> = 8.2 Hz, 1H), 7.39–7.29 (m, 2H), 6.76 (d, <i>J</i> = 0.8 Hz, 1H), 4.21 (q, <i>J</i> = 6.9 Hz, 2H), 3.88 (s, 4H), 3.78 (s, 3H), 2.37 (s, 3H), 1.94–1.83 (m, 4H), 1.41 (t, <i>J</i> = 6.9 Hz, 3H).</div></div><div id="sec8_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 8-(3,3-Dimethylazetidin-1-yl)-<i>N</i>-(2-ethoxy-4-(4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)phenyl)-6-methylpyrido[3,4-<i>d</i>]pyrimidin-2-amine <b>47</b></h5><div class="NLM_p last">Using 8-chloro-<i>N</i>-(2-ethoxy-4-(4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)phenyl)-6-methylpyrido[3,4-<i>d</i>]pyrimidin-2-amine <b>44</b> and 3,3-dimethylazetidine hydrochloride. Yield = 70%. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>30</sub>N<sub>8</sub>O (M + 2H)/2 223.1266, found 223.1261; <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 9.05 (s, 1H), 8.56 (d, <i>J</i> = 8.5 Hz, 1H), 8.54 (s, 1H), 7.37 (d, <i>J</i> = 1.5 Hz, 1H), 7.34 (dd, <i>J</i> = 8.5, 1.5 Hz, 1H), 6.77 (s, 1H), 4.29 (q, <i>J</i> = 7.0 Hz, 2H), 4.21 (br s, 4H), 3.87 (s, 3H), 2.44 (s, 3H), 1.54 (t, <i>J</i> = 7.0 Hz, 3H), 1.38 (s, 6H).</div></div><div id="sec8_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> 8-(2,2-Dimethylazetidin-1-yl)-<i>N</i>-(2-ethoxy-4-(4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)phenyl)-6-methylpyrido[3,4-<i>d</i>]pyrimidin-2-amine <b>48</b></h5><div class="NLM_p last">Using 8-chloro-<i>N</i>-(2-ethoxy-4-(4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)phenyl)-6-methylpyrido[3,4-<i>d</i>]pyrimidin-2-amine <b>44</b> and 2,2-dimethylazetidine. Yield = 89%. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>29</sub>N<sub>8</sub>O (M + H) 445.2459, found 445.2461; <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.98 (s, 1H), 8.54 (s, 1H), 8.52 (d, <i>J</i> = 8.0 Hz, 1H), 7.35 (d, <i>J</i> = 2.0 Hz, 1H), 7.33 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 6.65 (s, 1H), 4.70–4.66 (m, 2H), 4.27 (d, <i>J</i> = 7.0 Hz, 2H), 3.85 (s, 3H), 2.39 (s, 3H), 2.22 (dd, <i>J</i> = 9.0, 7.5 Hz, 2H), 1.71 (s, 6H), 1.54 (t, <i>J</i> = 7.0 Hz, 3H).</div></div></div></div><div id="sec8_2_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Biochemical Assays</h3><div class="NLM_p last">MPS1 and CDK2 counterscreen assay were performed as reported previously.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div></div><div id="sec8_2_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> MSD Assay</h3><div class="NLM_p last">An electrochemiluminescence assay (Meso Scale Discovery, MSD) for detection of autophosphorylation of MPS1 at pTpS<sup>33/37</sup> sites in cell lysates has been described previously.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Autophosphorylation of MPS1 at pTpS<sup>33/37</sup> and total MPS1-GFP levels in MPS1-doxycycline inducible DLD-1 xenografts were determined by MSD assays as described previously.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Results were presented as the ratio of Phospho-MPS1/Total MPS1.</div></div><div id="sec8_2_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Microsomal Metabolism</h3><div class="NLM_p last">Microsomal clearance was determined in female CD1 mice, female Sprague–Dawley rats, and mixed gender human liver microsomes obtained from Tebu-Bio (Peterborough, U.K.) following incubation of 1 μM compound at 37 °C in 1 mg/mL microsomal protein, 3 mmol/L MgCl<sub>2</sub>, 1 mmol/L NADPH, 2.5 mmol/L, UDP-glucuronic acid, and 10 mmol/L phosphate buffer (pH 7.4) (all purchased from Sigma-Aldrich, Gillingham, U.K). Reactions were started by addition of the cofactors following 10 min preincubation of microsomes with test compound and were terminated at −1, 0, 5, 10, 15, and 30 min with three volumes of ice-cold methanol containing internal standard. Samples were centrifuged at 2800<i>g</i> for 30 min at 4 °C and the supernatants analyzed. Control incubations were prepared as above with omission of cofactors. Compound measurements were performed by LCMS on an Agilent quadrupole time-of-flight instrument (Agilent 6510) following separation with a 6 min gradient of 0.1% formic acid in methanol on a 50 × 2.1 mm 2.6 μm C18 column (Kinetex Phenomenex). For metabolite identification, the gradient was extended to 20 min and MS/MS carried out with fragment elucidation for ions of interest.</div></div><div id="sec8_2_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Pharmacokinetic Studies</h3><div class="NLM_p">Animals were adapted to laboratory conditions for at least 1 week prior to dosing and were allowed food and water <i>ad libitum</i>. Compounds were administered iv or po (mouse, 0.1 mL/10 g in 10% DMSO, 5% tween 20 in saline; rat, 0.05 mL/10 g in 10% DMSO, 5% tween 20 in saline; dog, 10% in DMSO in saline). Blood samples were collected from the tail vein (20 μL) at 8 time points over the 24 h post dose and spotted on Whatman B cards (VWR) together with a standard curve and quality controls spiked in control blood. Cards were allowed to dry at r.t. for at least 6 h. Cards were punched and 6 mm discs were extracted with 200 μL of methanol containing 500 nM olomoucine as an internal standard. Following centrifugation, extracts were analyzed by multiple reaction monitoring of precursor and product ions by ESI-LCMS/MS on a QTRAP 4000 (ABSciex) following gradient separation with 0.1% formic acid in methanol on a Phenomenex Kinetex C18 UPLC column (50 × 2.1 mm, 2.6 μM). Quantitation was carried out with an external calibration (typically 8 points ranging from 1 nM to 25 μM). Quality controls were included (three concentrations) at the beginning and the end of the analytical run and were within 20% of nominal concentrations.</div><div class="NLM_p">Pharmacokinetic parameters were derived from noncompartmental analysis using Phoenix Pharsight WinNonlin (model 200 and 201) version 6.1/6.3.</div><div class="NLM_p last">All experiments using animals were performed in accordance with the local Animal Welfare and Ethical Review Board, the UK Home Office Animals Scientific Procedures Act 1986, and with the United Kingdom National Cancer Research Institute Guidelines for the Welfare of Animals in Cancer Research.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The ICR does not undertake research in nonrodent species and requires internal ethical review when such studies are sponsored by organizations with whom we collaborate. Collaborator-sponsored nonrodent pharmacology studies of compound <b>36</b> necessary for the prediction of therapeutic window and application to the clinic were approved by the ICR Animal Welfare and Ethics Review Board and were conducted in full compliance with national regulations at AAALAC accredited R&D sites.</div></div><div id="sec8_2_4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> PK/PD Experiments</h3><div class="NLM_p last">These experiments were conducted as previously described.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00690" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57377" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57377" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00690" class="ext-link">10.1021/acs.jmedchem.8b00690</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00690/suppl_file/jm8b00690_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Experimental procedures and analytical data for all formamides (<b>10–13</b> and <b>29–33</b>) and corresponding intermediates, CYP, hERG activity, and P-gp efflux data as well as kinase selectivity profiling of <b>36</b>. Tables with standard deviations for all compounds as well as antiproliferative (GI<sub>50</sub>) data for several compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00690/suppl_file/jm8b00690_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00690/suppl_file/jm8b00690_si_001.csv">jm8b00690_si_001.csv (1.76 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00690/suppl_file/jm8b00690_si_002.pdf">jm8b00690_si_002.pdf (1.22 MB)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB ID code for <b>36</b> bound to MPS1 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6H3K">6H3K</a>.</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b00690" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35625" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35625" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Swen Hoelder</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8636-1488" title="Orcid link">http://orcid.org/0000-0001-8636-1488</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#88fbffede6a6e0e7ede4ecedfac8e1ebfaa6e9eba6fde3"><span class="__cf_email__" data-cfemail="e09397858ece888f858c848592a0898392ce8183ce958b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hannah
L. Woodward</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paolo Innocenti</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kwai-Ming J. Cheung</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela Hayes</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennie Roberts</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan T. Henley</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amir Faisal</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span>; 
    <span>Present Address:
                        (A.F.) SBA School of Science and Engineering, Lahore University of Management Sciences, D.H.A., Lahore 54792, Pakistan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Grace Wing-Yan Mak</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary Box</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isaac M. Westwood</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">Division
of Structural Biology, The Institute of
Cancer Research, London SW3 6JB, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nora Cronin</span> - <span class="hlFld-Affiliation affiliation">Division
of Structural Biology, The Institute of
Cancer Research, London SW3 6JB, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Carter</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melanie Valenti</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexis De Haven Brandon</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa O’Fee</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Harry Saville</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jessica Schmitt</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rosemary Burke</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabio Broccatelli</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rob L. M. van Montfort</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">Division
of Structural Biology, The Institute of
Cancer Research, London SW3 6JB, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Florence I. Raynaud</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suzanne A. Eccles</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Spiros Linardopoulos</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">The
Breakthrough Breast Cancer Research Centre, Division of Breast Cancer
Research, The Institute of Cancer Research, London SW3 6JB, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julian Blagg</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SM2 5NG, United Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7409-0323" title="Orcid link">http://orcid.org/0000-0002-7409-0323</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): The authors are current or former employees of The Institute of Cancer Research, which has a commercial interest in the development of kinase inhibitors.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87708" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87708" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by Cancer Research UK [grant number C309/A11566]. We also acknowledge the Cancer Research Technology Pioneer Fund and Sixth Element Capital for funding (to P.I.) and NHS funding to the NIHR Biomedical Research Centre. S.L. is also supported by Breakthrough Breast Cancer. We thank Dr. Amin Mirza, Dr. Maggie Liu, and Mr. Meirion Richards for their help with LC, NMR, and mass spectrometry. We are grateful to the staff of DIAMOND Light Source for their support during data collection.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">CDK2</td><td class="NLM_def"><p class="first last">cyclin-dependent kinase 2</p></td></tr><tr><td class="NLM_term">Cl</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human Ether-à-go-go-Related Gene</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">L.E.</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">MLM</td><td class="NLM_def"><p class="first last">mouse liver microsomes</p></td></tr><tr><td class="NLM_term">MPS</td><td class="NLM_def"><p class="first last">monopolar spindle kinase</p></td></tr><tr><td class="NLM_term">MSD</td><td class="NLM_def"><p class="first last">MesoScale Discovery</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">PARP</td><td class="NLM_def"><p class="first last">poly ADP ribose polymerase</p></td></tr><tr><td class="NLM_term">PLK1</td><td class="NLM_def"><p class="first last">polo-like kinase</p></td></tr><tr><td class="NLM_term">PTEN</td><td class="NLM_def"><p class="first last">phosphatase and tensin homologue</p></td></tr><tr><td class="NLM_term">SAC</td><td class="NLM_def"><p class="first last">spindle assembly checkpoint</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsomes</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub></td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78002" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78002" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 33 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardwick, K. G.</span></span> <span> </span><span class="NLM_article-title">The spindle checkpoint</span>. <i>Trends Genet.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">4</span>, <span class="refDoi"> DOI: 10.1016/S0168-9525(97)01340-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1016%2FS0168-9525%2897%2901340-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=9448456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADyaK1cXltlSjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1998&pages=1-4&author=K.+G.+Hardwick&title=The+spindle+checkpoint&doi=10.1016%2FS0168-9525%2897%2901340-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The spindle checkpoint</span></div><div class="casAuthors">Hardwick, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Genetics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-4</span>CODEN:
                <span class="NLM_cas:coden">TRGEE2</span>;
        ISSN:<span class="NLM_cas:issn">0168-9525</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 33 refs., on the spindle checkpoint, localization of checkpoint components, global signaling, and a role for the checkpoint proteins in the timing of a normal mitosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCK07I41QTXrVg90H21EOLACvtfcHk0ljcp1canCW8kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltlSjuw%253D%253D&md5=b7c46a342b829847a9c7ebacbbe03915</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0168-9525%2897%2901340-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0168-9525%252897%252901340-1%26sid%3Dliteratum%253Aachs%26aulast%3DHardwick%26aufirst%3DK.%2BG.%26atitle%3DThe%2520spindle%2520checkpoint%26jtitle%3DTrends%2520Genet.%26date%3D1998%26volume%3D14%26spage%3D1%26epage%3D4%26doi%3D10.1016%2FS0168-9525%2897%2901340-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mills, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmandt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGill, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amendola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodricks, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogg, D.</span></span> <span> </span><span class="NLM_article-title">Expression of TTK, a novel human protein kinase, is associated with cell proliferation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">16000</span>– <span class="NLM_lpage">16006</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=16000-16006&author=G.+B.+Millsauthor=R.+Schmandtauthor=M.+McGillauthor=A.+Amendolaauthor=M.+Hillauthor=K.+Jacobsauthor=C.+Mayauthor=A.+M.+Rodricksauthor=S.+Campbellauthor=D.+Hogg&title=Expression+of+TTK%2C+a+novel+human+protein+kinase%2C+is+associated+with+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DSchmandt%26aufirst%3DR.%26aulast%3DMcGill%26aufirst%3DM.%26aulast%3DAmendola%26aufirst%3DA.%26aulast%3DHill%26aufirst%3DM.%26aulast%3DJacobs%26aufirst%3DK.%26aulast%3DMay%26aufirst%3DC.%26aulast%3DRodricks%26aufirst%3DA.%2BM.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DHogg%26aufirst%3DD.%26atitle%3DExpression%2520of%2520TTK%252C%2520a%2520novel%2520human%2520protein%2520kinase%252C%2520is%2520associated%2520with%2520cell%2520proliferation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D16000%26epage%3D16006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lauze, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoelcker, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luca, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutz, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winey, M.</span></span> <span> </span><span class="NLM_article-title">Yeast spindle pole body duplication gene MPS1 encodes an essential dual specificity protein kinase</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1655</span>– <span class="NLM_lpage">1663</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=1655-1663&author=E.+Lauzeauthor=B.+Stoelckerauthor=F.+C.+Lucaauthor=E.+Weissauthor=A.+R.+Schutzauthor=M.+Winey&title=Yeast+spindle+pole+body+duplication+gene+MPS1+encodes+an+essential+dual+specificity+protein+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLauze%26aufirst%3DE.%26aulast%3DStoelcker%26aufirst%3DB.%26aulast%3DLuca%26aufirst%3DF.%2BC.%26aulast%3DWeiss%26aufirst%3DE.%26aulast%3DSchutz%26aufirst%3DA.%2BR.%26aulast%3DWiney%26aufirst%3DM.%26atitle%3DYeast%2520spindle%2520pole%2520body%2520duplication%2520gene%2520MPS1%2520encodes%2520an%2520essential%2520dual%2520specificity%2520protein%2520kinase%26jtitle%3DEMBO%2520J.%26date%3D1995%26volume%3D14%26spage%3D1655%26epage%3D1663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Musacchio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmon, E. D.</span></span> <span> </span><span class="NLM_article-title">The spindle-assembly checkpoint in space and time</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">393</span>, <span class="refDoi"> DOI: 10.1038/nrm2163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1038%2Fnrm2163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=17426725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFSjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=379-393&author=A.+Musacchioauthor=E.+D.+Salmon&title=The+spindle-assembly+checkpoint+in+space+and+time&doi=10.1038%2Fnrm2163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The spindle-assembly checkpoint in space and time</span></div><div class="casAuthors">Musacchio, Andrea; Salmon, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">379-393</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In eukaryotes, the spindle-assembly checkpoint (SAC) is a ubiquitous safety device that ensures the fidelity of chromosome segregation in mitosis.  The SAC prevents chromosome missegregation and aneuploidy, and its dysfunction is implicated in tumorigenesis.  Recent mol. analyses have begun to shed light on the complex interaction of the checkpoint proteins with kinetochores - structures that mediate the binding of spindle microtubules to chromosomes in mitosis.  These studies are finally starting to reveal the mechanisms of checkpoint activation and silencing during mitotic progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBFNiU9YS2zbVg90H21EOLACvtfcHk0ljcp1canCW8kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFSjsr0%253D&md5=b790220dccee5f0ad57f41aef0a3be32</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrm2163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2163%26sid%3Dliteratum%253Aachs%26aulast%3DMusacchio%26aufirst%3DA.%26aulast%3DSalmon%26aufirst%3DE.%2BD.%26atitle%3DThe%2520spindle-assembly%2520checkpoint%2520in%2520space%2520and%2520time%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D379%26epage%3D393%26doi%3D10.1038%2Fnrm2163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daniel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coulter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilsbach, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabrielson, E.</span></span> <span> </span><span class="NLM_article-title">High levels of the MPS1 checkpoint protein are protective of aneuploidy in breast cancer cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">5384</span>– <span class="NLM_lpage">5389</span>, <span class="refDoi"> DOI: 10.1073/pnas.1007645108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1073%2Fpnas.1007645108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=5384-5389&author=J.+Danielauthor=J.+Coulterauthor=J.-H.+Wooauthor=K.+Wilsbachauthor=E.+Gabrielson&title=High+levels+of+the+MPS1+checkpoint+protein+are+protective+of+aneuploidy+in+breast+cancer+cells&doi=10.1073%2Fpnas.1007645108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1007645108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1007645108%26sid%3Dliteratum%253Aachs%26aulast%3DDaniel%26aufirst%3DJ.%26aulast%3DCoulter%26aufirst%3DJ.%26aulast%3DWoo%26aufirst%3DJ.-H.%26aulast%3DWilsbach%26aufirst%3DK.%26aulast%3DGabrielson%26aufirst%3DE.%26atitle%3DHigh%2520levels%2520of%2520the%2520MPS1%2520checkpoint%2520protein%2520are%2520protective%2520of%2520aneuploidy%2520in%2520breast%2520cancer%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D5384%26epage%3D5389%26doi%3D10.1073%2Fpnas.1007645108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brough, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankum, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sims, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendes-Pereira, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajrami, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa-Cabral, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rafiq, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerone, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natrajan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiu, K.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetterskog, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dedes, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambros, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawjee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linardopoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis-Filho, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashworth, A.</span></span> <span> </span><span class="NLM_article-title">Functional viability profiles of breast cancer</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">260</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-11-0107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1158%2F2159-8290.CD-11-0107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=260-273&author=R.+Broughauthor=J.+R.+Frankumauthor=D.+Simsauthor=A.+Mackayauthor=A.+M.+Mendes-Pereiraauthor=I.+Bajramiauthor=S.+Costa-Cabralauthor=R.+Rafiqauthor=A.+S.+Ahmadauthor=M.+A.+Ceroneauthor=R.+Natrajanauthor=R.+Sharpeauthor=K.-K.+Shiuauthor=D.+Wetterskogauthor=K.+J.+Dedesauthor=M.+B.+Lambrosauthor=T.+Rawjeeauthor=S.+Linardopoulosauthor=J.+S.+Reis-Filhoauthor=N.+C.+Turnerauthor=C.+J.+Lordauthor=A.+Ashworth&title=Functional+viability+profiles+of+breast+cancer&doi=10.1158%2F2159-8290.CD-11-0107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-11-0107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-11-0107%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DR.%26aulast%3DFrankum%26aufirst%3DJ.%2BR.%26aulast%3DSims%26aufirst%3DD.%26aulast%3DMackay%26aufirst%3DA.%26aulast%3DMendes-Pereira%26aufirst%3DA.%2BM.%26aulast%3DBajrami%26aufirst%3DI.%26aulast%3DCosta-Cabral%26aufirst%3DS.%26aulast%3DRafiq%26aufirst%3DR.%26aulast%3DAhmad%26aufirst%3DA.%2BS.%26aulast%3DCerone%26aufirst%3DM.%2BA.%26aulast%3DNatrajan%26aufirst%3DR.%26aulast%3DSharpe%26aufirst%3DR.%26aulast%3DShiu%26aufirst%3DK.-K.%26aulast%3DWetterskog%26aufirst%3DD.%26aulast%3DDedes%26aufirst%3DK.%2BJ.%26aulast%3DLambros%26aufirst%3DM.%2BB.%26aulast%3DRawjee%26aufirst%3DT.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3DReis-Filho%26aufirst%3DJ.%2BS.%26aulast%3DTurner%26aufirst%3DN.%2BC.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DFunctional%2520viability%2520profiles%2520of%2520breast%2520cancer%26jtitle%3DCancer%2520Discovery%26date%3D2011%26volume%3D1%26spage%3D260%26epage%3D273%26doi%3D10.1158%2F2159-8290.CD-11-0107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Resio, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellman, D.</span></span> <span> </span><span class="NLM_article-title">Causes and consequences of aneuploidy in cancer</span>. <i>Nat. Rev. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1038/nrg3123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1038%2Fnrg3123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=22269907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFSnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=189-203&author=D.+J.+Gordonauthor=B.+Resioauthor=D.+Pellman&title=Causes+and+consequences+of+aneuploidy+in+cancer&doi=10.1038%2Fnrg3123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Causes and consequences of aneuploidy in cancer</span></div><div class="casAuthors">Gordon, David J.; Resio, Benjamin; Pellman, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">189-203</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Genetic instability, which includes both numerical and structural chromosomal abnormalities, is a hallmark of cancer.  Whereas the structural chromosome rearrangements have received substantial attention, the role of whole-chromosome aneuploidy in cancer is much less well-understood.  Here we review recent progress in understanding the roles of whole-chromosome aneuploidy in cancer, including the mechanistic causes of aneuploidy, the cellular responses to chromosome gains or losses and how cells might adapt to tolerate these usually detrimental alterations.  We also explore the role of aneuploidy in cellular transformation and discuss the possibility of developing aneuploidy-specific therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz4uwB4F0Xu7Vg90H21EOLACvtfcHk0lj4B0_tjsLqRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFSnu7k%253D&md5=9c730e7390d7aafd54301777e2270721</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrg3123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg3123%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DD.%2BJ.%26aulast%3DResio%26aufirst%3DB.%26aulast%3DPellman%26aufirst%3DD.%26atitle%3DCauses%2520and%2520consequences%2520of%2520aneuploidy%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2012%26volume%3D13%26spage%3D189%26epage%3D203%26doi%3D10.1038%2Fnrg3123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lengauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzler, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span> <span> </span><span class="NLM_article-title">Genetic instabilities in human cancers</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>396</i></span>,  <span class="NLM_fpage">643</span>– <span class="NLM_lpage">649</span>, <span class="refDoi"> DOI: 10.1038/25292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1038%2F25292" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=396&publication_year=1998&pages=643-649&author=C.+Lengauerauthor=K.+W.+Kinzlerauthor=B.+Vogelstein&title=Genetic+instabilities+in+human+cancers&doi=10.1038%2F25292"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F25292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F25292%26sid%3Dliteratum%253Aachs%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26atitle%3DGenetic%2520instabilities%2520in%2520human%2520cancers%26jtitle%3DNature%26date%3D1998%26volume%3D396%26spage%3D643%26epage%3D649%26doi%3D10.1038%2F25292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carter, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eklund, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohane, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szallasi, Z.</span></span> <span> </span><span class="NLM_article-title">A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1043</span>– <span class="NLM_lpage">1048</span>, <span class="refDoi"> DOI: 10.1038/ng1861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1038%2Fng1861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=16921376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BD28XovVWjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2006&pages=1043-1048&author=S.+L.+Carterauthor=A.+C.+Eklundauthor=I.+S.+Kohaneauthor=L.+N.+Harrisauthor=Z.+Szallasi&title=A+signature+of+chromosomal+instability+inferred+from+gene+expression+profiles+predicts+clinical+outcome+in+multiple+human+cancers&doi=10.1038%2Fng1861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers</span></div><div class="casAuthors">Carter, Scott L.; Eklund, Aron C.; Kohane, Isaac S.; Harris, Lyndsay N.; Szallasi, Zoltan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1043-1048</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We developed a computational method to characterize aneuploidy in tumor samples based on coordinated aberrations in expression of genes localized to each chromosomal region.  We summarized the total level of chromosomal aberration in a given tumor in a univariate measure termed total functional aneuploidy.  We identified a signature of chromosomal instability from specific genes whose expression was consistently correlated with total functional aneuploidy in several cancer types.  Net overexpression of this signature was predictive of poor clin. outcome in 12 cancer data sets representing six cancer types.  Also, the signature of chromosomal instability was higher in metastasis samples than in primary tumors and was able to stratify grade 1 and grade 2 breast tumors according to clin. outcome.  These results provide a means to assess the potential role of chromosomal instability in detg. malignant potential over a broad range of tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaDdEb7DAh87Vg90H21EOLACvtfcHk0lj4B0_tjsLqRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovVWjtr0%253D&md5=8d236ca65fd69447f0ed3bf0ac28eba8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fng1861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1861%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DS.%2BL.%26aulast%3DEklund%26aufirst%3DA.%2BC.%26aulast%3DKohane%26aufirst%3DI.%2BS.%26aulast%3DHarris%26aufirst%3DL.%2BN.%26aulast%3DSzallasi%26aufirst%3DZ.%26atitle%3DA%2520signature%2520of%2520chromosomal%2520instability%2520inferred%2520from%2520gene%2520expression%2520profiles%2520predicts%2520clinical%2520outcome%2520in%2520multiple%2520human%2520cancers%26jtitle%3DNat.%2520Genet.%26date%3D2006%26volume%3D38%26spage%3D1043%26epage%3D1048%26doi%3D10.1038%2Fng1861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, D.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wersto, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilsbach, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabrielson, E.</span></span> <span> </span><span class="NLM_article-title">Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-05-0903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1158%2F1078-0432.CCR-05-0903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=16428479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtlKjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=405-410&author=B.+Yuanauthor=Y.+Xuauthor=J.-H.+Wooauthor=Y.+Wangauthor=Y.+K.+Baeauthor=D.-S.+Yoonauthor=R.+P.+Werstoauthor=E.+Tullyauthor=K.+Wilsbachauthor=E.+Gabrielson&title=Increased+expression+of+mitotic+checkpoint+genes+in+breast+cancer+cells+with+chromosomal+instability&doi=10.1158%2F1078-0432.CCR-05-0903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Increased Expression of Mitotic Checkpoint Genes in Breast Cancer Cells with Chromosomal Instability</span></div><div class="casAuthors">Yuan, Bibo; Xu, Yi; Woo, Ju-Hyung; Wang, Yunyue; Bae, Young Kyung; Yoon, Dae-Sung; Wersto, Robert P.; Tully, Ellen; Wilsbach, Kathleen; Gabrielson, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">405-410</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Most breast cancers have chromosomal instability that seems related to defective mitotic spindle checkpoints.  Because the mol. basis of this defect is unknown, we evaluated breast cancer cell lines and tissues for possible defects involving the major mitotic checkpoint genes responsible for maintaining chromosomal stability.  Exptl. Design: We analyzed sequences and expression levels (RNA and protein) of eight major spindle checkpoint genes (MAD1L1, MAD2L1, MAD2L2, BUB1, BUB1B, BUB3, CDC20, and TTK) in a panel of 12 breast cancer cell lines, most with established genetic instability and defective spindle damage checkpoint response.  MRNA levels of these genes were also measured in primary tumor samples, and immunohistochem. staining was used to evaluate BUB1B protein levels in a panel of 270 addnl. cases of breast cancer.  Results: No functionally significant sequence variations were found for any of the eight genes in the breast cancer cell lines with chromosomal instability.  More surprisingly, the mRNA and protein levels for these checkpoint genes are significantly higher in the genetically unstable breast cancer cell lines and in high-grade primary breast cancer tissues than in the stable (and checkpoint proficient) MCF-10A and normal mammary epithelial cells, or in normal breast tissues.  In fact, overexpression of the BUB1B protein is a marker that recognizes nearly 80% of breast cancers in paraffin-embedded tissues.  Conclusions: Defective mitotic spindle checkpoints in breast cancer are most likely not caused by low expression or mutations of these eight checkpoint genes.  High levels of these particular transcripts could represent a cellular compensation for defects in other mol. components of the mitotic spindle damage checkpoint, and increased expression of these genes might be markers of breast cancers with chromosomal instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYcNtMRC1xcrVg90H21EOLACvtfcHk0ljqFyG-yoC4TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtlKjtw%253D%253D&md5=06a8afcd6636218ae3a7bf38fe9939b4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-0903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-0903%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DWoo%26aufirst%3DJ.-H.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBae%26aufirst%3DY.%2BK.%26aulast%3DYoon%26aufirst%3DD.-S.%26aulast%3DWersto%26aufirst%3DR.%2BP.%26aulast%3DTully%26aufirst%3DE.%26aulast%3DWilsbach%26aufirst%3DK.%26aulast%3DGabrielson%26aufirst%3DE.%26atitle%3DIncreased%2520expression%2520of%2520mitotic%2520checkpoint%2520genes%2520in%2520breast%2520cancer%2520cells%2520with%2520chromosomal%2520instability%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D405%26epage%3D410%26doi%3D10.1158%2F1078-0432.CCR-05-0903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mizukami, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kono, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daigo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsunoda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, H.</span></span> <span> </span><span class="NLM_article-title">Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">1448</span>– <span class="NLM_lpage">1454</span>, <span class="refDoi"> DOI: 10.1111/j.1349-7006.2008.00844.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1111%2Fj.1349-7006.2008.00844.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=18452554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1eitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=1448-1454&author=Y.+Mizukamiauthor=K.+Konoauthor=Y.+Daigoauthor=A.+Takanoauthor=T.+Tsunodaauthor=Y.+Kawaguchiauthor=Y.+Nakamuraauthor=H.+Fujii&title=Detection+of+novel+cancer-testis+antigen-specific+T-cell+responses+in+TIL%2C+regional+lymph+nodes%2C+and+PBL+in+patients+with+esophageal+squamous+cell+carcinoma&doi=10.1111%2Fj.1349-7006.2008.00844.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma</span></div><div class="casAuthors">Mizukami, Yoshiki; Kono, Koji; Daigo, Yataro; Takano, Atsushi; Tsunoda, Takuya; Kawaguchi, Yoshihiko; Nakamura, Yusuke; Fujii, Hideki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1448-1454</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">The authors recently identified three HLA-A2402-restricted epitope peptides derived from cancer-testis antigens (CTA), TTK protein kinase (TTK), lymphocyte antigen 6 complex locus K (LY6K), and insulin-like growth factor (IGF)-II mRNA binding protein 3 (IMP-3) for the development of immunotherapies against esophageal squamous cell carcinoma (ESCC).  To evaluate their immunotherapeutic potential in ESCC patients, the authors estd. by ELISPOT assay the TTK-, LY6K-, or IMP-3-specific T-cell immune responses in tumor-infiltrating lymphocytes (TIL), regional lymph node lymphocytes (RLNL), and peripheral blood lymphocytes (PBL) expanded from 20HLA-A2402 (+) ESCC patients, and correlated their immune activity with the expression levels of TTK, LY6K, and IMP-3, and MHC class I in the tumors.  Induction of TTK-antigen specific T-cell response in TIL to the peptide-pulsed target cells was detected in 14 out of 20 (70%) cases, while LY6K or IMP-3 specific T-cell activity was obsd. in 11 of 20 (55%) or in eight of 20 (40%) cases, resp.  Furthermore, T-cell activity in RLNL and PBL was detectable in the similar proportion of the 20 ESCC patients.  Interestingly, CTA-specific T-cell immune response was found in 13 of 14 (93%) TIL obtained from ESCC tumors with strong MHC class I expression, while it could be obsd. only in two of six (33%) TIL from ESCC tumors with weak MHC class I expression.  These results strongly suggest the pre-existence of specific T-cell responses to HLA-A24-restricted epitope peptides from TTK, LY6K, and IMP-3 in ESCC patients.  Monitoring antigen-specific T-cell responses, as well as the expression levels of MHC class I and epitope CTA in tumors, should be a selection index for application of cancer vaccine therapies to the patients who are likely to show good immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru8reosidZGbVg90H21EOLACvtfcHk0ljqFyG-yoC4TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1eitLo%253D&md5=dcb4be9405b2f37475bcd8785b27722a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2008.00844.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2008.00844.x%26sid%3Dliteratum%253Aachs%26aulast%3DMizukami%26aufirst%3DY.%26aulast%3DKono%26aufirst%3DK.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DTsunoda%26aufirst%3DT.%26aulast%3DKawaguchi%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DFujii%26aufirst%3DH.%26atitle%3DDetection%2520of%2520novel%2520cancer-testis%2520antigen-specific%2520T-cell%2520responses%2520in%2520TIL%252C%2520regional%2520lymph%2520nodes%252C%2520and%2520PBL%2520in%2520patients%2520with%2520esophageal%2520squamous%2520cell%2520carcinoma%26jtitle%3DCancer%2520Sci.%26date%3D2008%26volume%3D99%26spage%3D1448%26epage%3D1454%26doi%3D10.1111%2Fj.1349-7006.2008.00844.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salvatore, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nappi, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salerno, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugolini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miccoli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basolo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castellone, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirafici, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melillo, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fusco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittner, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoro, M.</span></span> <span> </span><span class="NLM_article-title">A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">10148</span>– <span class="NLM_lpage">10158</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-1887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1158%2F0008-5472.CAN-07-1887" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=10148-10158&author=G.+Salvatoreauthor=T.+C.+Nappiauthor=P.+Salernoauthor=Y.+Jiangauthor=C.+Garbiauthor=C.+Ugoliniauthor=P.+Miccoliauthor=F.+Basoloauthor=M.+D.+Castelloneauthor=A.+M.+Ciraficiauthor=R.+M.+Melilloauthor=A.+Fuscoauthor=M.+L.+Bittnerauthor=M.+Santoro&title=A+cell+proliferation+and+chromosomal+instability+signature+in+anaplastic+thyroid+carcinoma&doi=10.1158%2F0008-5472.CAN-07-1887"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-1887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-1887%26sid%3Dliteratum%253Aachs%26aulast%3DSalvatore%26aufirst%3DG.%26aulast%3DNappi%26aufirst%3DT.%2BC.%26aulast%3DSalerno%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DGarbi%26aufirst%3DC.%26aulast%3DUgolini%26aufirst%3DC.%26aulast%3DMiccoli%26aufirst%3DP.%26aulast%3DBasolo%26aufirst%3DF.%26aulast%3DCastellone%26aufirst%3DM.%2BD.%26aulast%3DCirafici%26aufirst%3DA.%2BM.%26aulast%3DMelillo%26aufirst%3DR.%2BM.%26aulast%3DFusco%26aufirst%3DA.%26aulast%3DBittner%26aufirst%3DM.%2BL.%26aulast%3DSantoro%26aufirst%3DM.%26atitle%3DA%2520cell%2520proliferation%2520and%2520chromosomal%2520instability%2520signature%2520in%2520anaplastic%2520thyroid%2520carcinoma%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D10148%26epage%3D10158%26doi%3D10.1158%2F0008-5472.CAN-07-1887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thykjaer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruhøffer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demtröder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederiksen, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knudsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ørntoft, T. F.</span></span> <span> </span><span class="NLM_article-title">Identification of gene expression patterns in superficial and invasive human bladder cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2492</span>– <span class="NLM_lpage">2499</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=2492-2499&author=T.+Thykjaerauthor=C.+Workmanauthor=M.+Kruh%C3%B8fferauthor=K.+Demtr%C3%B6derauthor=H.+Wolfauthor=L.+D.+Andersenauthor=C.+M.+Frederiksenauthor=S.+Knudsenauthor=T.+F.+%C3%98rntoft&title=Identification+of+gene+expression+patterns+in+superficial+and+invasive+human+bladder+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThykjaer%26aufirst%3DT.%26aulast%3DWorkman%26aufirst%3DC.%26aulast%3DKruh%25C3%25B8ffer%26aufirst%3DM.%26aulast%3DDemtr%25C3%25B6der%26aufirst%3DK.%26aulast%3DWolf%26aufirst%3DH.%26aulast%3DAndersen%26aufirst%3DL.%2BD.%26aulast%3DFrederiksen%26aufirst%3DC.%2BM.%26aulast%3DKnudsen%26aufirst%3DS.%26aulast%3D%25C3%2598rntoft%26aufirst%3DT.%2BF.%26atitle%3DIdentification%2520of%2520gene%2520expression%2520patterns%2520in%2520superficial%2520and%2520invasive%2520human%2520bladder%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D2492%26epage%3D2499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wengner, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemeister, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koppitz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosemund, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoeckigt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lienau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prechtl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raschke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisk, A.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Ahsen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michels, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreft, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Nussbaum, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brands, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mumberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegelbauer, K.</span></span> <span> </span><span class="NLM_article-title">Novel MPS1 kinase inhibitors with potent antitumor activity</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">583</span>– <span class="NLM_lpage">592</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-15-0500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1158%2F1535-7163.MCT-15-0500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=26832791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsVSqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=583-592&author=A.+M.+Wengnerauthor=G.+Siemeisterauthor=M.+Koppitzauthor=V.+Schulzeauthor=D.+Kosemundauthor=U.+Klarauthor=D.+Stoeckigtauthor=R.+Neuhausauthor=P.+Lienauauthor=B.+Baderauthor=S.+Prechtlauthor=M.+Raschkeauthor=A.-L.+Friskauthor=O.+von+Ahsenauthor=M.+Michelsauthor=B.+Kreftauthor=F.+von+Nussbaumauthor=M.+Brandsauthor=D.+Mumbergauthor=K.+Ziegelbauer&title=Novel+MPS1+kinase+inhibitors+with+potent+antitumor+activity&doi=10.1158%2F1535-7163.MCT-15-0500"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity</span></div><div class="casAuthors">Wengner, Antje M.; Siemeister, Gerhard; Koppitz, Marcus; Schulze, Volker; Kosemund, Dirk; Klar, Ulrich; Stoeckigt, Detlef; Neuhaus, Roland; Lienau, Philip; Bader, Benjamin; Prechtl, Stefan; Raschke, Marian; Frisk, Anna-Lena; von Ahsen, Oliver; Michels, Martin; Kreft, Bertolt; von Nussbaum, Franz; Brands, Michael; Mumberg, Dominik; Ziegelbauer, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">583-592</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Monopolar spindle 1 (Mps1) has been shown to function as the key kinase that activates the spindle assembly checkpoint (SAC) to secure proper distribution of chromosomes to daughter cells.  Here, we report the structure and functional characterization of two novel selective Mps1 inhibitors, BAY 1161909 and BAY 1217389, derived from structurally distinct chem. classes.  BAY 1161909 and BAY 1217389 inhibited Mps1 kinase activity with IC50 values below 10 nmol/L while showing an excellent selectivity profile.  In cellular mechanistic assays, both Mps1 inhibitors abrogated nocodazole-induced SAC activity and induced premature exit from mitosis ("mitotic breakthrough"), resulting in multinuclearity and tumor cell death.  Both compds. efficiently inhibited tumor cell proliferation in vitro (IC50 nmol/L range).  In vivo, BAY 1161909 and BAY 1217389 achieved moderate efficacy in monotherapy in tumor xenograft studies.  However, in line with its unique mode of action, when combined with paclitaxel, low doses of Mps1 inhibitor reduced paclitaxel-induced mitotic arrest by the weakening of SAC activity.  As a result, combination therapy strongly improved efficacy over paclitaxel or Mps1 inhibitor monotreatment at the resp. MTDs in a broad range of xenograft models, including those showing acquired or intrinsic paclitaxel resistance.  Both Mps1 inhibitors showed good tolerability without adding toxicity to paclitaxel monotherapy.  These preclin. findings validate the innovative concept of SAC abrogation for cancer therapy and justify clin. proof-of-concept studies evaluating the Mps1 inhibitors BAY 1161909 and BAY 1217389 in combination with antimitotic cancer drugs to enhance their efficacy and potentially overcome resistance.  Mol Cancer Ther; 15(4); 583-92. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGZQmIvWHFcLVg90H21EOLACvtfcHk0li7mZK5lv7i2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsVSqt7g%253D&md5=f2b5cf0daf178088479be4be2aefa6b7</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-15-0500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-15-0500%26sid%3Dliteratum%253Aachs%26aulast%3DWengner%26aufirst%3DA.%2BM.%26aulast%3DSiemeister%26aufirst%3DG.%26aulast%3DKoppitz%26aufirst%3DM.%26aulast%3DSchulze%26aufirst%3DV.%26aulast%3DKosemund%26aufirst%3DD.%26aulast%3DKlar%26aufirst%3DU.%26aulast%3DStoeckigt%26aufirst%3DD.%26aulast%3DNeuhaus%26aufirst%3DR.%26aulast%3DLienau%26aufirst%3DP.%26aulast%3DBader%26aufirst%3DB.%26aulast%3DPrechtl%26aufirst%3DS.%26aulast%3DRaschke%26aufirst%3DM.%26aulast%3DFrisk%26aufirst%3DA.-L.%26aulast%3Dvon%2BAhsen%26aufirst%3DO.%26aulast%3DMichels%26aufirst%3DM.%26aulast%3DKreft%26aufirst%3DB.%26aulast%3Dvon%2BNussbaum%26aufirst%3DF.%26aulast%3DBrands%26aufirst%3DM.%26aulast%3DMumberg%26aufirst%3DD.%26aulast%3DZiegelbauer%26aufirst%3DK.%26atitle%3DNovel%2520MPS1%2520kinase%2520inhibitors%2520with%2520potent%2520antitumor%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2016%26volume%3D15%26spage%3D583%26epage%3D592%26doi%3D10.1158%2F1535-7163.MCT-15-0500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiarash, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brokx, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beletskaya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">Functional characterization of CFI-402257, a potent and selective MPS1/TTK kinase inhibitor, for the treatment of cancer</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">3127</span>– <span class="NLM_lpage">3132</span>, <span class="refDoi"> DOI: 10.1073/pnas.1700234114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1073%2Fpnas.1700234114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=28270606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvVyjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=3127-3132&author=J.+M.+Masonauthor=X.+Weiauthor=G.+C.+Fletcherauthor=R.+Kiarashauthor=R.+Brokxauthor=R.+Hodgsonauthor=I.+Beletskayaauthor=M.+R.+Brayauthor=T.+W.+Mak&title=Functional+characterization+of+CFI-402257%2C+a+potent+and+selective+MPS1%2FTTK+kinase+inhibitor%2C+for+the+treatment+of+cancer&doi=10.1073%2Fpnas.1700234114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer</span></div><div class="casAuthors">Mason, Jacqueline M.; Wei, Xin; Fletcher, Graham C.; Kiarash, Reza; Brokx, Richard; Hodgson, Richard; Beletskaya, Irina; Bray, Mark R.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3127-3132</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Loss of cell-cycle control is a hallmark of human cancer.  Cell-cycle checkpoints are essential for maintaining genome integrity and balanced growth and division.  They are specifically deregulated in cancer cells and contain regulators that represent potential therapeutic targets.  Monopolar spindle 1 (Mps1; also known as TTK protein kinase) is a core component of the spindle assembly checkpoint (SAC), a genome-surveillance mechanism that is important for cell survival, and has emerged as a candidate target for anticancer therapy.  Here, the authors report the cellular and antitumor effects of CFI-402257, a potent (Mps1 Ki = 0.09±0.02 nM; cellular Mps1 EC50 = 6.5±0.5 nM), highly selective, and orally active small-mol. inhibitor of Mps1 that was identified through a drug-discovery program.  Human cancer cells treated with CFI-402257 exhibit effects consistent with Mps1 kinase inhibition, specifically SAC inactivation, leading to chromosome missegregation, aneuploidy, and ultimately cell death.  Oral administration of CFI-402257 in monotherapy or in combination with an anti-programmed cell death 1 (PD-1) antibody in mouse models of human cancer results in inhibition of tumor growth at doses that are well-tolerated.  The authors' findings provide a rationale for the clin. evaluation of CFI-402257 in patients with solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFQJ3eg_c-qLVg90H21EOLACvtfcHk0li7mZK5lv7i2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvVyjsL8%253D&md5=bb9742c8d07314e7d3c322bef71ef0ff</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1700234114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1700234114%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DFletcher%26aufirst%3DG.%2BC.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DBrokx%26aufirst%3DR.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DBray%26aufirst%3DM.%2BR.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DFunctional%2520characterization%2520of%2520CFI-402257%252C%2520a%2520potent%2520and%2520selective%2520MPS1%252FTTK%2520kinase%2520inhibitor%252C%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3D3127%26epage%3D3132%26doi%3D10.1073%2Fpnas.1700234114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faisal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrake, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavetsias, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atrash, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, K.-M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boxall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Haven Brandon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAndrew, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matijssen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linardopoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Montfort, R. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of orally bioavailable 1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine inhibitors of mitotic kinase monopolar spindle 1 (MPS1)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">10045</span>– <span class="NLM_lpage">10065</span>, <span class="refDoi"> DOI: 10.1021/jm401395s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401395s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVShsLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=10045-10065&author=S.+Naudauthor=I.+M.+Westwoodauthor=A.+Faisalauthor=P.+Sheldrakeauthor=V.+Bavetsiasauthor=B.+Atrashauthor=K.-M.+J.+Cheungauthor=M.+Liuauthor=A.+Hayesauthor=J.+Schmittauthor=A.+Woodauthor=V.+Choiauthor=K.+Boxallauthor=G.+Makauthor=M.+Gurdenauthor=M.+Valentiauthor=A.+de+Haven+Brandonauthor=A.+Henleyauthor=R.+Bakerauthor=C.+McAndrewauthor=B.+Matijssenauthor=R.+Burkeauthor=S.+Hoelderauthor=S.+A.+Ecclesauthor=F.+I.+Raynaudauthor=S.+Linardopoulosauthor=R.+L.+M.+van+Montfortauthor=J.+Blagg&title=Structure-based+design+of+orally+bioavailable+1H-pyrrolo%5B3%2C2-c%5Dpyridine+inhibitors+of+mitotic+kinase+monopolar+spindle+1+%28MPS1%29&doi=10.1021%2Fjm401395s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Orally Bioavailable 1H-Pyrrolo[3,2-c]pyridine Inhibitors of Mitotic Kinase Monopolar Spindle 1 (MPS1)</span></div><div class="casAuthors">Naud, Sebastien; Westwood, Isaac M.; Faisal, Amir; Sheldrake, Peter; Bavetsias, Vassilios; Atrash, Butrus; Cheung, Kwai-Ming J.; Liu, Manjuan; Hayes, Angela; Schmitt, Jessica; Wood, Amy; Choi, Vanessa; Boxall, Kathy; Mak, Grace; Gurden, Mark; Valenti, Melanie; de Haven Brandon, Alexis; Henley, Alan; Baker, Ross; McAndrew, Craig; Matijssen, Berry; Burke, Rosemary; Hoelder, Swen; Eccles, Suzanne A.; Raynaud, Florence I.; Linardopoulos, Spiros; van Montfort, Rob L. M.; Blagg, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10045-10065</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The protein kinase MPS1 is a crucial component of the spindle assembly checkpoint signal and is aberrantly overexpressed in many human cancers.  MPS1 is one of the top 25 genes overexpressed in tumors with chromosomal instability and aneuploidy.  PTEN-deficient breast tumor cells are particularly dependent upon MPS1 for their survival, making it a target of significant interest in oncol.  The authors report the discovery and optimization of potent and selective MPS1 inhibitors based on the 1H-pyrrolo-[3,2-c]-pyridine scaffold, guided by structure-based design and cellular characterization of MPS1 inhibition, leading to CCT251455.  This potent and selective chem. tool stabilizes an inactive conformation of MPS1 with the activation loop ordered in a manner incompatible with ATP and substrate-peptide binding; it displays a favorable oral pharmacokinetic profile, shows dose-dependent inhibition of MPS1 in an HCT116 human tumor xenograft model, and is an attractive tool compd. to elucidate further the therapeutic potential of MPS1 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVRsRcyzCEBLVg90H21EOLACvtfcHk0lirkmRgxicM4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVShsLzO&md5=6564efe14dec83774e94c355be756845</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm401395s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401395s%26sid%3Dliteratum%253Aachs%26aulast%3DNaud%26aufirst%3DS.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DFaisal%26aufirst%3DA.%26aulast%3DSheldrake%26aufirst%3DP.%26aulast%3DBavetsias%26aufirst%3DV.%26aulast%3DAtrash%26aufirst%3DB.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DChoi%26aufirst%3DV.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DMak%26aufirst%3DG.%26aulast%3DGurden%26aufirst%3DM.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3Dde%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DHenley%26aufirst%3DA.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DMcAndrew%26aufirst%3DC.%26aulast%3DMatijssen%26aufirst%3DB.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DHoelder%26aufirst%3DS.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3DStructure-based%2520design%2520of%2520orally%2520bioavailable%25201H-pyrrolo%255B3%252C2-c%255Dpyridine%2520inhibitors%2520of%2520mitotic%2520kinase%2520monopolar%2520spindle%25201%2520%2528MPS1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D10045%26epage%3D10065%26doi%3D10.1021%2Fjm401395s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Innocenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solanki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henley, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faisal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, G. W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Haven Brandon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Fee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saville, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matijssen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Montfort, R. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linardopoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span> <span> </span><span class="NLM_article-title">Rapid discovery of pyrido[3,4-<i>d</i>]pyrimidine inhibitors of monopolar spindle kinase 1 (MPS1) using a structure-based hybridization approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3671</span>– <span class="NLM_lpage">3688</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01811</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01811" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsF2qsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3671-3688&author=P.+Innocentiauthor=H.+L.+Woodwardauthor=S.+Solankiauthor=S.+Naudauthor=I.+M.+Westwoodauthor=N.+Croninauthor=A.+Hayesauthor=J.+Robertsauthor=A.+T.+Henleyauthor=R.+Bakerauthor=A.+Faisalauthor=G.+W.-Y.+Makauthor=G.+Boxauthor=M.+Valentiauthor=A.+De+Haven+Brandonauthor=L.+O%E2%80%99Feeauthor=H.+Savilleauthor=J.+Schmittauthor=B.+Matijssenauthor=R.+Burkeauthor=R.+L.+M.+van+Montfortauthor=F.+I.+Raynaudauthor=S.+A.+Ecclesauthor=S.+Linardopoulosauthor=J.+Blaggauthor=S.+Hoelder&title=Rapid+discovery+of+pyrido%5B3%2C4-d%5Dpyrimidine+inhibitors+of+monopolar+spindle+kinase+1+%28MPS1%29+using+a+structure-based+hybridization+approach&doi=10.1021%2Facs.jmedchem.5b01811"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle Kinase 1 (MPS1) Using a Structure-Based Hybridization Approach</span></div><div class="casAuthors">Innocenti, Paolo; Woodward, Hannah L.; Solanki, Savade; Naud, Sebastien; Westwood, Isaac M.; Cronin, Nora; Hayes, Angela; Roberts, Jennie; Henley, Alan T.; Baker, Ross; Faisal, Amir; Mak, Grace Wing-Yan; Box, Gary; Valenti, Melanie; De Haven Brandon, Alexis; O'Fee, Lisa; Saville, Harry; Schmitt, Jessica; Matijssen, Berry; Burke, Rosemary; van Montfort, Rob L. M.; Raynaud, Florence I.; Eccles, Suzanne A.; Linardopoulos, Spiros; Blagg, Julian; Hoelder, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3671-3688</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monopolar spindle 1 (MPS1) plays a central role in the transition of cells from metaphase to anaphase and is one of the main components of the spindle assembly checkpoint.  Chromosomally unstable cancer cells rely heavily on MPS1 to cope with the stress arising from abnormal nos. of chromosomes and centrosomes and are thus more sensitive to MPS1 inhibition than normal cells.  We report the discovery and optimization of a series of new pyrido[3,4-d]pyrimidine based inhibitors via a structure-based hybridization approach from our previously reported inhibitor CCT251455 and a modestly potent screening hit.  Compds. in this novel series display excellent potency and selectivity for MPS1, which translates into biomarker modulation in an in vivo human tumor xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr42v6loNvM1bVg90H21EOLACvtfcHk0lirkmRgxicM4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsF2qsro%253D&md5=dd858ed11744e0b036061baf5e2c181a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01811%26sid%3Dliteratum%253Aachs%26aulast%3DInnocenti%26aufirst%3DP.%26aulast%3DWoodward%26aufirst%3DH.%2BL.%26aulast%3DSolanki%26aufirst%3DS.%26aulast%3DNaud%26aufirst%3DS.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DCronin%26aufirst%3DN.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DHenley%26aufirst%3DA.%2BT.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DFaisal%26aufirst%3DA.%26aulast%3DMak%26aufirst%3DG.%2BW.-Y.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DDe%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Fee%26aufirst%3DL.%26aulast%3DSaville%26aufirst%3DH.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DMatijssen%26aufirst%3DB.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DRapid%2520discovery%2520of%2520pyrido%255B3%252C4-d%255Dpyrimidine%2520inhibitors%2520of%2520monopolar%2520spindle%2520kinase%25201%2520%2528MPS1%2529%2520using%2520a%2520structure-based%2520hybridization%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3671%26epage%3D3688%26doi%3D10.1021%2Facs.jmedchem.5b01811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tardif, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassiano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimbora, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douce, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorweiler, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostanin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papac, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baichwal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAlexander, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willardsen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettstein, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, B. L.</span></span> <span> </span><span class="NLM_article-title">Characterization of the cellular and antitumor effects of MPI-0479605, a small-molecule inhibitor of the mitotic kinase MPS1</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2267</span>– <span class="NLM_lpage">2275</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-11-0453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1158%2F1535-7163.MCT-11-0453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=21980130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylurnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=2267-2275&author=K.+D.+Tardifauthor=A.+Rogersauthor=J.+Cassianoauthor=B.+L.+Rothauthor=D.+M.+Cimboraauthor=R.+McKinnonauthor=A.+Petersonauthor=T.+B.+Douceauthor=R.+Robinsonauthor=I.+Dorweilerauthor=T.+Davisauthor=M.+A.+Hessauthor=K.+Ostaninauthor=D.+I.+Papacauthor=V.+Baichwalauthor=I.+McAlexanderauthor=J.+A.+Willardsenauthor=M.+Saundersauthor=H.+Christopheauthor=D.+V.+Kumarauthor=D.+A.+Wettsteinauthor=R.+O.+Carlsonauthor=B.+L.+Williams&title=Characterization+of+the+cellular+and+antitumor+effects+of+MPI-0479605%2C+a+small-molecule+inhibitor+of+the+mitotic+kinase+MPS1&doi=10.1158%2F1535-7163.MCT-11-0453"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the Cellular and Antitumor Effects of MPI-0479605, a Small-Molecule Inhibitor of the Mitotic Kinase Mps1</span></div><div class="casAuthors">Tardif, Keith D.; Rogers, Aaron; Cassiano, Jared; Roth, Bruce L.; Cimbora, Daniel M.; McKinnon, Rena; Peterson, Ashley; Douce, Thomas B.; Robinson, Rosann; Dorweiler, Irene; Davis, Thaylon; Hess, Mark A.; Ostanin, Kirill; Papac, Damon I.; Baichwal, Vijay; McAlexander, Ian; Willardsen, J. Adam; Saunders, Michael; Christophe, Hoarau; Kumar, D. Vijay; Wettstein, Daniel A.; Carlson, Robert O.; Williams, Brandi L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2267-2275</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Mps1 is a dual specificity protein kinase that is essential for the bipolar attachment of chromosomes to the mitotic spindle and for maintaining the spindle assembly checkpoint until all chromosomes are properly attached.  Mps1 is expressed at high levels during mitosis and is abundantly expressed in cancer cells.  Disruption of Mps1 function induces aneuploidy and cell death.  We report the identification of MPI-0479605, a potent and selective ATP competitive inhibitor of Mps1.  Cells treated with MPI-0479605 undergo aberrant mitosis, resulting in aneuploidy and formation of micronuclei.  In cells with wild-type p53, this promotes the induction of a postmitotic checkpoint characterized by the ATM- and RAD3-related-dependent activation of the p53-p21 pathway.  In both wild-type and p53 mutant cells lines, there is a growth arrest and inhibition of DNA synthesis.  Subsequently, cells undergo mitotic catastrophe and/or an apoptotic response.  In xenograft models, MPI-0479605 inhibits tumor growth, suggesting that drugs targeting Mps1 may have utility as novel cancer therapeutics.  Mol Cancer Ther; 10(12); 2267-75.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMIODujnZWCLVg90H21EOLACvtfcHk0liY0BGUHiDENw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylurnO&md5=e243764443e9dfda40fc84a329d776c2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0453%26sid%3Dliteratum%253Aachs%26aulast%3DTardif%26aufirst%3DK.%2BD.%26aulast%3DRogers%26aufirst%3DA.%26aulast%3DCassiano%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCimbora%26aufirst%3DD.%2BM.%26aulast%3DMcKinnon%26aufirst%3DR.%26aulast%3DPeterson%26aufirst%3DA.%26aulast%3DDouce%26aufirst%3DT.%2BB.%26aulast%3DRobinson%26aufirst%3DR.%26aulast%3DDorweiler%26aufirst%3DI.%26aulast%3DDavis%26aufirst%3DT.%26aulast%3DHess%26aufirst%3DM.%2BA.%26aulast%3DOstanin%26aufirst%3DK.%26aulast%3DPapac%26aufirst%3DD.%2BI.%26aulast%3DBaichwal%26aufirst%3DV.%26aulast%3DMcAlexander%26aufirst%3DI.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26aulast%3DSaunders%26aufirst%3DM.%26aulast%3DChristophe%26aufirst%3DH.%26aulast%3DKumar%26aufirst%3DD.%2BV.%26aulast%3DWettstein%26aufirst%3DD.%2BA.%26aulast%3DCarlson%26aufirst%3DR.%2BO.%26aulast%3DWilliams%26aufirst%3DB.%2BL.%26atitle%3DCharacterization%2520of%2520the%2520cellular%2520and%2520antitumor%2520effects%2520of%2520MPI-0479605%252C%2520a%2520small-molecule%2520inhibitor%2520of%2520the%2520mitotic%2520kinase%2520MPS1%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D2267%26epage%3D2275%26doi%3D10.1158%2F1535-7163.MCT-11-0453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tannous, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Stoop, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowski, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewandrowski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiddingh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sol, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagerweij, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wedekind, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niers, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barazas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, R. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geerts, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Witt Hamer, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagemann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandertop, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Tellingen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noske, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Würdinger, T.</span></span> <span> </span><span class="NLM_article-title">Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs</span>. <i>J. Natl. Canc. Inst.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">1322</span>– <span class="NLM_lpage">1331</span>, <span class="refDoi"> DOI: 10.1093/jnci/djt168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1093%2Fjnci%2Fdjt168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=23940287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVKgu7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2013&pages=1322-1331&author=B.+A.+Tannousauthor=M.+Keramiauthor=P.+M.+Van+der+Stoopauthor=N.+Kwiatkowskiauthor=J.+Wangauthor=W.+Zhouauthor=A.+F.+Kesslerauthor=G.+Lewandrowskiauthor=L.+Hiddinghauthor=N.+Solauthor=T.+Lagerweijauthor=L.+Wedekindauthor=J.+M.+Niersauthor=M.+Barazasauthor=R.+J.+A.+Nilssonauthor=D.+Geertsauthor=P.+C.+De+Witt+Hamerauthor=C.+Hagemannauthor=W.+P.+Vandertopauthor=O.+Van+Tellingenauthor=D.+P.+Noskeauthor=N.+S.+Grayauthor=T.+W%C3%BCrdinger&title=Effects+of+the+selective+MPS1+inhibitor+MPS1-IN-3+on+glioblastoma+sensitivity+to+antimitotic+drugs&doi=10.1093%2Fjnci%2Fdjt168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the Selective MPS1 Inhibitor MPS1-IN-3 on Glioblastoma Sensitivity to Antimitotic Drugs</span></div><div class="casAuthors">Tannous, Bakhos A.; Kerami, Mariam; Van der Stoop, Petra M.; Kwiatkowski, Nicholas; Wang, Jinhua; Zhou, Wenjun; Kessler, Almuth F.; Lewandrowski, Grant; Hiddingh, Lotte; Sol, Nik; Lagerweij, Tonny; Wedekind, Laurine; Niers, Johanna M.; Barazas, Marco; Nilsson, R. Jonas A.; Geerts, Dirk; De Witt Hamer, Philip C.; Hagemann, Carsten; Vandertop, W. Peter; Van Tellingen, Olaf; Noske, David P.; Gray, Nathanael S.; Wuerdinger, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1322-1331</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background Glioblastomas exhibit a high level of chemotherapeutic resistance, including to the antimitotic agents vincristine and taxol.  During the mitotic agent-induced arrest, glioblastoma cells are able to perform damage-control and self-repair to continue proliferation.  Monopolar spindle 1 (MPS1/TTK) is a checkpoint kinase and a gatekeeper of the mitotic arrest.  Methods We used glioblastoma cells to det. the expression of MPS1 and to det. the effects of MPS1 inhibition on mitotic errors and cell viability in combination with vincristine and taxol.  The effect of MPS1 inhibition was assessed in different orthotopic glioblastoma mouse models (n = 3-7 mice/group).  MPS1 expression levels were examd. in relation to patient survival.  Results Using publicly available gene expression data, we detd. that MPS1 overexpression corresponds pos. with tumor grade and neg. with patient survival (two-sided t test, P < .001).  Patients with high MPS1 expression (n = 203) had a median and mean survival of 487 and 913 days (95% confidence intervals [CI] = 751 to 1075), resp., and a 2-yr survival rate of 35%, whereas patients with intermediate MPS1 expression (n = 140) had a median and mean survival of 858 and 1183 days (95% CI = 1177 to 1189), resp., and a 2-yr survival rate of 56%.  We demonstrate that MPS1 inhibition by RNAi results in sensitization to antimitotic agents.  We developed a selective small-mol. inhibitor of MPS1, MPS1-IN-3, which caused mitotic aberrancies in glioblastoma cells and, in combination with vincristine, induced mitotic checkpoint override, increased aneuploidy, and augmented cell death.  MPS1-IN-3 sensitizes glioblastoma cells to vincristine in orthotopic mouse models (two-sided log-rank test, P < .01), resulting in prolonged survival without toxicity.  Conclusions Our results collectively demonstrate that MPS1, a putative therapeutic target in glioblastoma, can be selectively inhibited by MPS1-IN-3 sensitizing glioblastoma cells to antimitotic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUG67Lkc5qcbVg90H21EOLACvtfcHk0liY0BGUHiDENw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVKgu7fK&md5=b7e51ef38e02d9fbf0ce0191af530b3a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjt168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjt168%26sid%3Dliteratum%253Aachs%26aulast%3DTannous%26aufirst%3DB.%2BA.%26aulast%3DKerami%26aufirst%3DM.%26aulast%3DVan%2Bder%2BStoop%26aufirst%3DP.%2BM.%26aulast%3DKwiatkowski%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DKessler%26aufirst%3DA.%2BF.%26aulast%3DLewandrowski%26aufirst%3DG.%26aulast%3DHiddingh%26aufirst%3DL.%26aulast%3DSol%26aufirst%3DN.%26aulast%3DLagerweij%26aufirst%3DT.%26aulast%3DWedekind%26aufirst%3DL.%26aulast%3DNiers%26aufirst%3DJ.%2BM.%26aulast%3DBarazas%26aufirst%3DM.%26aulast%3DNilsson%26aufirst%3DR.%2BJ.%2BA.%26aulast%3DGeerts%26aufirst%3DD.%26aulast%3DDe%2BWitt%2BHamer%26aufirst%3DP.%2BC.%26aulast%3DHagemann%26aufirst%3DC.%26aulast%3DVandertop%26aufirst%3DW.%2BP.%26aulast%3DVan%2BTellingen%26aufirst%3DO.%26aulast%3DNoske%26aufirst%3DD.%2BP.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DW%25C3%25BCrdinger%26aufirst%3DT.%26atitle%3DEffects%2520of%2520the%2520selective%2520MPS1%2520inhibitor%2520MPS1-IN-3%2520on%2520glioblastoma%2520sensitivity%2520to%2520antimitotic%2520drugs%26jtitle%3DJ.%2520Natl.%2520Canc.%2520Inst.%26date%3D2013%26volume%3D105%26spage%3D1322%26epage%3D1331%26doi%3D10.1093%2Fjnci%2Fdjt168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ide, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daigo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuoka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagashira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanazawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishioka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dohi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshizawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span> <span> </span><span class="NLM_article-title">A unique hinge binder of extremely selective aminopyridine-based MPS1 (TTK) kinase inhibitors with cellular activity</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2247</span>– <span class="NLM_lpage">2260</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.02.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1016%2Fj.bmc.2015.02.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=2247-2260&author=K.-I.+Kusakabeauthor=N.+Ideauthor=Y.+Daigoauthor=T.+Itohauthor=T.+Yamamotoauthor=E.+Kojimaauthor=Y.+Mitsuokaauthor=G.+Tadanoauthor=S.+Tagashiraauthor=K.+Higashinoauthor=Y.+Okanoauthor=Y.+Satoauthor=M.+Inoueauthor=M.+Iguchiauthor=T.+Kanazawaauthor=Y.+Ishiokaauthor=K.+Dohiauthor=Y.+Kidoauthor=S.+Sakamotoauthor=S.+Andoauthor=M.+Maedaauthor=M.+Higakiauthor=H.+Yoshizawaauthor=H.+Muraiauthor=Y.+Nakamura&title=A+unique+hinge+binder+of+extremely+selective+aminopyridine-based+MPS1+%28TTK%29+kinase+inhibitors+with+cellular+activity&doi=10.1016%2Fj.bmc.2015.02.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.02.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.02.042%26sid%3Dliteratum%253Aachs%26aulast%3DKusakabe%26aufirst%3DK.-I.%26aulast%3DIde%26aufirst%3DN.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DKojima%26aufirst%3DE.%26aulast%3DMitsuoka%26aufirst%3DY.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DTagashira%26aufirst%3DS.%26aulast%3DHigashino%26aufirst%3DK.%26aulast%3DOkano%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DIguchi%26aufirst%3DM.%26aulast%3DKanazawa%26aufirst%3DT.%26aulast%3DIshioka%26aufirst%3DY.%26aulast%3DDohi%26aufirst%3DK.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DHigaki%26aufirst%3DM.%26aulast%3DYoshizawa%26aufirst%3DH.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DA%2520unique%2520hinge%2520binder%2520of%2520extremely%2520selective%2520aminopyridine-based%2520MPS1%2520%2528TTK%2529%2520kinase%2520inhibitors%2520with%2520cellular%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D2247%26epage%3D2260%26doi%3D10.1016%2Fj.bmc.2015.02.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awrey, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beletskaya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plotnikova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiarash, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D. C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris-Brandts, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ban, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadeem, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chirgadze, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauls, H. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of inhibitors of the mitotic kinase TTK based on <i>N</i>-(3-(3-sulfamoylphenyl)-1<i>H</i>-indazol-5-yl)-acetamides and carboxamides</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">4968</span>– <span class="NLM_lpage">4997</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.06.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1016%2Fj.bmc.2014.06.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=25043312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFyjt7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=4968-4997&author=R.+Lauferauthor=G.+Ngauthor=Y.+Liuauthor=N.+K.+B.+Patelauthor=L.+G.+Edwardsauthor=Y.+Langauthor=S.-W.+Liauthor=M.+Feherauthor=D.+E.+Awreyauthor=G.+Leungauthor=I.+Beletskayaauthor=O.+Plotnikovaauthor=J.+M.+Masonauthor=R.+Hodgsonauthor=X.+Weiauthor=G.+Maoauthor=X.+Luoauthor=P.+Huangauthor=E.+Greenauthor=R.+Kiarashauthor=D.+C.-C.+Linauthor=M.+Harris-Brandtsauthor=F.+Banauthor=V.+Nadeemauthor=T.+W.+Makauthor=G.+J.+Panauthor=W.+Qiuauthor=N.+Y.+Chirgadzeauthor=H.+W.+Pauls&title=Discovery+of+inhibitors+of+the+mitotic+kinase+TTK+based+on+N-%283-%283-sulfamoylphenyl%29-1H-indazol-5-yl%29-acetamides+and+carboxamides&doi=10.1016%2Fj.bmc.2014.06.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)acetamides and carboxamides</span></div><div class="casAuthors">Laufer, Radoslaw; Ng, Grace; Liu, Yong; Patel, Narendra Kumar B.; Edwards, Louise G.; Lang, Yunhui; Li, Sze-Wan; Feher, Miklos; Awrey, Don E.; Leung, Genie; Beletskaya, Irina; Plotnikova, Olga; Mason, Jacqueline M.; Hodgson, Richard; Wei, Xin; Mao, Guodong; Luo, Xunyi; Huang, Ping; Green, Erin; Kiarash, Reza; Lin, Dan Chi-Chia; Harris-Brandts, Marees; Ban, Fuqiang; Nadeem, Vincent; Mak, Tak W.; Pan, Guohua J.; Qiu, Wei; Chirgadze, Nickolay Y.; Pauls, Henry W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4968-4997</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">TTK kinase was identified by inhouse siRNA screen and pursued as a tractable, novel target for cancer treatment.  A screening campaign and systematic optimization, supported by computer modeling led to an indazole core with key sulfamoylphenyl and acetamido moieties at positions 3 and 5, resp., establishing a novel chem. class culminating in identification of I (CFI-400936).  This potent inhibitor of TTK (IC50 = 3.6 nM) demonstrated good activity in cell based assay and selectivity against a panel of human kinases.  A complex TTK x-ray crystal structure and results of a xenograft study with TTK inhibitors from this class are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYMVdifCP5IrVg90H21EOLACvtfcHk0lj7fAEJ27WgzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFyjt7fK&md5=71dac8de6f21ee67d1c18fd4e521a4f9</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.06.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.06.027%26sid%3Dliteratum%253Aachs%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DNg%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DPatel%26aufirst%3DN.%2BK.%2BB.%26aulast%3DEdwards%26aufirst%3DL.%2BG.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.-W.%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DAwrey%26aufirst%3DD.%2BE.%26aulast%3DLeung%26aufirst%3DG.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DG.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DGreen%26aufirst%3DE.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DD.%2BC.-C.%26aulast%3DHarris-Brandts%26aufirst%3DM.%26aulast%3DBan%26aufirst%3DF.%26aulast%3DNadeem%26aufirst%3DV.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DPan%26aufirst%3DG.%2BJ.%26aulast%3DQiu%26aufirst%3DW.%26aulast%3DChirgadze%26aufirst%3DN.%2BY.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DDiscovery%2520of%2520inhibitors%2520of%2520the%2520mitotic%2520kinase%2520TTK%2520based%2520on%2520N-%25283-%25283-sulfamoylphenyl%2529-1H-indazol-5-yl%2529-acetamides%2520and%2520carboxamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D4968%26epage%3D4997%26doi%3D10.1016%2Fj.bmc.2014.06.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallin, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rymer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanochko, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trajkovic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timofeevski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lappin, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span> <span> </span><span class="NLM_article-title">Mitotic checkpoint kinase MPS1 has a role in normal physiology which impacts clinical utility</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0138616</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0138616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1371%2Fjournal.pone.0138616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=26398286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ymsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0138616&author=R.+Martinezauthor=A.+Blasinaauthor=J.+F.+Hallinauthor=W.+Huauthor=I.+Rymerauthor=J.+Fanauthor=R.+L.+Hoffmanauthor=S.+Murphyauthor=M.+Marxauthor=G.+Yanochkoauthor=D.+Trajkovicauthor=D.+Dinhauthor=S.+Timofeevskiauthor=Z.+Zhuauthor=P.+Sunauthor=P.+B.+Lappinauthor=B.+W.+Murray&title=Mitotic+checkpoint+kinase+MPS1+has+a+role+in+normal+physiology+which+impacts+clinical+utility&doi=10.1371%2Fjournal.pone.0138616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Mitotic checkpoint kinase Mps1 has a role in normal physiology which impacts clinical utility</span></div><div class="casAuthors">Martinez, Ricardo; Blasina, Alessandra; Hallin, Jill F.; Hu, Wenyue; Rymer, Isha; Fan, Jeffery; Hoffman, Robert L.; Murphy, Sean; Marx, Matthew; Yanochko, Gina; Trajkovic, Dusko; Dinh, Dac; Timofeevski, Sergei; Zhu, Zhou; Sun, Peiquing; Lappin, Patrick B.; Murray, Brion W.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e0138616/1-e0138616/23</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Cell cycle checkpoint intervention is an effective therapeutic strategy for cancer when applied to patients predisposed to respond and the treatment is well-tolerated.  A crit. cell cycle process that could be targeted is the mitotic checkpoint (spindle assembly checkpoint) which governs the metaphase-to-anaphase transition and insures proper chromosomal segregation.  The mitotic checkpoint kinase Mps1 was selected to explore whether enhancement in genomic instability is a viable therapeutic strategy.  The basal-a subset of triple-neg. breast cancer was chosen as a model system because it has a higher incidence of chromosomal instability and Mps1 expression is up-regulated.  Depletion of Mps1 reduces tumor cell viability relative to normal cells.  Highly selective, extremely potent Mps1 kinase inhibitors were created to investigate the roles of Mps1 catalytic activity in tumor cells and normal physiol. (PF-7006, PF-3837; Ki<0.5 nM; cellular IC50 2-6 nM).  Treatment of tumor cells in vitro with PF-7006 modulates expected Mps1-dependent biol. as demonstrated by mol. and phenotypic measures (reduced pHH3-Ser10 levels, shorter duration of mitosis, micro-nucleation, and apoptosis).  Tumor-bearing mice treated with PF-7006 exhibit tumor growth inhibition concomitant with pharmacodynamic modulation of a downstream biomarker (pHH3-Ser10).  Unfortunately, efficacy only occurs at drug exposures that cause dose-limiting body wt. loss, gastrointestinal toxicities, and neutropenia.  Mps1 inhibitor toxicities may be mitigated by inducing G1 cell cycle arrest in Rb1-competent cells with the cyclin-dependent kinase-4/6 inhibitor palbociclib.  Using an isogenic cellular model system, PF-7006 is shown to be selectively cytotoxic to Rb1-deficient cells relative to Rb1-competent cells (also a measure of kinase selectivity).  Human bone marrow cells pretreated with palbociclib have decreased PF-7006-dependent apoptosis relative to cells without palbociclib pretreatment.  Collectively, this study raises a concern that single agent therapies inhibiting Mps1 will not be well-tolerated clin. but may be when combined with a selective CDK4/6 drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc-9LR3Gfty7Vg90H21EOLACvtfcHk0lj7fAEJ27WgzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ymsLo%253D&md5=68fc918b70df2cd020be0c4fec209c12</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0138616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0138616%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DBlasina%26aufirst%3DA.%26aulast%3DHallin%26aufirst%3DJ.%2BF.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DRymer%26aufirst%3DI.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DHoffman%26aufirst%3DR.%2BL.%26aulast%3DMurphy%26aufirst%3DS.%26aulast%3DMarx%26aufirst%3DM.%26aulast%3DYanochko%26aufirst%3DG.%26aulast%3DTrajkovic%26aufirst%3DD.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DLappin%26aufirst%3DP.%2BB.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26atitle%3DMitotic%2520checkpoint%2520kinase%2520MPS1%2520has%2520a%2520role%2520in%2520normal%2520physiology%2520which%2520impacts%2520clinical%2520utility%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0138616%26doi%3D10.1371%2Fjournal.pone.0138616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maia, A. R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Man, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boon, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omerzu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterrenburg, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinsen, M. B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willemsen-Seegers, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Roos, J. A. D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Doornmalen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uitdehaag, J. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kops, G. J. P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonkers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buijsman, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaman, G. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medema, R. H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model</span>. <i>Ann. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2180</span>– <span class="NLM_lpage">2192</span>, <span class="refDoi"> DOI: 10.1093/annonc/mdv293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1093%2Fannonc%2Fmdv293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=26153498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FhsVCrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=2180-2192&author=A.+R.+R.+Maiaauthor=J.+de+Manauthor=U.+Boonauthor=A.+Janssenauthor=J.+Y.+Songauthor=M.+Omerzuauthor=J.+G.+Sterrenburgauthor=M.+B.+W.+Prinsenauthor=N.+Willemsen-Seegersauthor=J.+A.+D.+M.+de+Roosauthor=A.+M.+van+Doornmalenauthor=J.+C.+M.+Uitdehaagauthor=G.+J.+P.+L.+Kopsauthor=J.+Jonkersauthor=R.+C.+Buijsmanauthor=G.+J.+R.+Zamanauthor=R.+H.+Medema&title=Inhibition+of+the+spindle+assembly+checkpoint+kinase+TTK+enhances+the+efficacy+of+docetaxel+in+a+triple-negative+breast+cancer+model&doi=10.1093%2Fannonc%2Fmdv293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model</span></div><div class="casAuthors">Maia A R R; Janssen A; de Man J; Sterrenburg J G; Prinsen M B W; Willemsen-Seegers N; de Roos J A D M; van Doornmalen A M; Uitdehaag J C M; Buijsman R C; Zaman G J R; Boon U; Song J-Y; Omerzu M; Kops G J P L; Jonkers J; Medema R H</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2180-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Triple-negative breast cancers (TNBC) are considered the most aggressive type of breast cancer, for which no targeted therapy exists at the moment.  These tumors are characterized by having a high degree of chromosome instability and often overexpress the spindle assembly checkpoint kinase TTK.  To explore the potential of TTK inhibition as a targeted therapy in TNBC, we developed a highly potent and selective small molecule inhibitor of TTK, NTRC 0066-0.  RESULTS AND CONCLUSIONS:  The compound is characterized by long residence time on the target and inhibits the proliferation of a wide variety of human cancer cell lines with potency in the same range as marketed cytotoxic agents.  In cell lines and in mice, NTRC 0066-0 inhibits the phosphorylation of a TTK substrate and induces chromosome missegregation.  NTRC 0066-0 inhibits tumor growth in MDA-MB-231 xenografts as a single agent after oral application.  To address the effect of the inhibitor in breast cancer, we used a well-defined mouse model that spontaneously develops breast tumors that share key morphologic and molecular features with human TNBC.  Our studies show that combination of NTRC 0066-0 with a therapeutic dose of docetaxel resulted in doubling of mouse survival and extended tumor remission, without toxicity.  Furthermore, we observed that treatment efficacy is only achieved upon co-administration of the two compounds, which suggests a synergistic in vivo effect.  Therefore, we propose TTK inhibition as a novel therapeutic target for neoadjuvant therapy in TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQW4bdSIlyWFQ8IxFYvehhofW6udTcc2eYegM5byJyf67ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FhsVCrtg%253D%253D&md5=579aa33d6fd0de70b6c68ae86d8316c0</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdv293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdv293%26sid%3Dliteratum%253Aachs%26aulast%3DMaia%26aufirst%3DA.%2BR.%2BR.%26aulast%3Dde%2BMan%26aufirst%3DJ.%26aulast%3DBoon%26aufirst%3DU.%26aulast%3DJanssen%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DJ.%2BY.%26aulast%3DOmerzu%26aufirst%3DM.%26aulast%3DSterrenburg%26aufirst%3DJ.%2BG.%26aulast%3DPrinsen%26aufirst%3DM.%2BB.%2BW.%26aulast%3DWillemsen-Seegers%26aufirst%3DN.%26aulast%3Dde%2BRoos%26aufirst%3DJ.%2BA.%2BD.%2BM.%26aulast%3Dvan%2BDoornmalen%26aufirst%3DA.%2BM.%26aulast%3DUitdehaag%26aufirst%3DJ.%2BC.%2BM.%26aulast%3DKops%26aufirst%3DG.%2BJ.%2BP.%2BL.%26aulast%3DJonkers%26aufirst%3DJ.%26aulast%3DBuijsman%26aufirst%3DR.%2BC.%26aulast%3DZaman%26aufirst%3DG.%2BJ.%2BR.%26aulast%3DMedema%26aufirst%3DR.%2BH.%26atitle%3DInhibition%2520of%2520the%2520spindle%2520assembly%2520checkpoint%2520kinase%2520TTK%2520enhances%2520the%2520efficacy%2520of%2520docetaxel%2520in%2520a%2520triple-negative%2520breast%2520cancer%2520model%26jtitle%3DAnn.%2520Oncol.%26date%3D2015%26volume%3D26%26spage%3D2180%26epage%3D2192%26doi%3D10.1093%2Fannonc%2Fmdv293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wengner, A. M.</span>; <span class="NLM_string-name">Siemeister, G.</span></span> <span> </span><span class="NLM_article-title">Combinations for the Treatment of Cancer Comprising a MPS-1 Kinase Inhibitor and a Mitotic Inhibitor</span>. <span class="NLM_patent">WO2014198645</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+M.+Wengner&author=G.+Siemeister&title=Combinations+for+the+Treatment+of+Cancer+Comprising+a+MPS-1+Kinase+Inhibitor+and+a+Mitotic+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWengner%26aufirst%3DA.%2BM.%26atitle%3DCombinations%2520for%2520the%2520Treatment%2520of%2520Cancer%2520Comprising%2520a%2520MPS-1%2520Kinase%2520Inhibitor%2520and%2520a%2520Mitotic%2520Inhibitor%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wengner, A. M.</span>; <span class="NLM_string-name">Siemeister, G.</span></span> <span> </span><span class="NLM_article-title">Combination of a Imidazopyridazine Derivative and a Mitotic Agent for the Treatment of Cancer</span>. <span class="NLM_patent">WO2014198776A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+M.+Wengner&author=G.+Siemeister&title=Combination+of+a+Imidazopyridazine+Derivative+and+a+Mitotic+Agent+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWengner%26aufirst%3DA.%2BM.%26atitle%3DCombination%2520of%2520a%2520Imidazopyridazine%2520Derivative%2520and%2520a%2520Mitotic%2520Agent%2520for%2520the%2520Treatment%2520of%2520Cancer%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ide, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daigo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashizume, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nozu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagashira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanazawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishioka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dohi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baba, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of imidazo[1,2-<i>b</i>]pyridazine derivatives: selective and orally available MPS1 (TTK) kinase inhibitors exhibiting remarkable antiproliferative activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1760</span>– <span class="NLM_lpage">1775</span>, <span class="refDoi"> DOI: 10.1021/jm501599u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501599u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2it7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1760-1775&author=K.-I.+Kusakabeauthor=N.+Ideauthor=Y.+Daigoauthor=T.+Itohauthor=T.+Yamamotoauthor=H.+Hashizumeauthor=K.+Nozuauthor=H.+Yoshidaauthor=G.+Tadanoauthor=S.+Tagashiraauthor=K.+Higashinoauthor=Y.+Okanoauthor=Y.+Satoauthor=M.+Inoueauthor=M.+Iguchiauthor=T.+Kanazawaauthor=Y.+Ishiokaauthor=K.+Dohiauthor=Y.+Kidoauthor=S.+Sakamotoauthor=S.+Andoauthor=M.+Maedaauthor=M.+Higakiauthor=Y.+Babaauthor=Y.+Nakamura&title=Discovery+of+imidazo%5B1%2C2-b%5Dpyridazine+derivatives%3A+selective+and+orally+available+MPS1+%28TTK%29+kinase+inhibitors+exhibiting+remarkable+antiproliferative+activity&doi=10.1021%2Fjm501599u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Imidazo[1,2-b]pyridazine Derivatives: Selective and Orally Available Mps1 (TTK) Kinase Inhibitors Exhibiting Remarkable Antiproliferative Activity</span></div><div class="casAuthors">Kusakabe, Ken-ichi; Ide, Nobuyuki; Daigo, Yataro; Itoh, Takeshi; Yamamoto, Takahiko; Hashizume, Hiroshi; Nozu, Kohei; Yoshida, Hiroshi; Tadano, Genta; Tagashira, Sachie; Higashino, Kenichi; Okano, Yousuke; Sato, Yuji; Inoue, Makiko; Iguchi, Motofumi; Kanazawa, Takayuki; Ishioka, Yukichi; Dohi, Keiji; Kido, Yasuto; Sakamoto, Shingo; Ando, Shigeru; Maeda, Masahiro; Higaki, Masayo; Baba, Yoshiyasu; Nakamura, Yusuke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1760-1775</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monopolar spindle 1 (Mps1) is an attractive oncol. target due to its high expression level in cancer cells as well as the correlation of its expression levels with histol. grades of cancers.  An imidazo[1,2-a]pyrazine 10a was identified during an HTS campaign.  Although 10a exhibited good biochem. activity, its moderate cellular as well as antiproliferative activities needed to be improved.  The cocrystal structure of an analog of 10a guided our lead optimization to introduce substituents at the 6-position of the scaffold, giving the 6-aryl substituted 21b which had improved cellular activity but no oral bioavailability in rat.  Property-based optimization at the 6-position and a scaffold change led to the discovery of the imidazo[1,2-b]pyridazine-based 27f, an extremely potent (cellular Mps1 IC50 = 0.70 nM, A549 IC50 = 6.0 nM), selective Mps1 inhibitor over 192 kinases, which could be orally administered and was active in vivo.  This 27f demonstrated remarkable antiproliferative activity in the nanomolar range against various tissue cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8D9nRl5vWabVg90H21EOLACvtfcHk0lgtC2gu2gs6og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2it7g%253D&md5=bee62a50247a363dc3e35fcdeac6a64f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm501599u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501599u%26sid%3Dliteratum%253Aachs%26aulast%3DKusakabe%26aufirst%3DK.-I.%26aulast%3DIde%26aufirst%3DN.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DHashizume%26aufirst%3DH.%26aulast%3DNozu%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DTagashira%26aufirst%3DS.%26aulast%3DHigashino%26aufirst%3DK.%26aulast%3DOkano%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DIguchi%26aufirst%3DM.%26aulast%3DKanazawa%26aufirst%3DT.%26aulast%3DIshioka%26aufirst%3DY.%26aulast%3DDohi%26aufirst%3DK.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DHigaki%26aufirst%3DM.%26aulast%3DBaba%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520imidazo%255B1%252C2-b%255Dpyridazine%2520derivatives%253A%2520selective%2520and%2520orally%2520available%2520MPS1%2520%2528TTK%2529%2520kinase%2520inhibitors%2520exhibiting%2520remarkable%2520antiproliferative%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1760%26epage%3D1775%26doi%3D10.1021%2Fjm501599u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wahba, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Hadaad, H. A.</span></span> <span> </span><span class="NLM_article-title">Current approaches in treatment of triple-negative breast cancer</span>. <i>Cancer Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=26175926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlslGjtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=106-116&author=H.+A.+Wahbaauthor=H.+A.+El-Hadaad&title=Current+approaches+in+treatment+of+triple-negative+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Current approaches in treatment of triple-negative breast cancer</span></div><div class="casAuthors">Wahba, Hanan Ahmed; El-Hadaad, Hend Ahmed</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2Spec.Iss.</span>),
    <span class="NLM_cas:pages">106-116</span>CODEN:
                <span class="NLM_cas:coden">CBMADQ</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Tianjin Medical University Cancer Institute and Hospital</span>)
        </div><div class="casAbstract">Triple-neg. breast cancer (TNBC) is diagnosed more frequently in younger and premenopausal women and is highly prevalent in African American women.  TNBC is a term derived from tumors that are characterized by the absence of ER, PgR, and HER2.  So patients with TNBC do not benefit from hormonal or trastuzumab-based therapies.  TNBCs are biol. aggressive, although some reports suggest that they respond to chemotherapy better than other types of breast cancer, prognosis remains poor.  This is due to: shortened disease-free interval in the adjuvant and neoadjuvant setting and a more aggressive course in the metastatic setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoriUOaFeoi1bVg90H21EOLACvtfcHk0lgtC2gu2gs6og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlslGjtr8%253D&md5=05e14e8e08ac1aafca78a730c6c7ba30</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWahba%26aufirst%3DH.%2BA.%26aulast%3DEl-Hadaad%26aufirst%3DH.%2BA.%26atitle%3DCurrent%2520approaches%2520in%2520treatment%2520of%2520triple-negative%2520breast%2520cancer%26jtitle%3DCancer%2520Biol.%2520Med.%26date%3D2015%26volume%3D12%26spage%3D106%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Innocenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Fee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span> <span> </span><span class="NLM_article-title">Expanding the scope of fused pyrimidines as kinase inhibitor scaffolds: synthesis and modification of pyrido[3,4-<i>d</i>]pyrimidines</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">893</span>– <span class="NLM_lpage">904</span>, <span class="refDoi"> DOI: 10.1039/C4OB02238F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1039%2FC4OB02238F" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=893-904&author=P.+Innocentiauthor=H.+Woodwardauthor=L.+O%E2%80%99Feeauthor=S.+Hoelder&title=Expanding+the+scope+of+fused+pyrimidines+as+kinase+inhibitor+scaffolds%3A+synthesis+and+modification+of+pyrido%5B3%2C4-d%5Dpyrimidines&doi=10.1039%2FC4OB02238F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2FC4OB02238F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4OB02238F%26sid%3Dliteratum%253Aachs%26aulast%3DInnocenti%26aufirst%3DP.%26aulast%3DWoodward%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Fee%26aufirst%3DL.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DExpanding%2520the%2520scope%2520of%2520fused%2520pyrimidines%2520as%2520kinase%2520inhibitor%2520scaffolds%253A%2520synthesis%2520and%2520modification%2520of%2520pyrido%255B3%252C4-d%255Dpyrimidines%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D893%26epage%3D904%26doi%3D10.1039%2FC4OB02238F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">VanderWel, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repine, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booth, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobrusin, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fry, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toogood, P. L.</span></span> <span> </span><span class="NLM_article-title">Pyrido[2,3-<i>d</i>]pyrimidin-7-ones as specific inhibitors of cyclin-dependent kinase 4</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">2371</span>– <span class="NLM_lpage">2387</span>, <span class="refDoi"> DOI: 10.1021/jm049355+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049355%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVGisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2371-2387&author=S.+N.+VanderWelauthor=P.+J.+Harveyauthor=D.+J.+McNamaraauthor=J.+T.+Repineauthor=P.+R.+Kellerauthor=J.+Quinauthor=R.+J.+Boothauthor=W.+L.+Elliottauthor=E.+M.+Dobrusinauthor=D.+W.+Fryauthor=P.+L.+Toogood&title=Pyrido%5B2%2C3-d%5Dpyrimidin-7-ones+as+specific+inhibitors+of+cyclin-dependent+kinase+4&doi=10.1021%2Fjm049355%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrido[2,3-d]pyrimidin-7-ones as Specific Inhibitors of Cyclin-Dependent Kinase 4</span></div><div class="casAuthors">VanderWel, Scott N.; Harvey, Patricia J.; McNamara, Dennis J.; Repine, Joseph T.; Keller, Paul R.; Quin, John, III; Booth, R. John; Elliott, William L.; Dobrusin, Ellen M.; Fry, David W.; Toogood, Peter L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2371-2387</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of the cell cycle kinase, cyclin-dependent kinase-4 (Cdk4), is expected to provide an effective method for the treatment of proliferative diseases such as cancer.  The pyrido[2,3-d]pyrimidin-7-one template has been identified previously as a privileged structure for the inhibition of ATP-dependent kinases, and good potency against Cdks has been reported for representative examples.  Obtaining selectivity for individual Cdk enzymes, particularly Cdk4, has been challenging.  A series of pyrido[2,3-d]pyrimidin-7-ones I (R1 = Me2CH, Et2CH, cyclopentyl; R2 = H, Me, Et, F3C; R3 = H, Me, F, Cl, COMe, MeO2C, etc.; X = HOCH, H2NCH, CH2N, CH2CH2, etc.) was synthesized and investigated as selective inhibitors of Cdk4.  The introduction of a Me substituent at the C-5 position of the pyrido[2,3-d]pyrimidin-7-one template is sufficient to confer excellent selectivity for Cdk4 vs other Cdks and representative tyrosine kinases.  Further optimization led to the identification of highly potent and selective inhibitors of Cdk4 that exhibit potent antiproliferative activity against human tumor cells in vitro.  The most selective Cdk4 inhibitors were evaluated for antitumor activity against MDA-MB-435 human breast carcinoma xenografts in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKNHZHOwd7c7Vg90H21EOLACvtfcHk0lgtC2gu2gs6og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVGisLo%253D&md5=ef3c86bbdfaea0080d1103313d094ccd</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm049355%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049355%252B%26sid%3Dliteratum%253Aachs%26aulast%3DVanderWel%26aufirst%3DS.%2BN.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DMcNamara%26aufirst%3DD.%2BJ.%26aulast%3DRepine%26aufirst%3DJ.%2BT.%26aulast%3DKeller%26aufirst%3DP.%2BR.%26aulast%3DQuin%26aufirst%3DJ.%26aulast%3DBooth%26aufirst%3DR.%2BJ.%26aulast%3DElliott%26aufirst%3DW.%2BL.%26aulast%3DDobrusin%26aufirst%3DE.%2BM.%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DToogood%26aufirst%3DP.%2BL.%26atitle%3DPyrido%255B2%252C3-d%255Dpyrimidin-7-ones%2520as%2520specific%2520inhibitors%2520of%2520cyclin-dependent%2520kinase%25204%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2371%26epage%3D2387%26doi%3D10.1021%2Fjm049355%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toogood, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repine, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanderWel, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherry, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodfuehrer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barvian, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fry, D. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">2388</span>– <span class="NLM_lpage">2406</span>, <span class="refDoi"> DOI: 10.1021/jm049354h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049354h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVGisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2388-2406&author=P.+L.+Toogoodauthor=P.+J.+Harveyauthor=J.+T.+Repineauthor=D.+J.+Sheehanauthor=S.+N.+VanderWelauthor=H.+Zhouauthor=P.+R.+Kellerauthor=D.+J.+McNamaraauthor=D.+Sherryauthor=T.+Zhuauthor=J.+Brodfuehrerauthor=C.+Choiauthor=M.+R.+Barvianauthor=D.+W.+Fry&title=Discovery+of+a+potent+and+selective+inhibitor+of+cyclin-dependent+kinase+4%2F6&doi=10.1021%2Fjm049354h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective Inhibitor of Cyclin-Dependent Kinase 4/6</span></div><div class="casAuthors">Toogood, Peter L.; Harvey, Patricia J.; Repine, Joseph T.; Sheehan, Derek J.; VanderWel, Scott N.; Zhou, Hairong; Keller, Paul R.; McNamara, Dennis J.; Sherry, Debra; Zhu, Tong; Brodfuehrer, Joanne; Choi, Chung; Barvian, Mark R.; Fry, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2388-2406</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A pharmacol. approach to inhibition of cyclin-dependent kinases 4 and 6 (Cdk4/6) using highly selective small mol. inhibitors has the potential to provide novel cancer therapies for clin. use.  Achieving high levels of selectivity for Cdk4/6, vs. other ATP-dependent kinases, presents a significant challenge.  The pyrido[2,3-d]pyrimidin-7-one template provides an effective platform for the inhibition of a broad cross-section of kinases, including Cdks.  It is now demonstrated that the modification of pyrido[2,3-d]pyrimidin-7-ones to include a 2-aminopyridine side chain at the C2-position provides inhibitors with exquisite selectivity for Cdk4/6 in vitro.  This selectivity profile is recapitulated in cells where the most selective inhibitors create a G1 block at concns. up to 100-fold the IC50 for cell proliferation.  On the basis of its selectivity profile and pharmacokinetic profile, compd. I (PD 0332991) was identified as a drug candidate for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX577J5U0r97Vg90H21EOLACvtfcHk0lgRhleuUQjfZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVGisL0%253D&md5=23cbe58426ff1975695712db7c1b128a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm049354h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049354h%26sid%3Dliteratum%253Aachs%26aulast%3DToogood%26aufirst%3DP.%2BL.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DRepine%26aufirst%3DJ.%2BT.%26aulast%3DSheehan%26aufirst%3DD.%2BJ.%26aulast%3DVanderWel%26aufirst%3DS.%2BN.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DKeller%26aufirst%3DP.%2BR.%26aulast%3DMcNamara%26aufirst%3DD.%2BJ.%26aulast%3DSherry%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DBrodfuehrer%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DBarvian%26aufirst%3DM.%2BR.%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520cyclin-dependent%2520kinase%25204%252F6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2388%26epage%3D2406%26doi%3D10.1021%2Fjm049354h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aboagye, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balkwill, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balmain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruder, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Double, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farningham, D. A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glennie, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelland, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratford, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozer, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wedge, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span> <span> </span><span class="NLM_article-title">Guidelines for the welfare and use of animals in cancer research</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">1555</span>– <span class="NLM_lpage">1577</span>, <span class="refDoi"> DOI: 10.1038/sj.bjc.6605642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1038%2Fsj.bjc.6605642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=20502460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A280%3ADC%252BC3czmvFyhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=1555-1577&author=P.+Workmanauthor=E.+O.+Aboagyeauthor=F.+Balkwillauthor=A.+Balmainauthor=G.+Bruderauthor=D.+J.+Chaplinauthor=J.+A.+Doubleauthor=J.+Everittauthor=D.+A.+H.+Farninghamauthor=M.+J.+Glennieauthor=L.+R.+Kellandauthor=V.+Robinsonauthor=I.+J.+Stratfordauthor=G.+M.+Tozerauthor=S.+Watsonauthor=S.+R.+Wedgeauthor=S.+A.+Eccles&title=Guidelines+for+the+welfare+and+use+of+animals+in+cancer+research&doi=10.1038%2Fsj.bjc.6605642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Guidelines for the welfare and use of animals in cancer research</span></div><div class="casAuthors">Workman P; Aboagye E O; Balkwill F; Balmain A; Bruder G; Chaplin D J; Double J A; Everitt J; Farningham D A H; Glennie M J; Kelland L R; Robinson V; Stratford I J; Tozer G M; Watson S; Wedge S R; Eccles S A</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1555-77</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Animal experiments remain essential to understand the fundamental mechanisms underpinning malignancy and to discover improved methods to prevent, diagnose and treat cancer.  Excellent standards of animal care are fully consistent with the conduct of high quality cancer research.  Here we provide updated guidelines on the welfare and use of animals in cancer research.  All experiments should incorporate the 3Rs: replacement, reduction and refinement.  Focusing on animal welfare, we present recommendations on all aspects of cancer research, including: study design, statistics and pilot studies; choice of tumour models (e.g., genetically engineered, orthotopic and metastatic); therapy (including drugs and radiation); imaging (covering techniques, anaesthesia and restraint); humane endpoints (including tumour burden and site); and publication of best practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkVD7D529OLg5nADWVYHg1fW6udTcc2ebsvKpapUULhbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czmvFyhsQ%253D%253D&md5=55f4c62e16fb1ebaa1f05d59caba3989</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605642%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DAboagye%26aufirst%3DE.%2BO.%26aulast%3DBalkwill%26aufirst%3DF.%26aulast%3DBalmain%26aufirst%3DA.%26aulast%3DBruder%26aufirst%3DG.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DDouble%26aufirst%3DJ.%2BA.%26aulast%3DEveritt%26aufirst%3DJ.%26aulast%3DFarningham%26aufirst%3DD.%2BA.%2BH.%26aulast%3DGlennie%26aufirst%3DM.%2BJ.%26aulast%3DKelland%26aufirst%3DL.%2BR.%26aulast%3DRobinson%26aufirst%3DV.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26aulast%3DWatson%26aufirst%3DS.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26atitle%3DGuidelines%2520for%2520the%2520welfare%2520and%2520use%2520of%2520animals%2520in%2520cancer%2520research%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2010%26volume%3D102%26spage%3D1555%26epage%3D1577%26doi%3D10.1038%2Fsj.bjc.6605642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faisal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, G. W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurden, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xavier, C. P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderhub, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innocenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Haven Brandon, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Fee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">vanMontfort, R. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linardopoulos, S.</span></span> <span> </span><span class="NLM_article-title">Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure <i>in vivo</i> MPS1 inhibition vs therapeutic efficacy</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">1166</span>– <span class="NLM_lpage">1176</span>, <span class="refDoi"> DOI: 10.1038/bjc.2017.75</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1038%2Fbjc.2017.75" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=28334731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotVKht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2017&pages=1166-1176&author=A.+Faisalauthor=G.+W.+Y.+Makauthor=M.+D.+Gurdenauthor=C.+P.+R.+Xavierauthor=S.+J.+Anderhubauthor=P.+Innocentiauthor=I.+M.+Westwoodauthor=S.+Naudauthor=A.+Hayesauthor=G.+Boxauthor=M.+R.+Valentiauthor=A.+K.+De+Haven+Brandonauthor=L.+O%E2%80%99Feeauthor=J.+Schmittauthor=H.+L.+Woodwardauthor=R.+Burkeauthor=R.+L.+M.+vanMontfortauthor=J.+Blaggauthor=F.+I.+Raynaudauthor=S.+A.+Ecclesauthor=S.+Hoelderauthor=S.+Linardopoulos&title=Characterisation+of+CCT271850%2C+a+selective%2C+oral+and+potent+MPS1+inhibitor%2C+used+to+directly+measure+in+vivo+MPS1+inhibition+vs+therapeutic+efficacy&doi=10.1038%2Fbjc.2017.75"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure in vivo MPS1 inhibition vs therapeutic efficacy</span></div><div class="casAuthors">Faisal, Amir; Mak, Grace W. Y.; Gurden, Mark D.; Xavier, Cristina P. R.; Anderhub, Simon J.; Innocenti, Paolo; Westwood, Isaac M.; Naud, Sebastien; Hayes, Angela; Box, Gary; Valenti, Melanie R.; De Haven Brandon, Alexis K.; O'Fee, Lisa; Schmitt, Jessica; Woodward, Hannah L.; Burke, Rosemary; van Montfort, Rob L. M.; Blagg, Julian; Raynaud, Florence I.; Eccles, Suzanne A.; Hoelder, Swen; Linardopoulos, Spiros</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1166-1176</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: The main role of the cell cycle is to enable error-free DNA replication, chromosome segregation and cytokinesis.  One of the best characterized checkpoint pathways is the spindle assembly checkpoint, which prevents anaphase onset until the appropriate attachment and tension across kinetochores is achieved.  MPS1 kinase activity is essential for the activation of the spindle assembly checkpoint and has been shown to be deregulated in human tumors with chromosomal instability and aneuploidy.  Therefore, MPS1 inhibition represents an attractive strategy to target cancers.  Methods: To evaluate CCT271850 cellular potency, two specific antibodies that recognize the activation sites of MPS1 were used and its antiproliferative activity was detd. in 91 human cancer cell lines.  DLD1 cells with induced GFP-MPS1 and HCT116 cells were used in in vivo studies to directly measure MPS1 inhibition and efficacy of CCT271850 treatment.  Results: CCT271850 selectively and potently inhibits MPS1 kinase activity in biochem. and cellular assays and in in vivo models.  Mechanistically, tumor cells treated with CCT271850 acquire aberrant nos. of chromosomes and the majority of cells divide their chromosomes without proper alignment because of abrogation of the mitotic checkpoint, leading to cell death.  We demonstrated a moderate level of efficacy of CCT271850 as a single agent in a human colorectal carcinoma xenograft model.  Conclusions: CCT271850 is a potent, selective and orally bioavailable MPS1 kinase inhibitor.  On the basis of in vivo pharmacodynamic vs efficacy relationships, we predict that more than 80% inhibition of MPS1 activity for at least 24 h is required to achieve tumor stasis or regression by CCT271850.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodu8v7zdjvabVg90H21EOLACvtfcHk0lj9l7ODOVR3fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotVKht74%253D&md5=656368a488e47677a8cb455de962371e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2017.75&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2017.75%26sid%3Dliteratum%253Aachs%26aulast%3DFaisal%26aufirst%3DA.%26aulast%3DMak%26aufirst%3DG.%2BW.%2BY.%26aulast%3DGurden%26aufirst%3DM.%2BD.%26aulast%3DXavier%26aufirst%3DC.%2BP.%2BR.%26aulast%3DAnderhub%26aufirst%3DS.%2BJ.%26aulast%3DInnocenti%26aufirst%3DP.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DNaud%26aufirst%3DS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DValenti%26aufirst%3DM.%2BR.%26aulast%3DDe%2BHaven%2BBrandon%26aufirst%3DA.%2BK.%26aulast%3DO%25E2%2580%2599Fee%26aufirst%3DL.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DWoodward%26aufirst%3DH.%2BL.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DvanMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DHoelder%26aufirst%3DS.%26aulast%3DLinardopoulos%26aufirst%3DS.%26atitle%3DCharacterisation%2520of%2520CCT271850%252C%2520a%2520selective%252C%2520oral%2520and%2520potent%2520MPS1%2520inhibitor%252C%2520used%2520to%2520directly%2520measure%2520in%2520vivo%2520MPS1%2520inhibition%2520vs%2520therapeutic%2520efficacy%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2017%26volume%3D116%26spage%3D1166%26epage%3D1176%26doi%3D10.1038%2Fbjc.2017.75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Milletti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storchi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sforna, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruciani, G.</span></span> <span> </span><span class="NLM_article-title">New and original pka prediction method using grid molecular interaction fields</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2172</span>– <span class="NLM_lpage">2181</span>, <span class="refDoi"> DOI: 10.1021/ci700018y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci700018y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSnsLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=2172-2181&author=F.+Millettiauthor=L.+Storchiauthor=G.+Sfornaauthor=G.+Cruciani&title=New+and+original+pka+prediction+method+using+grid+molecular+interaction+fields&doi=10.1021%2Fci700018y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">New and Original pKa Prediction Method Using Grid Molecular Interaction Fields</span></div><div class="casAuthors">Milletti, Francesca; Storchi, Loriano; Sforna, Gianluca; Cruciani, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2172-2181</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One of the most important physicochem. properties of a mol. is pKa.  It is known that two parameters imperative in ADME profiling, soly., and lipophilicity are governed by pKa, and receptor binding can be influenced by pKa.  Because most drugs are ionized in physiol. conditions, pKa is particularly relevant to medicinal chem.  Despite the numerous advances in high-throughput measurements, in silico detn. is still the fastest and cheapest way of obtaining pKa.  This paper presents a new original computational method for pKa prediction of org. compds.  Descriptors were generated using the program GRID, and these descriptors are based on mol. interaction fields precomputed on a set of mol. fragments.  The new method was developed, trained, and cross-validated by using a large and diverse data set of 24 617 pKa values.  This paper presents the results for a class of 421 acidic nitrogen compds. (RMSE = 0.41, r2 = 0.97, q2 = 0.87) and for a class of 947 six-membered N-heterocyclic bases (RMSE = 0.60, r2 = 0.93, q2 = 0.85).  For external validation 28 novel compds. were selected that covered nine different ionizable groups, and 39 pKa values could be exptl. detd. by spectral gradient anal. (SGA).  Comparison of exptl. pKa with calcd. pKa demonstrated that the predictive ability of the method is good (external set, r2 = 0.85, RMSE = 0.90).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzEk0uiS1E6rVg90H21EOLACvtfcHk0lj9l7ODOVR3fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSnsLrF&md5=f2b1dec853ccb0ef1a40540d234232fb</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fci700018y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700018y%26sid%3Dliteratum%253Aachs%26aulast%3DMilletti%26aufirst%3DF.%26aulast%3DStorchi%26aufirst%3DL.%26aulast%3DSforna%26aufirst%3DG.%26aulast%3DCruciani%26aufirst%3DG.%26atitle%3DNew%2520and%2520original%2520pka%2520prediction%2520method%2520using%2520grid%2520molecular%2520interaction%2520fields%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D2172%26epage%3D2181%26doi%3D10.1021%2Fci700018y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 11 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Younho Lee, Hyunkyung Kim, Haelee Kim, Ha Yeon Cho, Jun-Goo Jee, Kyung-Ah Seo, Jung Beom Son, Eunhwa Ko, Hwan Geun Choi, Nam Doo Kim, <span class="NLM_string-name hlFld-ContribAuthor">Ikyon Kim</span>. </span><span class="cited-content_cbyCitation_article-title">X-ray Crystal Structure-Guided Design and Optimization of 7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile Scaffold as a Potent and Orally Active Monopolar Spindle 1 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6985-6995. <a href="https://doi.org/10.1021/acs.jmedchem.1c00542" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00542</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00542%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DX-ray%252BCrystal%252BStructure-Guided%252BDesign%252Band%252BOptimization%252Bof%252B7H-Pyrrolo%25255B2%25252C3-d%25255Dpyrimidine-5-carbonitrile%252BScaffold%252Bas%252Ba%252BPotent%252Band%252BOrally%252BActive%252BMonopolar%252BSpindle%252B1%252BInhibitor%26aulast%3DLee%26aufirst%3DYounho%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D25032021%26date%3D04052021%26volume%3D64%26issue%3D10%26spage%3D6985%26epage%3D6995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jennifer R. Riggs, Jan Elsner, Dan Cashion, Dale Robinson, Lida Tehrani, Mark Nagy, Kimberly E. Fultz, Rama Krishna Narla, Xiaohui Peng, Tam Tran, Ashutosh Kulkarni, Sogole Bahmanyar, Kevin Condroski, Barbra Pagarigan, Gustavo Fenalti, Laurie LeBrun, Katerina Leftheris, Dan Zhu, <span class="NLM_string-name hlFld-ContribAuthor">John F. Boylan</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Optimization Leading to an Orally Active TTK Protein Kinase Inhibitor with Robust Single Agent Efficacy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4401-4410. <a href="https://doi.org/10.1021/acs.jmedchem.8b01869" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01869</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01869%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BOptimization%252BLeading%252Bto%252Ban%252BOrally%252BActive%252BTTK%252BProtein%252BKinase%252BInhibitor%252Bwith%252BRobust%252BSingle%252BAgent%252BEfficacy%26aulast%3DRiggs%26aufirst%3DJennifer%2BR.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D28112018%26date%3D30042019%26date%3D18042019%26volume%3D62%26issue%3D9%26spage%3D4401%26epage%3D4410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pedro  Novais</span>, <span class="hlFld-ContribAuthor ">Patrícia M. A.  Silva</span>, <span class="hlFld-ContribAuthor ">Isabel  Amorim</span>, <span class="hlFld-ContribAuthor ">Hassan  Bousbaa</span>. </span><span class="cited-content_cbyCitation_article-title">Second-Generation Antimitotics in Cancer Clinical Trials. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutics</span><span> <strong>2021,</strong> <em>13 </em>
                                    (7)
                                     , 1011. <a href="https://doi.org/10.3390/pharmaceutics13071011" title="DOI URL">https://doi.org/10.3390/pharmaceutics13071011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pharmaceutics13071011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpharmaceutics13071011%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutics%26atitle%3DSecond-Generation%252BAntimitotics%252Bin%252BCancer%252BClinical%252BTrials%26aulast%3DNovais%26aufirst%3DPedro%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D7%26spage%3D1011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongmei  Chen</span>, <span class="hlFld-ContribAuthor ">Yumei  Chen</span>, <span class="hlFld-ContribAuthor ">Di  Yang</span>, <span class="hlFld-ContribAuthor ">Zhaopeng  Zheng</span>, <span class="hlFld-ContribAuthor ">Zhixu  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and
              antitumor
              activity of novel pyridino[2,3‐
              d
              ]pyrimidine urea derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2021,</strong> <em>136 </em><a href="https://doi.org/10.1002/jhet.4287" title="DOI URL">https://doi.org/10.1002/jhet.4287</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.4287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.4287%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bantitumor%252Bactivity%252Bof%252Bnovel%252Bpyridino%25255B2%25252C3%2525E2%252580%252590%252Bd%252B%25255Dpyrimidine%252Burea%252Bderivatives%26aulast%3DChen%26aufirst%3DDongmei%26date%3D2021%26date%3D2021%26volume%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Minhao  Huang</span>, <span class="hlFld-ContribAuthor ">Yongjun  Huang</span>, <span class="hlFld-ContribAuthor ">Jing  Guo</span>, <span class="hlFld-ContribAuthor ">Lei  Yu</span>, <span class="hlFld-ContribAuthor ">Yu  Chang</span>, <span class="hlFld-ContribAuthor ">Xiaolu  Wang</span>, <span class="hlFld-ContribAuthor ">Jinfeng  Luo</span>, <span class="hlFld-ContribAuthor ">Yanhui  Huang</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Lu</span>, <span class="hlFld-ContribAuthor ">Yong  Xu</span>, <span class="hlFld-ContribAuthor ">Zhimin  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhang  Zhang</span>, <span class="hlFld-ContribAuthor ">Ke  Ding</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrido[2, 3-d]pyrimidin-7(8H)-ones as new selective orally bioavailable Threonine Tyrosine Kinase (TTK) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113023. <a href="https://doi.org/10.1016/j.ejmech.2020.113023" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113023%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyrido%25255B2%25252C%252B3-d%25255Dpyrimidin-7%2525288H%252529-ones%252Bas%252Bnew%252Bselective%252Borally%252Bbioavailable%252BThreonine%252BTyrosine%252BKinase%252B%252528TTK%252529%252Binhibitors%26aulast%3DHuang%26aufirst%3DMinhao%26date%3D2021%26volume%3D211%26spage%3D113023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomas  Opsomer</span>, <span class="hlFld-ContribAuthor ">Wim  Dehaen</span>. </span><span class="cited-content_cbyCitation_article-title">1,2,4-Triazoles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.14854-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.14854-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.14854-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.14854-1%26sid%3Dliteratum%253Aachs%26atitle%3D1%25252C2%25252C4-Triazoles%26aulast%3DOpsomer%26aufirst%3DTomas%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3Dvol.%25205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed  Monier</span>, <span class="hlFld-ContribAuthor ">Doaa  Abdel-Latif</span>, <span class="hlFld-ContribAuthor ">Ahmed  El-Mekabaty</span>, <span class="hlFld-ContribAuthor ">Başak D.  Mert</span>, <span class="hlFld-ContribAuthor ">Khaled M.  Elattar</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the Chemistry of 6-6 Bicyclic Systems: Chemistry of Pyrido[3,4- d]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Current Organic Synthesis</span><span> <strong>2019,</strong> <em>16 </em>
                                    (6)
                                     , 812-854. <a href="https://doi.org/10.2174/1570179416666190704113647" title="DOI URL">https://doi.org/10.2174/1570179416666190704113647</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570179416666190704113647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570179416666190704113647%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Organic%2520Synthesis%26atitle%3DAdvances%252Bin%252Bthe%252BChemistry%252Bof%252B6-6%252BBicyclic%252BSystems%25253A%252BChemistry%252Bof%252BPyrido%25255B3%25252C4-%252Bd%25255Dpyrimidines%26aulast%3DMonier%26aufirst%3DMohamed%26date%3D2019%26volume%3D16%26issue%3D6%26spage%3D812%26epage%3D854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon J.  Anderhub</span>, <span class="hlFld-ContribAuthor ">Grace Wing-Yan  Mak</span>, <span class="hlFld-ContribAuthor ">Mark D.  Gurden</span>, <span class="hlFld-ContribAuthor ">Amir  Faisal</span>, <span class="hlFld-ContribAuthor ">Konstantinos  Drosopoulos</span>, <span class="hlFld-ContribAuthor ">Katie  Walsh</span>, <span class="hlFld-ContribAuthor ">Hannah L.  Woodward</span>, <span class="hlFld-ContribAuthor ">Paolo  Innocenti</span>, <span class="hlFld-ContribAuthor ">Isaac M.  Westwood</span>, <span class="hlFld-ContribAuthor ">Sébastien  Naud</span>, <span class="hlFld-ContribAuthor ">Angela  Hayes</span>, <span class="hlFld-ContribAuthor ">Efthymia  Theofani</span>, <span class="hlFld-ContribAuthor ">Simone  Filosto</span>, <span class="hlFld-ContribAuthor ">Harry  Saville</span>, <span class="hlFld-ContribAuthor ">Rosemary  Burke</span>, <span class="hlFld-ContribAuthor ">Rob L.M.  van Montfort</span>, <span class="hlFld-ContribAuthor ">Florence I.  Raynaud</span>, <span class="hlFld-ContribAuthor ">Julian  Blagg</span>, <span class="hlFld-ContribAuthor ">Swen  Hoelder</span>, <span class="hlFld-ContribAuthor ">Suzanne A.  Eccles</span>, <span class="hlFld-ContribAuthor ">Spiros  Linardopoulos</span>. </span><span class="cited-content_cbyCitation_article-title">High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2019,</strong> <em>18 </em>
                                    (10)
                                     , 1696-1707. <a href="https://doi.org/10.1158/1535-7163.MCT-18-1203" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-18-1203</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-18-1203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-18-1203%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DHigh%252BProliferation%252BRate%252Band%252Ba%252BCompromised%252BSpindle%252BAssembly%252BCheckpoint%252BConfers%252BSensitivity%252Bto%252Bthe%252BMPS1%252BInhibitor%252BBOS172722%252Bin%252BTriple-Negative%252BBreast%252BCancers%26aulast%3DAnderhub%26aufirst%3DSimon%2BJ.%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D10%26spage%3D1696%26epage%3D1707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shutao  Wang</span>, <span class="hlFld-ContribAuthor ">Muxin  Zhang</span>, <span class="hlFld-ContribAuthor ">Di  Liang</span>, <span class="hlFld-ContribAuthor ">Wei  Sun</span>, <span class="hlFld-ContribAuthor ">Chaozai  Zhang</span>, <span class="hlFld-ContribAuthor ">Mengnan  Jiang</span>, <span class="hlFld-ContribAuthor ">Junli  Liu</span>, <span class="hlFld-ContribAuthor ">Jiaguo  Li</span>, <span class="hlFld-ContribAuthor ">Chenchen  Li</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular design and anticancer activities of small-molecule monopolar spindle 1 inhibitors: A Medicinal chemistry perspective. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>175 </em>, 247-268. <a href="https://doi.org/10.1016/j.ejmech.2019.04.047" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.04.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.04.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.04.047%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMolecular%252Bdesign%252Band%252Banticancer%252Bactivities%252Bof%252Bsmall-molecule%252Bmonopolar%252Bspindle%252B1%252Binhibitors%25253A%252BA%252BMedicinal%252Bchemistry%252Bperspective%26aulast%3DWang%26aufirst%3DShutao%26date%3D2019%26volume%3D175%26spage%3D247%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabio  Broccatelli</span>, <span class="hlFld-ContribAuthor ">Cornelis  E.C.A Hop</span>, <span class="hlFld-ContribAuthor ">Matthew  Wright</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies to optimize drug half-life in lead candidate identification. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (3)
                                     , 221-230. <a href="https://doi.org/10.1080/17460441.2019.1569625" title="DOI URL">https://doi.org/10.1080/17460441.2019.1569625</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2019.1569625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2019.1569625%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DStrategies%252Bto%252Boptimize%252Bdrug%252Bhalf-life%252Bin%252Blead%252Bcandidate%252Bidentification%26aulast%3DBroccatelli%26aufirst%3DFabio%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D3%26spage%3D221%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wendy A.  Loughlin</span>, <span class="hlFld-ContribAuthor ">Asmaa  Boufridi</span>. </span><span class="cited-content_cbyCitation_article-title">6-6 Bicyclic Systems: Three Heteroatoms 1:2. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.14794-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.14794-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.14794-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.14794-8%26sid%3Dliteratum%253Aachs%26atitle%3D6-6%252BBicyclic%252BSystems%25253A%252BThree%252BHeteroatoms%252B1%25253A2%26aulast%3DLoughlin%26aufirst%3DWendy%2BA.%26date%3D2019%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00690&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Published MPS1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00690&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. MPS1 inhibitor <b>5</b>. “P-MPS1” indicates an electrochemiluminescence mesoscale discovery (MSD)-based cellular assay that measured autophosphorylation of ectopically expressed MPS1 in HCT116 cells. Solubility conditions: HPLC, 1% DMSO, 10 mM PBS, pH 7.4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00690&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00690&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) amine, NMP, 100–130 °C; (ii) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C–r.t.; (iii) ArNHCHO <b>10</b>–<b>13</b> or <b>19</b>, NaH, THF, 0 °C–r.t.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0008.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00690&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) amine, NMP, 100–130 °C; (ii) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C–r.t.; (iii) ArNHCHO <b>12</b>, <b>13</b>, or <b>29</b>–<b>33</b>, NaH, THF, 0 °C–r.t.; (iv) ArNHCHO, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 120 °C.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0009.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00690&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C–r.t.; (ii) ArNHCHO <b>29</b>, NaH, THF, 0 °C–r.t.; (iii) amine, NMP, 100–130 °C.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Top: Superimposed crystal structure of MPS1 (green) bound to a pyrido[3,4-<i>d</i>]pyrimidine core (carbon atoms colored green), extracted from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EH0">5EH0</a>, onto the structure of CDK2 (blue), extracted from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1H08">1H08</a> (ligand hidden for clarity), showing the different gatekeeper residues present in MPS1 and CDK2. Bottom: 6-position methyl group on pyrido[3,4-<i>d</i>]pyrimidine core.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00690&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Results of a Met ID study showing oxidation products for the match pair of compounds <b>17</b> and <b>35</b> after treatment with HLM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00690&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Crystal structure of <b>36</b> bound to MPS1 (pdb code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6H3K">6H3K</a>). Compound <b>36</b> is shown with carbon atoms in yellow. Selected amino acids are shown in sea green and are labeled. Key hydrogen bonds are indicated as black dotted lines. (B) Close up of the neopentyl binding pocket. The neopentyl substituent is enveloped by residues Met671 and Pro673 from the activation loop. Protein surface is displayed as a transparent blue surface. The compound surface is shown in transparent yellow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00690&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/medium/jm-2018-00690m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Bar charts show the ratio of phosphylated-MPS1/total-MPS1 levels (gray) in the Dox-DLD1 model after treatment with <b>36</b> (left) and <b>41</b> (right) at specified doses and time points. The plasma levels at the respective time points are given in the table below the bar chart.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-18/acs.jmedchem.8b00690/20180920/images/large/jm-2018-00690m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00690&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i55">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78065" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78065" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 33 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardwick, K. G.</span></span> <span> </span><span class="NLM_article-title">The spindle checkpoint</span>. <i>Trends Genet.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">4</span>, <span class="refDoi"> DOI: 10.1016/S0168-9525(97)01340-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1016%2FS0168-9525%2897%2901340-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=9448456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADyaK1cXltlSjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1998&pages=1-4&author=K.+G.+Hardwick&title=The+spindle+checkpoint&doi=10.1016%2FS0168-9525%2897%2901340-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The spindle checkpoint</span></div><div class="casAuthors">Hardwick, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Genetics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-4</span>CODEN:
                <span class="NLM_cas:coden">TRGEE2</span>;
        ISSN:<span class="NLM_cas:issn">0168-9525</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 33 refs., on the spindle checkpoint, localization of checkpoint components, global signaling, and a role for the checkpoint proteins in the timing of a normal mitosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCK07I41QTXrVg90H21EOLACvtfcHk0ljCMdsBzguFRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltlSjuw%253D%253D&md5=b7c46a342b829847a9c7ebacbbe03915</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0168-9525%2897%2901340-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0168-9525%252897%252901340-1%26sid%3Dliteratum%253Aachs%26aulast%3DHardwick%26aufirst%3DK.%2BG.%26atitle%3DThe%2520spindle%2520checkpoint%26jtitle%3DTrends%2520Genet.%26date%3D1998%26volume%3D14%26spage%3D1%26epage%3D4%26doi%3D10.1016%2FS0168-9525%2897%2901340-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mills, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmandt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGill, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amendola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodricks, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogg, D.</span></span> <span> </span><span class="NLM_article-title">Expression of TTK, a novel human protein kinase, is associated with cell proliferation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">16000</span>– <span class="NLM_lpage">16006</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=16000-16006&author=G.+B.+Millsauthor=R.+Schmandtauthor=M.+McGillauthor=A.+Amendolaauthor=M.+Hillauthor=K.+Jacobsauthor=C.+Mayauthor=A.+M.+Rodricksauthor=S.+Campbellauthor=D.+Hogg&title=Expression+of+TTK%2C+a+novel+human+protein+kinase%2C+is+associated+with+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DSchmandt%26aufirst%3DR.%26aulast%3DMcGill%26aufirst%3DM.%26aulast%3DAmendola%26aufirst%3DA.%26aulast%3DHill%26aufirst%3DM.%26aulast%3DJacobs%26aufirst%3DK.%26aulast%3DMay%26aufirst%3DC.%26aulast%3DRodricks%26aufirst%3DA.%2BM.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DHogg%26aufirst%3DD.%26atitle%3DExpression%2520of%2520TTK%252C%2520a%2520novel%2520human%2520protein%2520kinase%252C%2520is%2520associated%2520with%2520cell%2520proliferation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D16000%26epage%3D16006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lauze, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoelcker, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luca, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutz, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winey, M.</span></span> <span> </span><span class="NLM_article-title">Yeast spindle pole body duplication gene MPS1 encodes an essential dual specificity protein kinase</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1655</span>– <span class="NLM_lpage">1663</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=1655-1663&author=E.+Lauzeauthor=B.+Stoelckerauthor=F.+C.+Lucaauthor=E.+Weissauthor=A.+R.+Schutzauthor=M.+Winey&title=Yeast+spindle+pole+body+duplication+gene+MPS1+encodes+an+essential+dual+specificity+protein+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLauze%26aufirst%3DE.%26aulast%3DStoelcker%26aufirst%3DB.%26aulast%3DLuca%26aufirst%3DF.%2BC.%26aulast%3DWeiss%26aufirst%3DE.%26aulast%3DSchutz%26aufirst%3DA.%2BR.%26aulast%3DWiney%26aufirst%3DM.%26atitle%3DYeast%2520spindle%2520pole%2520body%2520duplication%2520gene%2520MPS1%2520encodes%2520an%2520essential%2520dual%2520specificity%2520protein%2520kinase%26jtitle%3DEMBO%2520J.%26date%3D1995%26volume%3D14%26spage%3D1655%26epage%3D1663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Musacchio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmon, E. D.</span></span> <span> </span><span class="NLM_article-title">The spindle-assembly checkpoint in space and time</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">393</span>, <span class="refDoi"> DOI: 10.1038/nrm2163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1038%2Fnrm2163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=17426725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFSjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=379-393&author=A.+Musacchioauthor=E.+D.+Salmon&title=The+spindle-assembly+checkpoint+in+space+and+time&doi=10.1038%2Fnrm2163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The spindle-assembly checkpoint in space and time</span></div><div class="casAuthors">Musacchio, Andrea; Salmon, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">379-393</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In eukaryotes, the spindle-assembly checkpoint (SAC) is a ubiquitous safety device that ensures the fidelity of chromosome segregation in mitosis.  The SAC prevents chromosome missegregation and aneuploidy, and its dysfunction is implicated in tumorigenesis.  Recent mol. analyses have begun to shed light on the complex interaction of the checkpoint proteins with kinetochores - structures that mediate the binding of spindle microtubules to chromosomes in mitosis.  These studies are finally starting to reveal the mechanisms of checkpoint activation and silencing during mitotic progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBFNiU9YS2zbVg90H21EOLACvtfcHk0ljCMdsBzguFRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFSjsr0%253D&md5=b790220dccee5f0ad57f41aef0a3be32</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrm2163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2163%26sid%3Dliteratum%253Aachs%26aulast%3DMusacchio%26aufirst%3DA.%26aulast%3DSalmon%26aufirst%3DE.%2BD.%26atitle%3DThe%2520spindle-assembly%2520checkpoint%2520in%2520space%2520and%2520time%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D379%26epage%3D393%26doi%3D10.1038%2Fnrm2163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daniel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coulter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilsbach, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabrielson, E.</span></span> <span> </span><span class="NLM_article-title">High levels of the MPS1 checkpoint protein are protective of aneuploidy in breast cancer cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">5384</span>– <span class="NLM_lpage">5389</span>, <span class="refDoi"> DOI: 10.1073/pnas.1007645108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1073%2Fpnas.1007645108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=5384-5389&author=J.+Danielauthor=J.+Coulterauthor=J.-H.+Wooauthor=K.+Wilsbachauthor=E.+Gabrielson&title=High+levels+of+the+MPS1+checkpoint+protein+are+protective+of+aneuploidy+in+breast+cancer+cells&doi=10.1073%2Fpnas.1007645108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1007645108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1007645108%26sid%3Dliteratum%253Aachs%26aulast%3DDaniel%26aufirst%3DJ.%26aulast%3DCoulter%26aufirst%3DJ.%26aulast%3DWoo%26aufirst%3DJ.-H.%26aulast%3DWilsbach%26aufirst%3DK.%26aulast%3DGabrielson%26aufirst%3DE.%26atitle%3DHigh%2520levels%2520of%2520the%2520MPS1%2520checkpoint%2520protein%2520are%2520protective%2520of%2520aneuploidy%2520in%2520breast%2520cancer%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D5384%26epage%3D5389%26doi%3D10.1073%2Fpnas.1007645108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brough, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankum, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sims, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendes-Pereira, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajrami, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa-Cabral, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rafiq, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerone, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natrajan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiu, K.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetterskog, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dedes, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambros, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawjee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linardopoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis-Filho, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashworth, A.</span></span> <span> </span><span class="NLM_article-title">Functional viability profiles of breast cancer</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">260</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-11-0107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1158%2F2159-8290.CD-11-0107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=260-273&author=R.+Broughauthor=J.+R.+Frankumauthor=D.+Simsauthor=A.+Mackayauthor=A.+M.+Mendes-Pereiraauthor=I.+Bajramiauthor=S.+Costa-Cabralauthor=R.+Rafiqauthor=A.+S.+Ahmadauthor=M.+A.+Ceroneauthor=R.+Natrajanauthor=R.+Sharpeauthor=K.-K.+Shiuauthor=D.+Wetterskogauthor=K.+J.+Dedesauthor=M.+B.+Lambrosauthor=T.+Rawjeeauthor=S.+Linardopoulosauthor=J.+S.+Reis-Filhoauthor=N.+C.+Turnerauthor=C.+J.+Lordauthor=A.+Ashworth&title=Functional+viability+profiles+of+breast+cancer&doi=10.1158%2F2159-8290.CD-11-0107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-11-0107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-11-0107%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DR.%26aulast%3DFrankum%26aufirst%3DJ.%2BR.%26aulast%3DSims%26aufirst%3DD.%26aulast%3DMackay%26aufirst%3DA.%26aulast%3DMendes-Pereira%26aufirst%3DA.%2BM.%26aulast%3DBajrami%26aufirst%3DI.%26aulast%3DCosta-Cabral%26aufirst%3DS.%26aulast%3DRafiq%26aufirst%3DR.%26aulast%3DAhmad%26aufirst%3DA.%2BS.%26aulast%3DCerone%26aufirst%3DM.%2BA.%26aulast%3DNatrajan%26aufirst%3DR.%26aulast%3DSharpe%26aufirst%3DR.%26aulast%3DShiu%26aufirst%3DK.-K.%26aulast%3DWetterskog%26aufirst%3DD.%26aulast%3DDedes%26aufirst%3DK.%2BJ.%26aulast%3DLambros%26aufirst%3DM.%2BB.%26aulast%3DRawjee%26aufirst%3DT.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3DReis-Filho%26aufirst%3DJ.%2BS.%26aulast%3DTurner%26aufirst%3DN.%2BC.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DFunctional%2520viability%2520profiles%2520of%2520breast%2520cancer%26jtitle%3DCancer%2520Discovery%26date%3D2011%26volume%3D1%26spage%3D260%26epage%3D273%26doi%3D10.1158%2F2159-8290.CD-11-0107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Resio, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellman, D.</span></span> <span> </span><span class="NLM_article-title">Causes and consequences of aneuploidy in cancer</span>. <i>Nat. Rev. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1038/nrg3123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1038%2Fnrg3123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=22269907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFSnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=189-203&author=D.+J.+Gordonauthor=B.+Resioauthor=D.+Pellman&title=Causes+and+consequences+of+aneuploidy+in+cancer&doi=10.1038%2Fnrg3123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Causes and consequences of aneuploidy in cancer</span></div><div class="casAuthors">Gordon, David J.; Resio, Benjamin; Pellman, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">189-203</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Genetic instability, which includes both numerical and structural chromosomal abnormalities, is a hallmark of cancer.  Whereas the structural chromosome rearrangements have received substantial attention, the role of whole-chromosome aneuploidy in cancer is much less well-understood.  Here we review recent progress in understanding the roles of whole-chromosome aneuploidy in cancer, including the mechanistic causes of aneuploidy, the cellular responses to chromosome gains or losses and how cells might adapt to tolerate these usually detrimental alterations.  We also explore the role of aneuploidy in cellular transformation and discuss the possibility of developing aneuploidy-specific therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz4uwB4F0Xu7Vg90H21EOLACvtfcHk0ljlB1qJMmn2BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFSnu7k%253D&md5=9c730e7390d7aafd54301777e2270721</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrg3123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg3123%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DD.%2BJ.%26aulast%3DResio%26aufirst%3DB.%26aulast%3DPellman%26aufirst%3DD.%26atitle%3DCauses%2520and%2520consequences%2520of%2520aneuploidy%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2012%26volume%3D13%26spage%3D189%26epage%3D203%26doi%3D10.1038%2Fnrg3123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lengauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzler, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span> <span> </span><span class="NLM_article-title">Genetic instabilities in human cancers</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>396</i></span>,  <span class="NLM_fpage">643</span>– <span class="NLM_lpage">649</span>, <span class="refDoi"> DOI: 10.1038/25292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1038%2F25292" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=396&publication_year=1998&pages=643-649&author=C.+Lengauerauthor=K.+W.+Kinzlerauthor=B.+Vogelstein&title=Genetic+instabilities+in+human+cancers&doi=10.1038%2F25292"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F25292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F25292%26sid%3Dliteratum%253Aachs%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26atitle%3DGenetic%2520instabilities%2520in%2520human%2520cancers%26jtitle%3DNature%26date%3D1998%26volume%3D396%26spage%3D643%26epage%3D649%26doi%3D10.1038%2F25292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carter, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eklund, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohane, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szallasi, Z.</span></span> <span> </span><span class="NLM_article-title">A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1043</span>– <span class="NLM_lpage">1048</span>, <span class="refDoi"> DOI: 10.1038/ng1861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1038%2Fng1861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=16921376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BD28XovVWjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2006&pages=1043-1048&author=S.+L.+Carterauthor=A.+C.+Eklundauthor=I.+S.+Kohaneauthor=L.+N.+Harrisauthor=Z.+Szallasi&title=A+signature+of+chromosomal+instability+inferred+from+gene+expression+profiles+predicts+clinical+outcome+in+multiple+human+cancers&doi=10.1038%2Fng1861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers</span></div><div class="casAuthors">Carter, Scott L.; Eklund, Aron C.; Kohane, Isaac S.; Harris, Lyndsay N.; Szallasi, Zoltan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1043-1048</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We developed a computational method to characterize aneuploidy in tumor samples based on coordinated aberrations in expression of genes localized to each chromosomal region.  We summarized the total level of chromosomal aberration in a given tumor in a univariate measure termed total functional aneuploidy.  We identified a signature of chromosomal instability from specific genes whose expression was consistently correlated with total functional aneuploidy in several cancer types.  Net overexpression of this signature was predictive of poor clin. outcome in 12 cancer data sets representing six cancer types.  Also, the signature of chromosomal instability was higher in metastasis samples than in primary tumors and was able to stratify grade 1 and grade 2 breast tumors according to clin. outcome.  These results provide a means to assess the potential role of chromosomal instability in detg. malignant potential over a broad range of tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaDdEb7DAh87Vg90H21EOLACvtfcHk0ljlB1qJMmn2BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovVWjtr0%253D&md5=8d236ca65fd69447f0ed3bf0ac28eba8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fng1861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1861%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DS.%2BL.%26aulast%3DEklund%26aufirst%3DA.%2BC.%26aulast%3DKohane%26aufirst%3DI.%2BS.%26aulast%3DHarris%26aufirst%3DL.%2BN.%26aulast%3DSzallasi%26aufirst%3DZ.%26atitle%3DA%2520signature%2520of%2520chromosomal%2520instability%2520inferred%2520from%2520gene%2520expression%2520profiles%2520predicts%2520clinical%2520outcome%2520in%2520multiple%2520human%2520cancers%26jtitle%3DNat.%2520Genet.%26date%3D2006%26volume%3D38%26spage%3D1043%26epage%3D1048%26doi%3D10.1038%2Fng1861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, D.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wersto, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilsbach, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabrielson, E.</span></span> <span> </span><span class="NLM_article-title">Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-05-0903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1158%2F1078-0432.CCR-05-0903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=16428479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtlKjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=405-410&author=B.+Yuanauthor=Y.+Xuauthor=J.-H.+Wooauthor=Y.+Wangauthor=Y.+K.+Baeauthor=D.-S.+Yoonauthor=R.+P.+Werstoauthor=E.+Tullyauthor=K.+Wilsbachauthor=E.+Gabrielson&title=Increased+expression+of+mitotic+checkpoint+genes+in+breast+cancer+cells+with+chromosomal+instability&doi=10.1158%2F1078-0432.CCR-05-0903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Increased Expression of Mitotic Checkpoint Genes in Breast Cancer Cells with Chromosomal Instability</span></div><div class="casAuthors">Yuan, Bibo; Xu, Yi; Woo, Ju-Hyung; Wang, Yunyue; Bae, Young Kyung; Yoon, Dae-Sung; Wersto, Robert P.; Tully, Ellen; Wilsbach, Kathleen; Gabrielson, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">405-410</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Most breast cancers have chromosomal instability that seems related to defective mitotic spindle checkpoints.  Because the mol. basis of this defect is unknown, we evaluated breast cancer cell lines and tissues for possible defects involving the major mitotic checkpoint genes responsible for maintaining chromosomal stability.  Exptl. Design: We analyzed sequences and expression levels (RNA and protein) of eight major spindle checkpoint genes (MAD1L1, MAD2L1, MAD2L2, BUB1, BUB1B, BUB3, CDC20, and TTK) in a panel of 12 breast cancer cell lines, most with established genetic instability and defective spindle damage checkpoint response.  MRNA levels of these genes were also measured in primary tumor samples, and immunohistochem. staining was used to evaluate BUB1B protein levels in a panel of 270 addnl. cases of breast cancer.  Results: No functionally significant sequence variations were found for any of the eight genes in the breast cancer cell lines with chromosomal instability.  More surprisingly, the mRNA and protein levels for these checkpoint genes are significantly higher in the genetically unstable breast cancer cell lines and in high-grade primary breast cancer tissues than in the stable (and checkpoint proficient) MCF-10A and normal mammary epithelial cells, or in normal breast tissues.  In fact, overexpression of the BUB1B protein is a marker that recognizes nearly 80% of breast cancers in paraffin-embedded tissues.  Conclusions: Defective mitotic spindle checkpoints in breast cancer are most likely not caused by low expression or mutations of these eight checkpoint genes.  High levels of these particular transcripts could represent a cellular compensation for defects in other mol. components of the mitotic spindle damage checkpoint, and increased expression of these genes might be markers of breast cancers with chromosomal instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYcNtMRC1xcrVg90H21EOLACvtfcHk0liAUJ7qA5LNfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtlKjtw%253D%253D&md5=06a8afcd6636218ae3a7bf38fe9939b4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-0903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-0903%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DWoo%26aufirst%3DJ.-H.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBae%26aufirst%3DY.%2BK.%26aulast%3DYoon%26aufirst%3DD.-S.%26aulast%3DWersto%26aufirst%3DR.%2BP.%26aulast%3DTully%26aufirst%3DE.%26aulast%3DWilsbach%26aufirst%3DK.%26aulast%3DGabrielson%26aufirst%3DE.%26atitle%3DIncreased%2520expression%2520of%2520mitotic%2520checkpoint%2520genes%2520in%2520breast%2520cancer%2520cells%2520with%2520chromosomal%2520instability%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D405%26epage%3D410%26doi%3D10.1158%2F1078-0432.CCR-05-0903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mizukami, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kono, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daigo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsunoda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, H.</span></span> <span> </span><span class="NLM_article-title">Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">1448</span>– <span class="NLM_lpage">1454</span>, <span class="refDoi"> DOI: 10.1111/j.1349-7006.2008.00844.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1111%2Fj.1349-7006.2008.00844.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=18452554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1eitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=1448-1454&author=Y.+Mizukamiauthor=K.+Konoauthor=Y.+Daigoauthor=A.+Takanoauthor=T.+Tsunodaauthor=Y.+Kawaguchiauthor=Y.+Nakamuraauthor=H.+Fujii&title=Detection+of+novel+cancer-testis+antigen-specific+T-cell+responses+in+TIL%2C+regional+lymph+nodes%2C+and+PBL+in+patients+with+esophageal+squamous+cell+carcinoma&doi=10.1111%2Fj.1349-7006.2008.00844.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma</span></div><div class="casAuthors">Mizukami, Yoshiki; Kono, Koji; Daigo, Yataro; Takano, Atsushi; Tsunoda, Takuya; Kawaguchi, Yoshihiko; Nakamura, Yusuke; Fujii, Hideki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1448-1454</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">The authors recently identified three HLA-A2402-restricted epitope peptides derived from cancer-testis antigens (CTA), TTK protein kinase (TTK), lymphocyte antigen 6 complex locus K (LY6K), and insulin-like growth factor (IGF)-II mRNA binding protein 3 (IMP-3) for the development of immunotherapies against esophageal squamous cell carcinoma (ESCC).  To evaluate their immunotherapeutic potential in ESCC patients, the authors estd. by ELISPOT assay the TTK-, LY6K-, or IMP-3-specific T-cell immune responses in tumor-infiltrating lymphocytes (TIL), regional lymph node lymphocytes (RLNL), and peripheral blood lymphocytes (PBL) expanded from 20HLA-A2402 (+) ESCC patients, and correlated their immune activity with the expression levels of TTK, LY6K, and IMP-3, and MHC class I in the tumors.  Induction of TTK-antigen specific T-cell response in TIL to the peptide-pulsed target cells was detected in 14 out of 20 (70%) cases, while LY6K or IMP-3 specific T-cell activity was obsd. in 11 of 20 (55%) or in eight of 20 (40%) cases, resp.  Furthermore, T-cell activity in RLNL and PBL was detectable in the similar proportion of the 20 ESCC patients.  Interestingly, CTA-specific T-cell immune response was found in 13 of 14 (93%) TIL obtained from ESCC tumors with strong MHC class I expression, while it could be obsd. only in two of six (33%) TIL from ESCC tumors with weak MHC class I expression.  These results strongly suggest the pre-existence of specific T-cell responses to HLA-A24-restricted epitope peptides from TTK, LY6K, and IMP-3 in ESCC patients.  Monitoring antigen-specific T-cell responses, as well as the expression levels of MHC class I and epitope CTA in tumors, should be a selection index for application of cancer vaccine therapies to the patients who are likely to show good immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru8reosidZGbVg90H21EOLACvtfcHk0liAUJ7qA5LNfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1eitLo%253D&md5=dcb4be9405b2f37475bcd8785b27722a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2008.00844.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2008.00844.x%26sid%3Dliteratum%253Aachs%26aulast%3DMizukami%26aufirst%3DY.%26aulast%3DKono%26aufirst%3DK.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DTsunoda%26aufirst%3DT.%26aulast%3DKawaguchi%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DFujii%26aufirst%3DH.%26atitle%3DDetection%2520of%2520novel%2520cancer-testis%2520antigen-specific%2520T-cell%2520responses%2520in%2520TIL%252C%2520regional%2520lymph%2520nodes%252C%2520and%2520PBL%2520in%2520patients%2520with%2520esophageal%2520squamous%2520cell%2520carcinoma%26jtitle%3DCancer%2520Sci.%26date%3D2008%26volume%3D99%26spage%3D1448%26epage%3D1454%26doi%3D10.1111%2Fj.1349-7006.2008.00844.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salvatore, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nappi, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salerno, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugolini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miccoli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basolo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castellone, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirafici, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melillo, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fusco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittner, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoro, M.</span></span> <span> </span><span class="NLM_article-title">A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">10148</span>– <span class="NLM_lpage">10158</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-1887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1158%2F0008-5472.CAN-07-1887" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=10148-10158&author=G.+Salvatoreauthor=T.+C.+Nappiauthor=P.+Salernoauthor=Y.+Jiangauthor=C.+Garbiauthor=C.+Ugoliniauthor=P.+Miccoliauthor=F.+Basoloauthor=M.+D.+Castelloneauthor=A.+M.+Ciraficiauthor=R.+M.+Melilloauthor=A.+Fuscoauthor=M.+L.+Bittnerauthor=M.+Santoro&title=A+cell+proliferation+and+chromosomal+instability+signature+in+anaplastic+thyroid+carcinoma&doi=10.1158%2F0008-5472.CAN-07-1887"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-1887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-1887%26sid%3Dliteratum%253Aachs%26aulast%3DSalvatore%26aufirst%3DG.%26aulast%3DNappi%26aufirst%3DT.%2BC.%26aulast%3DSalerno%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DGarbi%26aufirst%3DC.%26aulast%3DUgolini%26aufirst%3DC.%26aulast%3DMiccoli%26aufirst%3DP.%26aulast%3DBasolo%26aufirst%3DF.%26aulast%3DCastellone%26aufirst%3DM.%2BD.%26aulast%3DCirafici%26aufirst%3DA.%2BM.%26aulast%3DMelillo%26aufirst%3DR.%2BM.%26aulast%3DFusco%26aufirst%3DA.%26aulast%3DBittner%26aufirst%3DM.%2BL.%26aulast%3DSantoro%26aufirst%3DM.%26atitle%3DA%2520cell%2520proliferation%2520and%2520chromosomal%2520instability%2520signature%2520in%2520anaplastic%2520thyroid%2520carcinoma%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D10148%26epage%3D10158%26doi%3D10.1158%2F0008-5472.CAN-07-1887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thykjaer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruhøffer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demtröder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederiksen, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knudsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ørntoft, T. F.</span></span> <span> </span><span class="NLM_article-title">Identification of gene expression patterns in superficial and invasive human bladder cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2492</span>– <span class="NLM_lpage">2499</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=2492-2499&author=T.+Thykjaerauthor=C.+Workmanauthor=M.+Kruh%C3%B8fferauthor=K.+Demtr%C3%B6derauthor=H.+Wolfauthor=L.+D.+Andersenauthor=C.+M.+Frederiksenauthor=S.+Knudsenauthor=T.+F.+%C3%98rntoft&title=Identification+of+gene+expression+patterns+in+superficial+and+invasive+human+bladder+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThykjaer%26aufirst%3DT.%26aulast%3DWorkman%26aufirst%3DC.%26aulast%3DKruh%25C3%25B8ffer%26aufirst%3DM.%26aulast%3DDemtr%25C3%25B6der%26aufirst%3DK.%26aulast%3DWolf%26aufirst%3DH.%26aulast%3DAndersen%26aufirst%3DL.%2BD.%26aulast%3DFrederiksen%26aufirst%3DC.%2BM.%26aulast%3DKnudsen%26aufirst%3DS.%26aulast%3D%25C3%2598rntoft%26aufirst%3DT.%2BF.%26atitle%3DIdentification%2520of%2520gene%2520expression%2520patterns%2520in%2520superficial%2520and%2520invasive%2520human%2520bladder%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D2492%26epage%3D2499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wengner, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemeister, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koppitz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosemund, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoeckigt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lienau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prechtl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raschke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisk, A.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Ahsen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michels, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreft, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Nussbaum, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brands, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mumberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegelbauer, K.</span></span> <span> </span><span class="NLM_article-title">Novel MPS1 kinase inhibitors with potent antitumor activity</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">583</span>– <span class="NLM_lpage">592</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-15-0500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1158%2F1535-7163.MCT-15-0500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=26832791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsVSqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=583-592&author=A.+M.+Wengnerauthor=G.+Siemeisterauthor=M.+Koppitzauthor=V.+Schulzeauthor=D.+Kosemundauthor=U.+Klarauthor=D.+Stoeckigtauthor=R.+Neuhausauthor=P.+Lienauauthor=B.+Baderauthor=S.+Prechtlauthor=M.+Raschkeauthor=A.-L.+Friskauthor=O.+von+Ahsenauthor=M.+Michelsauthor=B.+Kreftauthor=F.+von+Nussbaumauthor=M.+Brandsauthor=D.+Mumbergauthor=K.+Ziegelbauer&title=Novel+MPS1+kinase+inhibitors+with+potent+antitumor+activity&doi=10.1158%2F1535-7163.MCT-15-0500"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity</span></div><div class="casAuthors">Wengner, Antje M.; Siemeister, Gerhard; Koppitz, Marcus; Schulze, Volker; Kosemund, Dirk; Klar, Ulrich; Stoeckigt, Detlef; Neuhaus, Roland; Lienau, Philip; Bader, Benjamin; Prechtl, Stefan; Raschke, Marian; Frisk, Anna-Lena; von Ahsen, Oliver; Michels, Martin; Kreft, Bertolt; von Nussbaum, Franz; Brands, Michael; Mumberg, Dominik; Ziegelbauer, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">583-592</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Monopolar spindle 1 (Mps1) has been shown to function as the key kinase that activates the spindle assembly checkpoint (SAC) to secure proper distribution of chromosomes to daughter cells.  Here, we report the structure and functional characterization of two novel selective Mps1 inhibitors, BAY 1161909 and BAY 1217389, derived from structurally distinct chem. classes.  BAY 1161909 and BAY 1217389 inhibited Mps1 kinase activity with IC50 values below 10 nmol/L while showing an excellent selectivity profile.  In cellular mechanistic assays, both Mps1 inhibitors abrogated nocodazole-induced SAC activity and induced premature exit from mitosis ("mitotic breakthrough"), resulting in multinuclearity and tumor cell death.  Both compds. efficiently inhibited tumor cell proliferation in vitro (IC50 nmol/L range).  In vivo, BAY 1161909 and BAY 1217389 achieved moderate efficacy in monotherapy in tumor xenograft studies.  However, in line with its unique mode of action, when combined with paclitaxel, low doses of Mps1 inhibitor reduced paclitaxel-induced mitotic arrest by the weakening of SAC activity.  As a result, combination therapy strongly improved efficacy over paclitaxel or Mps1 inhibitor monotreatment at the resp. MTDs in a broad range of xenograft models, including those showing acquired or intrinsic paclitaxel resistance.  Both Mps1 inhibitors showed good tolerability without adding toxicity to paclitaxel monotherapy.  These preclin. findings validate the innovative concept of SAC abrogation for cancer therapy and justify clin. proof-of-concept studies evaluating the Mps1 inhibitors BAY 1161909 and BAY 1217389 in combination with antimitotic cancer drugs to enhance their efficacy and potentially overcome resistance.  Mol Cancer Ther; 15(4); 583-92. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGZQmIvWHFcLVg90H21EOLACvtfcHk0lhYhFKvJ3ur6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsVSqt7g%253D&md5=f2b5cf0daf178088479be4be2aefa6b7</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-15-0500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-15-0500%26sid%3Dliteratum%253Aachs%26aulast%3DWengner%26aufirst%3DA.%2BM.%26aulast%3DSiemeister%26aufirst%3DG.%26aulast%3DKoppitz%26aufirst%3DM.%26aulast%3DSchulze%26aufirst%3DV.%26aulast%3DKosemund%26aufirst%3DD.%26aulast%3DKlar%26aufirst%3DU.%26aulast%3DStoeckigt%26aufirst%3DD.%26aulast%3DNeuhaus%26aufirst%3DR.%26aulast%3DLienau%26aufirst%3DP.%26aulast%3DBader%26aufirst%3DB.%26aulast%3DPrechtl%26aufirst%3DS.%26aulast%3DRaschke%26aufirst%3DM.%26aulast%3DFrisk%26aufirst%3DA.-L.%26aulast%3Dvon%2BAhsen%26aufirst%3DO.%26aulast%3DMichels%26aufirst%3DM.%26aulast%3DKreft%26aufirst%3DB.%26aulast%3Dvon%2BNussbaum%26aufirst%3DF.%26aulast%3DBrands%26aufirst%3DM.%26aulast%3DMumberg%26aufirst%3DD.%26aulast%3DZiegelbauer%26aufirst%3DK.%26atitle%3DNovel%2520MPS1%2520kinase%2520inhibitors%2520with%2520potent%2520antitumor%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2016%26volume%3D15%26spage%3D583%26epage%3D592%26doi%3D10.1158%2F1535-7163.MCT-15-0500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiarash, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brokx, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beletskaya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">Functional characterization of CFI-402257, a potent and selective MPS1/TTK kinase inhibitor, for the treatment of cancer</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">3127</span>– <span class="NLM_lpage">3132</span>, <span class="refDoi"> DOI: 10.1073/pnas.1700234114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1073%2Fpnas.1700234114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=28270606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvVyjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=3127-3132&author=J.+M.+Masonauthor=X.+Weiauthor=G.+C.+Fletcherauthor=R.+Kiarashauthor=R.+Brokxauthor=R.+Hodgsonauthor=I.+Beletskayaauthor=M.+R.+Brayauthor=T.+W.+Mak&title=Functional+characterization+of+CFI-402257%2C+a+potent+and+selective+MPS1%2FTTK+kinase+inhibitor%2C+for+the+treatment+of+cancer&doi=10.1073%2Fpnas.1700234114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer</span></div><div class="casAuthors">Mason, Jacqueline M.; Wei, Xin; Fletcher, Graham C.; Kiarash, Reza; Brokx, Richard; Hodgson, Richard; Beletskaya, Irina; Bray, Mark R.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3127-3132</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Loss of cell-cycle control is a hallmark of human cancer.  Cell-cycle checkpoints are essential for maintaining genome integrity and balanced growth and division.  They are specifically deregulated in cancer cells and contain regulators that represent potential therapeutic targets.  Monopolar spindle 1 (Mps1; also known as TTK protein kinase) is a core component of the spindle assembly checkpoint (SAC), a genome-surveillance mechanism that is important for cell survival, and has emerged as a candidate target for anticancer therapy.  Here, the authors report the cellular and antitumor effects of CFI-402257, a potent (Mps1 Ki = 0.09±0.02 nM; cellular Mps1 EC50 = 6.5±0.5 nM), highly selective, and orally active small-mol. inhibitor of Mps1 that was identified through a drug-discovery program.  Human cancer cells treated with CFI-402257 exhibit effects consistent with Mps1 kinase inhibition, specifically SAC inactivation, leading to chromosome missegregation, aneuploidy, and ultimately cell death.  Oral administration of CFI-402257 in monotherapy or in combination with an anti-programmed cell death 1 (PD-1) antibody in mouse models of human cancer results in inhibition of tumor growth at doses that are well-tolerated.  The authors' findings provide a rationale for the clin. evaluation of CFI-402257 in patients with solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFQJ3eg_c-qLVg90H21EOLACvtfcHk0lhYhFKvJ3ur6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvVyjsL8%253D&md5=bb9742c8d07314e7d3c322bef71ef0ff</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1700234114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1700234114%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DFletcher%26aufirst%3DG.%2BC.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DBrokx%26aufirst%3DR.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DBray%26aufirst%3DM.%2BR.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DFunctional%2520characterization%2520of%2520CFI-402257%252C%2520a%2520potent%2520and%2520selective%2520MPS1%252FTTK%2520kinase%2520inhibitor%252C%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3D3127%26epage%3D3132%26doi%3D10.1073%2Fpnas.1700234114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faisal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrake, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavetsias, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atrash, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, K.-M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boxall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Haven Brandon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAndrew, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matijssen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linardopoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Montfort, R. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of orally bioavailable 1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine inhibitors of mitotic kinase monopolar spindle 1 (MPS1)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">10045</span>– <span class="NLM_lpage">10065</span>, <span class="refDoi"> DOI: 10.1021/jm401395s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401395s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVShsLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=10045-10065&author=S.+Naudauthor=I.+M.+Westwoodauthor=A.+Faisalauthor=P.+Sheldrakeauthor=V.+Bavetsiasauthor=B.+Atrashauthor=K.-M.+J.+Cheungauthor=M.+Liuauthor=A.+Hayesauthor=J.+Schmittauthor=A.+Woodauthor=V.+Choiauthor=K.+Boxallauthor=G.+Makauthor=M.+Gurdenauthor=M.+Valentiauthor=A.+de+Haven+Brandonauthor=A.+Henleyauthor=R.+Bakerauthor=C.+McAndrewauthor=B.+Matijssenauthor=R.+Burkeauthor=S.+Hoelderauthor=S.+A.+Ecclesauthor=F.+I.+Raynaudauthor=S.+Linardopoulosauthor=R.+L.+M.+van+Montfortauthor=J.+Blagg&title=Structure-based+design+of+orally+bioavailable+1H-pyrrolo%5B3%2C2-c%5Dpyridine+inhibitors+of+mitotic+kinase+monopolar+spindle+1+%28MPS1%29&doi=10.1021%2Fjm401395s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Orally Bioavailable 1H-Pyrrolo[3,2-c]pyridine Inhibitors of Mitotic Kinase Monopolar Spindle 1 (MPS1)</span></div><div class="casAuthors">Naud, Sebastien; Westwood, Isaac M.; Faisal, Amir; Sheldrake, Peter; Bavetsias, Vassilios; Atrash, Butrus; Cheung, Kwai-Ming J.; Liu, Manjuan; Hayes, Angela; Schmitt, Jessica; Wood, Amy; Choi, Vanessa; Boxall, Kathy; Mak, Grace; Gurden, Mark; Valenti, Melanie; de Haven Brandon, Alexis; Henley, Alan; Baker, Ross; McAndrew, Craig; Matijssen, Berry; Burke, Rosemary; Hoelder, Swen; Eccles, Suzanne A.; Raynaud, Florence I.; Linardopoulos, Spiros; van Montfort, Rob L. M.; Blagg, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10045-10065</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The protein kinase MPS1 is a crucial component of the spindle assembly checkpoint signal and is aberrantly overexpressed in many human cancers.  MPS1 is one of the top 25 genes overexpressed in tumors with chromosomal instability and aneuploidy.  PTEN-deficient breast tumor cells are particularly dependent upon MPS1 for their survival, making it a target of significant interest in oncol.  The authors report the discovery and optimization of potent and selective MPS1 inhibitors based on the 1H-pyrrolo-[3,2-c]-pyridine scaffold, guided by structure-based design and cellular characterization of MPS1 inhibition, leading to CCT251455.  This potent and selective chem. tool stabilizes an inactive conformation of MPS1 with the activation loop ordered in a manner incompatible with ATP and substrate-peptide binding; it displays a favorable oral pharmacokinetic profile, shows dose-dependent inhibition of MPS1 in an HCT116 human tumor xenograft model, and is an attractive tool compd. to elucidate further the therapeutic potential of MPS1 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVRsRcyzCEBLVg90H21EOLACvtfcHk0lhAPyyLW2WiMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVShsLzO&md5=6564efe14dec83774e94c355be756845</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm401395s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401395s%26sid%3Dliteratum%253Aachs%26aulast%3DNaud%26aufirst%3DS.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DFaisal%26aufirst%3DA.%26aulast%3DSheldrake%26aufirst%3DP.%26aulast%3DBavetsias%26aufirst%3DV.%26aulast%3DAtrash%26aufirst%3DB.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DChoi%26aufirst%3DV.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DMak%26aufirst%3DG.%26aulast%3DGurden%26aufirst%3DM.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3Dde%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DHenley%26aufirst%3DA.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DMcAndrew%26aufirst%3DC.%26aulast%3DMatijssen%26aufirst%3DB.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DHoelder%26aufirst%3DS.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3DStructure-based%2520design%2520of%2520orally%2520bioavailable%25201H-pyrrolo%255B3%252C2-c%255Dpyridine%2520inhibitors%2520of%2520mitotic%2520kinase%2520monopolar%2520spindle%25201%2520%2528MPS1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D10045%26epage%3D10065%26doi%3D10.1021%2Fjm401395s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Innocenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solanki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henley, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faisal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, G. W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Haven Brandon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Fee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saville, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matijssen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Montfort, R. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linardopoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span> <span> </span><span class="NLM_article-title">Rapid discovery of pyrido[3,4-<i>d</i>]pyrimidine inhibitors of monopolar spindle kinase 1 (MPS1) using a structure-based hybridization approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3671</span>– <span class="NLM_lpage">3688</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01811</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01811" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsF2qsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3671-3688&author=P.+Innocentiauthor=H.+L.+Woodwardauthor=S.+Solankiauthor=S.+Naudauthor=I.+M.+Westwoodauthor=N.+Croninauthor=A.+Hayesauthor=J.+Robertsauthor=A.+T.+Henleyauthor=R.+Bakerauthor=A.+Faisalauthor=G.+W.-Y.+Makauthor=G.+Boxauthor=M.+Valentiauthor=A.+De+Haven+Brandonauthor=L.+O%E2%80%99Feeauthor=H.+Savilleauthor=J.+Schmittauthor=B.+Matijssenauthor=R.+Burkeauthor=R.+L.+M.+van+Montfortauthor=F.+I.+Raynaudauthor=S.+A.+Ecclesauthor=S.+Linardopoulosauthor=J.+Blaggauthor=S.+Hoelder&title=Rapid+discovery+of+pyrido%5B3%2C4-d%5Dpyrimidine+inhibitors+of+monopolar+spindle+kinase+1+%28MPS1%29+using+a+structure-based+hybridization+approach&doi=10.1021%2Facs.jmedchem.5b01811"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle Kinase 1 (MPS1) Using a Structure-Based Hybridization Approach</span></div><div class="casAuthors">Innocenti, Paolo; Woodward, Hannah L.; Solanki, Savade; Naud, Sebastien; Westwood, Isaac M.; Cronin, Nora; Hayes, Angela; Roberts, Jennie; Henley, Alan T.; Baker, Ross; Faisal, Amir; Mak, Grace Wing-Yan; Box, Gary; Valenti, Melanie; De Haven Brandon, Alexis; O'Fee, Lisa; Saville, Harry; Schmitt, Jessica; Matijssen, Berry; Burke, Rosemary; van Montfort, Rob L. M.; Raynaud, Florence I.; Eccles, Suzanne A.; Linardopoulos, Spiros; Blagg, Julian; Hoelder, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3671-3688</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monopolar spindle 1 (MPS1) plays a central role in the transition of cells from metaphase to anaphase and is one of the main components of the spindle assembly checkpoint.  Chromosomally unstable cancer cells rely heavily on MPS1 to cope with the stress arising from abnormal nos. of chromosomes and centrosomes and are thus more sensitive to MPS1 inhibition than normal cells.  We report the discovery and optimization of a series of new pyrido[3,4-d]pyrimidine based inhibitors via a structure-based hybridization approach from our previously reported inhibitor CCT251455 and a modestly potent screening hit.  Compds. in this novel series display excellent potency and selectivity for MPS1, which translates into biomarker modulation in an in vivo human tumor xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr42v6loNvM1bVg90H21EOLACvtfcHk0lhAPyyLW2WiMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsF2qsro%253D&md5=dd858ed11744e0b036061baf5e2c181a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01811%26sid%3Dliteratum%253Aachs%26aulast%3DInnocenti%26aufirst%3DP.%26aulast%3DWoodward%26aufirst%3DH.%2BL.%26aulast%3DSolanki%26aufirst%3DS.%26aulast%3DNaud%26aufirst%3DS.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DCronin%26aufirst%3DN.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DHenley%26aufirst%3DA.%2BT.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DFaisal%26aufirst%3DA.%26aulast%3DMak%26aufirst%3DG.%2BW.-Y.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DDe%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Fee%26aufirst%3DL.%26aulast%3DSaville%26aufirst%3DH.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DMatijssen%26aufirst%3DB.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DRapid%2520discovery%2520of%2520pyrido%255B3%252C4-d%255Dpyrimidine%2520inhibitors%2520of%2520monopolar%2520spindle%2520kinase%25201%2520%2528MPS1%2529%2520using%2520a%2520structure-based%2520hybridization%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3671%26epage%3D3688%26doi%3D10.1021%2Facs.jmedchem.5b01811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tardif, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassiano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimbora, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douce, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorweiler, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostanin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papac, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baichwal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAlexander, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willardsen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettstein, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, B. L.</span></span> <span> </span><span class="NLM_article-title">Characterization of the cellular and antitumor effects of MPI-0479605, a small-molecule inhibitor of the mitotic kinase MPS1</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2267</span>– <span class="NLM_lpage">2275</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-11-0453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1158%2F1535-7163.MCT-11-0453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=21980130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylurnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=2267-2275&author=K.+D.+Tardifauthor=A.+Rogersauthor=J.+Cassianoauthor=B.+L.+Rothauthor=D.+M.+Cimboraauthor=R.+McKinnonauthor=A.+Petersonauthor=T.+B.+Douceauthor=R.+Robinsonauthor=I.+Dorweilerauthor=T.+Davisauthor=M.+A.+Hessauthor=K.+Ostaninauthor=D.+I.+Papacauthor=V.+Baichwalauthor=I.+McAlexanderauthor=J.+A.+Willardsenauthor=M.+Saundersauthor=H.+Christopheauthor=D.+V.+Kumarauthor=D.+A.+Wettsteinauthor=R.+O.+Carlsonauthor=B.+L.+Williams&title=Characterization+of+the+cellular+and+antitumor+effects+of+MPI-0479605%2C+a+small-molecule+inhibitor+of+the+mitotic+kinase+MPS1&doi=10.1158%2F1535-7163.MCT-11-0453"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the Cellular and Antitumor Effects of MPI-0479605, a Small-Molecule Inhibitor of the Mitotic Kinase Mps1</span></div><div class="casAuthors">Tardif, Keith D.; Rogers, Aaron; Cassiano, Jared; Roth, Bruce L.; Cimbora, Daniel M.; McKinnon, Rena; Peterson, Ashley; Douce, Thomas B.; Robinson, Rosann; Dorweiler, Irene; Davis, Thaylon; Hess, Mark A.; Ostanin, Kirill; Papac, Damon I.; Baichwal, Vijay; McAlexander, Ian; Willardsen, J. Adam; Saunders, Michael; Christophe, Hoarau; Kumar, D. Vijay; Wettstein, Daniel A.; Carlson, Robert O.; Williams, Brandi L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2267-2275</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Mps1 is a dual specificity protein kinase that is essential for the bipolar attachment of chromosomes to the mitotic spindle and for maintaining the spindle assembly checkpoint until all chromosomes are properly attached.  Mps1 is expressed at high levels during mitosis and is abundantly expressed in cancer cells.  Disruption of Mps1 function induces aneuploidy and cell death.  We report the identification of MPI-0479605, a potent and selective ATP competitive inhibitor of Mps1.  Cells treated with MPI-0479605 undergo aberrant mitosis, resulting in aneuploidy and formation of micronuclei.  In cells with wild-type p53, this promotes the induction of a postmitotic checkpoint characterized by the ATM- and RAD3-related-dependent activation of the p53-p21 pathway.  In both wild-type and p53 mutant cells lines, there is a growth arrest and inhibition of DNA synthesis.  Subsequently, cells undergo mitotic catastrophe and/or an apoptotic response.  In xenograft models, MPI-0479605 inhibits tumor growth, suggesting that drugs targeting Mps1 may have utility as novel cancer therapeutics.  Mol Cancer Ther; 10(12); 2267-75.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMIODujnZWCLVg90H21EOLACvtfcHk0liuRBkzOvnexA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylurnO&md5=e243764443e9dfda40fc84a329d776c2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0453%26sid%3Dliteratum%253Aachs%26aulast%3DTardif%26aufirst%3DK.%2BD.%26aulast%3DRogers%26aufirst%3DA.%26aulast%3DCassiano%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCimbora%26aufirst%3DD.%2BM.%26aulast%3DMcKinnon%26aufirst%3DR.%26aulast%3DPeterson%26aufirst%3DA.%26aulast%3DDouce%26aufirst%3DT.%2BB.%26aulast%3DRobinson%26aufirst%3DR.%26aulast%3DDorweiler%26aufirst%3DI.%26aulast%3DDavis%26aufirst%3DT.%26aulast%3DHess%26aufirst%3DM.%2BA.%26aulast%3DOstanin%26aufirst%3DK.%26aulast%3DPapac%26aufirst%3DD.%2BI.%26aulast%3DBaichwal%26aufirst%3DV.%26aulast%3DMcAlexander%26aufirst%3DI.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26aulast%3DSaunders%26aufirst%3DM.%26aulast%3DChristophe%26aufirst%3DH.%26aulast%3DKumar%26aufirst%3DD.%2BV.%26aulast%3DWettstein%26aufirst%3DD.%2BA.%26aulast%3DCarlson%26aufirst%3DR.%2BO.%26aulast%3DWilliams%26aufirst%3DB.%2BL.%26atitle%3DCharacterization%2520of%2520the%2520cellular%2520and%2520antitumor%2520effects%2520of%2520MPI-0479605%252C%2520a%2520small-molecule%2520inhibitor%2520of%2520the%2520mitotic%2520kinase%2520MPS1%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D2267%26epage%3D2275%26doi%3D10.1158%2F1535-7163.MCT-11-0453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tannous, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Stoop, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowski, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewandrowski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiddingh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sol, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagerweij, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wedekind, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niers, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barazas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, R. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geerts, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Witt Hamer, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagemann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandertop, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Tellingen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noske, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Würdinger, T.</span></span> <span> </span><span class="NLM_article-title">Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs</span>. <i>J. Natl. Canc. Inst.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">1322</span>– <span class="NLM_lpage">1331</span>, <span class="refDoi"> DOI: 10.1093/jnci/djt168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1093%2Fjnci%2Fdjt168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=23940287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVKgu7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2013&pages=1322-1331&author=B.+A.+Tannousauthor=M.+Keramiauthor=P.+M.+Van+der+Stoopauthor=N.+Kwiatkowskiauthor=J.+Wangauthor=W.+Zhouauthor=A.+F.+Kesslerauthor=G.+Lewandrowskiauthor=L.+Hiddinghauthor=N.+Solauthor=T.+Lagerweijauthor=L.+Wedekindauthor=J.+M.+Niersauthor=M.+Barazasauthor=R.+J.+A.+Nilssonauthor=D.+Geertsauthor=P.+C.+De+Witt+Hamerauthor=C.+Hagemannauthor=W.+P.+Vandertopauthor=O.+Van+Tellingenauthor=D.+P.+Noskeauthor=N.+S.+Grayauthor=T.+W%C3%BCrdinger&title=Effects+of+the+selective+MPS1+inhibitor+MPS1-IN-3+on+glioblastoma+sensitivity+to+antimitotic+drugs&doi=10.1093%2Fjnci%2Fdjt168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the Selective MPS1 Inhibitor MPS1-IN-3 on Glioblastoma Sensitivity to Antimitotic Drugs</span></div><div class="casAuthors">Tannous, Bakhos A.; Kerami, Mariam; Van der Stoop, Petra M.; Kwiatkowski, Nicholas; Wang, Jinhua; Zhou, Wenjun; Kessler, Almuth F.; Lewandrowski, Grant; Hiddingh, Lotte; Sol, Nik; Lagerweij, Tonny; Wedekind, Laurine; Niers, Johanna M.; Barazas, Marco; Nilsson, R. Jonas A.; Geerts, Dirk; De Witt Hamer, Philip C.; Hagemann, Carsten; Vandertop, W. Peter; Van Tellingen, Olaf; Noske, David P.; Gray, Nathanael S.; Wuerdinger, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1322-1331</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background Glioblastomas exhibit a high level of chemotherapeutic resistance, including to the antimitotic agents vincristine and taxol.  During the mitotic agent-induced arrest, glioblastoma cells are able to perform damage-control and self-repair to continue proliferation.  Monopolar spindle 1 (MPS1/TTK) is a checkpoint kinase and a gatekeeper of the mitotic arrest.  Methods We used glioblastoma cells to det. the expression of MPS1 and to det. the effects of MPS1 inhibition on mitotic errors and cell viability in combination with vincristine and taxol.  The effect of MPS1 inhibition was assessed in different orthotopic glioblastoma mouse models (n = 3-7 mice/group).  MPS1 expression levels were examd. in relation to patient survival.  Results Using publicly available gene expression data, we detd. that MPS1 overexpression corresponds pos. with tumor grade and neg. with patient survival (two-sided t test, P < .001).  Patients with high MPS1 expression (n = 203) had a median and mean survival of 487 and 913 days (95% confidence intervals [CI] = 751 to 1075), resp., and a 2-yr survival rate of 35%, whereas patients with intermediate MPS1 expression (n = 140) had a median and mean survival of 858 and 1183 days (95% CI = 1177 to 1189), resp., and a 2-yr survival rate of 56%.  We demonstrate that MPS1 inhibition by RNAi results in sensitization to antimitotic agents.  We developed a selective small-mol. inhibitor of MPS1, MPS1-IN-3, which caused mitotic aberrancies in glioblastoma cells and, in combination with vincristine, induced mitotic checkpoint override, increased aneuploidy, and augmented cell death.  MPS1-IN-3 sensitizes glioblastoma cells to vincristine in orthotopic mouse models (two-sided log-rank test, P < .01), resulting in prolonged survival without toxicity.  Conclusions Our results collectively demonstrate that MPS1, a putative therapeutic target in glioblastoma, can be selectively inhibited by MPS1-IN-3 sensitizing glioblastoma cells to antimitotic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUG67Lkc5qcbVg90H21EOLACvtfcHk0liuRBkzOvnexA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVKgu7fK&md5=b7e51ef38e02d9fbf0ce0191af530b3a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjt168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjt168%26sid%3Dliteratum%253Aachs%26aulast%3DTannous%26aufirst%3DB.%2BA.%26aulast%3DKerami%26aufirst%3DM.%26aulast%3DVan%2Bder%2BStoop%26aufirst%3DP.%2BM.%26aulast%3DKwiatkowski%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DKessler%26aufirst%3DA.%2BF.%26aulast%3DLewandrowski%26aufirst%3DG.%26aulast%3DHiddingh%26aufirst%3DL.%26aulast%3DSol%26aufirst%3DN.%26aulast%3DLagerweij%26aufirst%3DT.%26aulast%3DWedekind%26aufirst%3DL.%26aulast%3DNiers%26aufirst%3DJ.%2BM.%26aulast%3DBarazas%26aufirst%3DM.%26aulast%3DNilsson%26aufirst%3DR.%2BJ.%2BA.%26aulast%3DGeerts%26aufirst%3DD.%26aulast%3DDe%2BWitt%2BHamer%26aufirst%3DP.%2BC.%26aulast%3DHagemann%26aufirst%3DC.%26aulast%3DVandertop%26aufirst%3DW.%2BP.%26aulast%3DVan%2BTellingen%26aufirst%3DO.%26aulast%3DNoske%26aufirst%3DD.%2BP.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DW%25C3%25BCrdinger%26aufirst%3DT.%26atitle%3DEffects%2520of%2520the%2520selective%2520MPS1%2520inhibitor%2520MPS1-IN-3%2520on%2520glioblastoma%2520sensitivity%2520to%2520antimitotic%2520drugs%26jtitle%3DJ.%2520Natl.%2520Canc.%2520Inst.%26date%3D2013%26volume%3D105%26spage%3D1322%26epage%3D1331%26doi%3D10.1093%2Fjnci%2Fdjt168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ide, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daigo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuoka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagashira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanazawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishioka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dohi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshizawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span> <span> </span><span class="NLM_article-title">A unique hinge binder of extremely selective aminopyridine-based MPS1 (TTK) kinase inhibitors with cellular activity</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2247</span>– <span class="NLM_lpage">2260</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.02.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1016%2Fj.bmc.2015.02.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=2247-2260&author=K.-I.+Kusakabeauthor=N.+Ideauthor=Y.+Daigoauthor=T.+Itohauthor=T.+Yamamotoauthor=E.+Kojimaauthor=Y.+Mitsuokaauthor=G.+Tadanoauthor=S.+Tagashiraauthor=K.+Higashinoauthor=Y.+Okanoauthor=Y.+Satoauthor=M.+Inoueauthor=M.+Iguchiauthor=T.+Kanazawaauthor=Y.+Ishiokaauthor=K.+Dohiauthor=Y.+Kidoauthor=S.+Sakamotoauthor=S.+Andoauthor=M.+Maedaauthor=M.+Higakiauthor=H.+Yoshizawaauthor=H.+Muraiauthor=Y.+Nakamura&title=A+unique+hinge+binder+of+extremely+selective+aminopyridine-based+MPS1+%28TTK%29+kinase+inhibitors+with+cellular+activity&doi=10.1016%2Fj.bmc.2015.02.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.02.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.02.042%26sid%3Dliteratum%253Aachs%26aulast%3DKusakabe%26aufirst%3DK.-I.%26aulast%3DIde%26aufirst%3DN.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DKojima%26aufirst%3DE.%26aulast%3DMitsuoka%26aufirst%3DY.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DTagashira%26aufirst%3DS.%26aulast%3DHigashino%26aufirst%3DK.%26aulast%3DOkano%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DIguchi%26aufirst%3DM.%26aulast%3DKanazawa%26aufirst%3DT.%26aulast%3DIshioka%26aufirst%3DY.%26aulast%3DDohi%26aufirst%3DK.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DHigaki%26aufirst%3DM.%26aulast%3DYoshizawa%26aufirst%3DH.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DA%2520unique%2520hinge%2520binder%2520of%2520extremely%2520selective%2520aminopyridine-based%2520MPS1%2520%2528TTK%2529%2520kinase%2520inhibitors%2520with%2520cellular%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D2247%26epage%3D2260%26doi%3D10.1016%2Fj.bmc.2015.02.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awrey, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beletskaya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plotnikova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiarash, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D. C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris-Brandts, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ban, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadeem, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chirgadze, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauls, H. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of inhibitors of the mitotic kinase TTK based on <i>N</i>-(3-(3-sulfamoylphenyl)-1<i>H</i>-indazol-5-yl)-acetamides and carboxamides</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">4968</span>– <span class="NLM_lpage">4997</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.06.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1016%2Fj.bmc.2014.06.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=25043312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFyjt7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=4968-4997&author=R.+Lauferauthor=G.+Ngauthor=Y.+Liuauthor=N.+K.+B.+Patelauthor=L.+G.+Edwardsauthor=Y.+Langauthor=S.-W.+Liauthor=M.+Feherauthor=D.+E.+Awreyauthor=G.+Leungauthor=I.+Beletskayaauthor=O.+Plotnikovaauthor=J.+M.+Masonauthor=R.+Hodgsonauthor=X.+Weiauthor=G.+Maoauthor=X.+Luoauthor=P.+Huangauthor=E.+Greenauthor=R.+Kiarashauthor=D.+C.-C.+Linauthor=M.+Harris-Brandtsauthor=F.+Banauthor=V.+Nadeemauthor=T.+W.+Makauthor=G.+J.+Panauthor=W.+Qiuauthor=N.+Y.+Chirgadzeauthor=H.+W.+Pauls&title=Discovery+of+inhibitors+of+the+mitotic+kinase+TTK+based+on+N-%283-%283-sulfamoylphenyl%29-1H-indazol-5-yl%29-acetamides+and+carboxamides&doi=10.1016%2Fj.bmc.2014.06.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)acetamides and carboxamides</span></div><div class="casAuthors">Laufer, Radoslaw; Ng, Grace; Liu, Yong; Patel, Narendra Kumar B.; Edwards, Louise G.; Lang, Yunhui; Li, Sze-Wan; Feher, Miklos; Awrey, Don E.; Leung, Genie; Beletskaya, Irina; Plotnikova, Olga; Mason, Jacqueline M.; Hodgson, Richard; Wei, Xin; Mao, Guodong; Luo, Xunyi; Huang, Ping; Green, Erin; Kiarash, Reza; Lin, Dan Chi-Chia; Harris-Brandts, Marees; Ban, Fuqiang; Nadeem, Vincent; Mak, Tak W.; Pan, Guohua J.; Qiu, Wei; Chirgadze, Nickolay Y.; Pauls, Henry W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4968-4997</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">TTK kinase was identified by inhouse siRNA screen and pursued as a tractable, novel target for cancer treatment.  A screening campaign and systematic optimization, supported by computer modeling led to an indazole core with key sulfamoylphenyl and acetamido moieties at positions 3 and 5, resp., establishing a novel chem. class culminating in identification of I (CFI-400936).  This potent inhibitor of TTK (IC50 = 3.6 nM) demonstrated good activity in cell based assay and selectivity against a panel of human kinases.  A complex TTK x-ray crystal structure and results of a xenograft study with TTK inhibitors from this class are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYMVdifCP5IrVg90H21EOLACvtfcHk0lj-e3U-ankRzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFyjt7fK&md5=71dac8de6f21ee67d1c18fd4e521a4f9</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.06.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.06.027%26sid%3Dliteratum%253Aachs%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DNg%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DPatel%26aufirst%3DN.%2BK.%2BB.%26aulast%3DEdwards%26aufirst%3DL.%2BG.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.-W.%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DAwrey%26aufirst%3DD.%2BE.%26aulast%3DLeung%26aufirst%3DG.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DG.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DGreen%26aufirst%3DE.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DD.%2BC.-C.%26aulast%3DHarris-Brandts%26aufirst%3DM.%26aulast%3DBan%26aufirst%3DF.%26aulast%3DNadeem%26aufirst%3DV.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DPan%26aufirst%3DG.%2BJ.%26aulast%3DQiu%26aufirst%3DW.%26aulast%3DChirgadze%26aufirst%3DN.%2BY.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DDiscovery%2520of%2520inhibitors%2520of%2520the%2520mitotic%2520kinase%2520TTK%2520based%2520on%2520N-%25283-%25283-sulfamoylphenyl%2529-1H-indazol-5-yl%2529-acetamides%2520and%2520carboxamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D4968%26epage%3D4997%26doi%3D10.1016%2Fj.bmc.2014.06.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallin, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rymer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanochko, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trajkovic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timofeevski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lappin, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span> <span> </span><span class="NLM_article-title">Mitotic checkpoint kinase MPS1 has a role in normal physiology which impacts clinical utility</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0138616</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0138616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1371%2Fjournal.pone.0138616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=26398286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ymsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0138616&author=R.+Martinezauthor=A.+Blasinaauthor=J.+F.+Hallinauthor=W.+Huauthor=I.+Rymerauthor=J.+Fanauthor=R.+L.+Hoffmanauthor=S.+Murphyauthor=M.+Marxauthor=G.+Yanochkoauthor=D.+Trajkovicauthor=D.+Dinhauthor=S.+Timofeevskiauthor=Z.+Zhuauthor=P.+Sunauthor=P.+B.+Lappinauthor=B.+W.+Murray&title=Mitotic+checkpoint+kinase+MPS1+has+a+role+in+normal+physiology+which+impacts+clinical+utility&doi=10.1371%2Fjournal.pone.0138616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Mitotic checkpoint kinase Mps1 has a role in normal physiology which impacts clinical utility</span></div><div class="casAuthors">Martinez, Ricardo; Blasina, Alessandra; Hallin, Jill F.; Hu, Wenyue; Rymer, Isha; Fan, Jeffery; Hoffman, Robert L.; Murphy, Sean; Marx, Matthew; Yanochko, Gina; Trajkovic, Dusko; Dinh, Dac; Timofeevski, Sergei; Zhu, Zhou; Sun, Peiquing; Lappin, Patrick B.; Murray, Brion W.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e0138616/1-e0138616/23</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Cell cycle checkpoint intervention is an effective therapeutic strategy for cancer when applied to patients predisposed to respond and the treatment is well-tolerated.  A crit. cell cycle process that could be targeted is the mitotic checkpoint (spindle assembly checkpoint) which governs the metaphase-to-anaphase transition and insures proper chromosomal segregation.  The mitotic checkpoint kinase Mps1 was selected to explore whether enhancement in genomic instability is a viable therapeutic strategy.  The basal-a subset of triple-neg. breast cancer was chosen as a model system because it has a higher incidence of chromosomal instability and Mps1 expression is up-regulated.  Depletion of Mps1 reduces tumor cell viability relative to normal cells.  Highly selective, extremely potent Mps1 kinase inhibitors were created to investigate the roles of Mps1 catalytic activity in tumor cells and normal physiol. (PF-7006, PF-3837; Ki<0.5 nM; cellular IC50 2-6 nM).  Treatment of tumor cells in vitro with PF-7006 modulates expected Mps1-dependent biol. as demonstrated by mol. and phenotypic measures (reduced pHH3-Ser10 levels, shorter duration of mitosis, micro-nucleation, and apoptosis).  Tumor-bearing mice treated with PF-7006 exhibit tumor growth inhibition concomitant with pharmacodynamic modulation of a downstream biomarker (pHH3-Ser10).  Unfortunately, efficacy only occurs at drug exposures that cause dose-limiting body wt. loss, gastrointestinal toxicities, and neutropenia.  Mps1 inhibitor toxicities may be mitigated by inducing G1 cell cycle arrest in Rb1-competent cells with the cyclin-dependent kinase-4/6 inhibitor palbociclib.  Using an isogenic cellular model system, PF-7006 is shown to be selectively cytotoxic to Rb1-deficient cells relative to Rb1-competent cells (also a measure of kinase selectivity).  Human bone marrow cells pretreated with palbociclib have decreased PF-7006-dependent apoptosis relative to cells without palbociclib pretreatment.  Collectively, this study raises a concern that single agent therapies inhibiting Mps1 will not be well-tolerated clin. but may be when combined with a selective CDK4/6 drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc-9LR3Gfty7Vg90H21EOLACvtfcHk0lj-e3U-ankRzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ymsLo%253D&md5=68fc918b70df2cd020be0c4fec209c12</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0138616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0138616%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DBlasina%26aufirst%3DA.%26aulast%3DHallin%26aufirst%3DJ.%2BF.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DRymer%26aufirst%3DI.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DHoffman%26aufirst%3DR.%2BL.%26aulast%3DMurphy%26aufirst%3DS.%26aulast%3DMarx%26aufirst%3DM.%26aulast%3DYanochko%26aufirst%3DG.%26aulast%3DTrajkovic%26aufirst%3DD.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DLappin%26aufirst%3DP.%2BB.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26atitle%3DMitotic%2520checkpoint%2520kinase%2520MPS1%2520has%2520a%2520role%2520in%2520normal%2520physiology%2520which%2520impacts%2520clinical%2520utility%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0138616%26doi%3D10.1371%2Fjournal.pone.0138616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maia, A. R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Man, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boon, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omerzu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterrenburg, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinsen, M. B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willemsen-Seegers, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Roos, J. A. D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Doornmalen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uitdehaag, J. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kops, G. J. P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonkers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buijsman, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaman, G. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medema, R. H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model</span>. <i>Ann. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2180</span>– <span class="NLM_lpage">2192</span>, <span class="refDoi"> DOI: 10.1093/annonc/mdv293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1093%2Fannonc%2Fmdv293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=26153498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FhsVCrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=2180-2192&author=A.+R.+R.+Maiaauthor=J.+de+Manauthor=U.+Boonauthor=A.+Janssenauthor=J.+Y.+Songauthor=M.+Omerzuauthor=J.+G.+Sterrenburgauthor=M.+B.+W.+Prinsenauthor=N.+Willemsen-Seegersauthor=J.+A.+D.+M.+de+Roosauthor=A.+M.+van+Doornmalenauthor=J.+C.+M.+Uitdehaagauthor=G.+J.+P.+L.+Kopsauthor=J.+Jonkersauthor=R.+C.+Buijsmanauthor=G.+J.+R.+Zamanauthor=R.+H.+Medema&title=Inhibition+of+the+spindle+assembly+checkpoint+kinase+TTK+enhances+the+efficacy+of+docetaxel+in+a+triple-negative+breast+cancer+model&doi=10.1093%2Fannonc%2Fmdv293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model</span></div><div class="casAuthors">Maia A R R; Janssen A; de Man J; Sterrenburg J G; Prinsen M B W; Willemsen-Seegers N; de Roos J A D M; van Doornmalen A M; Uitdehaag J C M; Buijsman R C; Zaman G J R; Boon U; Song J-Y; Omerzu M; Kops G J P L; Jonkers J; Medema R H</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2180-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Triple-negative breast cancers (TNBC) are considered the most aggressive type of breast cancer, for which no targeted therapy exists at the moment.  These tumors are characterized by having a high degree of chromosome instability and often overexpress the spindle assembly checkpoint kinase TTK.  To explore the potential of TTK inhibition as a targeted therapy in TNBC, we developed a highly potent and selective small molecule inhibitor of TTK, NTRC 0066-0.  RESULTS AND CONCLUSIONS:  The compound is characterized by long residence time on the target and inhibits the proliferation of a wide variety of human cancer cell lines with potency in the same range as marketed cytotoxic agents.  In cell lines and in mice, NTRC 0066-0 inhibits the phosphorylation of a TTK substrate and induces chromosome missegregation.  NTRC 0066-0 inhibits tumor growth in MDA-MB-231 xenografts as a single agent after oral application.  To address the effect of the inhibitor in breast cancer, we used a well-defined mouse model that spontaneously develops breast tumors that share key morphologic and molecular features with human TNBC.  Our studies show that combination of NTRC 0066-0 with a therapeutic dose of docetaxel resulted in doubling of mouse survival and extended tumor remission, without toxicity.  Furthermore, we observed that treatment efficacy is only achieved upon co-administration of the two compounds, which suggests a synergistic in vivo effect.  Therefore, we propose TTK inhibition as a novel therapeutic target for neoadjuvant therapy in TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQW4bdSIlyWFQ8IxFYvehhofW6udTcc2eZKOnBiDjNhJLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FhsVCrtg%253D%253D&md5=579aa33d6fd0de70b6c68ae86d8316c0</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdv293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdv293%26sid%3Dliteratum%253Aachs%26aulast%3DMaia%26aufirst%3DA.%2BR.%2BR.%26aulast%3Dde%2BMan%26aufirst%3DJ.%26aulast%3DBoon%26aufirst%3DU.%26aulast%3DJanssen%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DJ.%2BY.%26aulast%3DOmerzu%26aufirst%3DM.%26aulast%3DSterrenburg%26aufirst%3DJ.%2BG.%26aulast%3DPrinsen%26aufirst%3DM.%2BB.%2BW.%26aulast%3DWillemsen-Seegers%26aufirst%3DN.%26aulast%3Dde%2BRoos%26aufirst%3DJ.%2BA.%2BD.%2BM.%26aulast%3Dvan%2BDoornmalen%26aufirst%3DA.%2BM.%26aulast%3DUitdehaag%26aufirst%3DJ.%2BC.%2BM.%26aulast%3DKops%26aufirst%3DG.%2BJ.%2BP.%2BL.%26aulast%3DJonkers%26aufirst%3DJ.%26aulast%3DBuijsman%26aufirst%3DR.%2BC.%26aulast%3DZaman%26aufirst%3DG.%2BJ.%2BR.%26aulast%3DMedema%26aufirst%3DR.%2BH.%26atitle%3DInhibition%2520of%2520the%2520spindle%2520assembly%2520checkpoint%2520kinase%2520TTK%2520enhances%2520the%2520efficacy%2520of%2520docetaxel%2520in%2520a%2520triple-negative%2520breast%2520cancer%2520model%26jtitle%3DAnn.%2520Oncol.%26date%3D2015%26volume%3D26%26spage%3D2180%26epage%3D2192%26doi%3D10.1093%2Fannonc%2Fmdv293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wengner, A. M.</span>; <span class="NLM_string-name">Siemeister, G.</span></span> <span> </span><span class="NLM_article-title">Combinations for the Treatment of Cancer Comprising a MPS-1 Kinase Inhibitor and a Mitotic Inhibitor</span>. <span class="NLM_patent">WO2014198645</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+M.+Wengner&author=G.+Siemeister&title=Combinations+for+the+Treatment+of+Cancer+Comprising+a+MPS-1+Kinase+Inhibitor+and+a+Mitotic+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWengner%26aufirst%3DA.%2BM.%26atitle%3DCombinations%2520for%2520the%2520Treatment%2520of%2520Cancer%2520Comprising%2520a%2520MPS-1%2520Kinase%2520Inhibitor%2520and%2520a%2520Mitotic%2520Inhibitor%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wengner, A. M.</span>; <span class="NLM_string-name">Siemeister, G.</span></span> <span> </span><span class="NLM_article-title">Combination of a Imidazopyridazine Derivative and a Mitotic Agent for the Treatment of Cancer</span>. <span class="NLM_patent">WO2014198776A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+M.+Wengner&author=G.+Siemeister&title=Combination+of+a+Imidazopyridazine+Derivative+and+a+Mitotic+Agent+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWengner%26aufirst%3DA.%2BM.%26atitle%3DCombination%2520of%2520a%2520Imidazopyridazine%2520Derivative%2520and%2520a%2520Mitotic%2520Agent%2520for%2520the%2520Treatment%2520of%2520Cancer%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ide, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daigo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashizume, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nozu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagashira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanazawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishioka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dohi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baba, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of imidazo[1,2-<i>b</i>]pyridazine derivatives: selective and orally available MPS1 (TTK) kinase inhibitors exhibiting remarkable antiproliferative activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1760</span>– <span class="NLM_lpage">1775</span>, <span class="refDoi"> DOI: 10.1021/jm501599u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501599u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2it7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1760-1775&author=K.-I.+Kusakabeauthor=N.+Ideauthor=Y.+Daigoauthor=T.+Itohauthor=T.+Yamamotoauthor=H.+Hashizumeauthor=K.+Nozuauthor=H.+Yoshidaauthor=G.+Tadanoauthor=S.+Tagashiraauthor=K.+Higashinoauthor=Y.+Okanoauthor=Y.+Satoauthor=M.+Inoueauthor=M.+Iguchiauthor=T.+Kanazawaauthor=Y.+Ishiokaauthor=K.+Dohiauthor=Y.+Kidoauthor=S.+Sakamotoauthor=S.+Andoauthor=M.+Maedaauthor=M.+Higakiauthor=Y.+Babaauthor=Y.+Nakamura&title=Discovery+of+imidazo%5B1%2C2-b%5Dpyridazine+derivatives%3A+selective+and+orally+available+MPS1+%28TTK%29+kinase+inhibitors+exhibiting+remarkable+antiproliferative+activity&doi=10.1021%2Fjm501599u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Imidazo[1,2-b]pyridazine Derivatives: Selective and Orally Available Mps1 (TTK) Kinase Inhibitors Exhibiting Remarkable Antiproliferative Activity</span></div><div class="casAuthors">Kusakabe, Ken-ichi; Ide, Nobuyuki; Daigo, Yataro; Itoh, Takeshi; Yamamoto, Takahiko; Hashizume, Hiroshi; Nozu, Kohei; Yoshida, Hiroshi; Tadano, Genta; Tagashira, Sachie; Higashino, Kenichi; Okano, Yousuke; Sato, Yuji; Inoue, Makiko; Iguchi, Motofumi; Kanazawa, Takayuki; Ishioka, Yukichi; Dohi, Keiji; Kido, Yasuto; Sakamoto, Shingo; Ando, Shigeru; Maeda, Masahiro; Higaki, Masayo; Baba, Yoshiyasu; Nakamura, Yusuke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1760-1775</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monopolar spindle 1 (Mps1) is an attractive oncol. target due to its high expression level in cancer cells as well as the correlation of its expression levels with histol. grades of cancers.  An imidazo[1,2-a]pyrazine 10a was identified during an HTS campaign.  Although 10a exhibited good biochem. activity, its moderate cellular as well as antiproliferative activities needed to be improved.  The cocrystal structure of an analog of 10a guided our lead optimization to introduce substituents at the 6-position of the scaffold, giving the 6-aryl substituted 21b which had improved cellular activity but no oral bioavailability in rat.  Property-based optimization at the 6-position and a scaffold change led to the discovery of the imidazo[1,2-b]pyridazine-based 27f, an extremely potent (cellular Mps1 IC50 = 0.70 nM, A549 IC50 = 6.0 nM), selective Mps1 inhibitor over 192 kinases, which could be orally administered and was active in vivo.  This 27f demonstrated remarkable antiproliferative activity in the nanomolar range against various tissue cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8D9nRl5vWabVg90H21EOLACvtfcHk0lgLVzAOExKj6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2it7g%253D&md5=bee62a50247a363dc3e35fcdeac6a64f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm501599u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501599u%26sid%3Dliteratum%253Aachs%26aulast%3DKusakabe%26aufirst%3DK.-I.%26aulast%3DIde%26aufirst%3DN.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DHashizume%26aufirst%3DH.%26aulast%3DNozu%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DTagashira%26aufirst%3DS.%26aulast%3DHigashino%26aufirst%3DK.%26aulast%3DOkano%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DIguchi%26aufirst%3DM.%26aulast%3DKanazawa%26aufirst%3DT.%26aulast%3DIshioka%26aufirst%3DY.%26aulast%3DDohi%26aufirst%3DK.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DHigaki%26aufirst%3DM.%26aulast%3DBaba%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520imidazo%255B1%252C2-b%255Dpyridazine%2520derivatives%253A%2520selective%2520and%2520orally%2520available%2520MPS1%2520%2528TTK%2529%2520kinase%2520inhibitors%2520exhibiting%2520remarkable%2520antiproliferative%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1760%26epage%3D1775%26doi%3D10.1021%2Fjm501599u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wahba, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Hadaad, H. A.</span></span> <span> </span><span class="NLM_article-title">Current approaches in treatment of triple-negative breast cancer</span>. <i>Cancer Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=26175926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlslGjtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=106-116&author=H.+A.+Wahbaauthor=H.+A.+El-Hadaad&title=Current+approaches+in+treatment+of+triple-negative+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Current approaches in treatment of triple-negative breast cancer</span></div><div class="casAuthors">Wahba, Hanan Ahmed; El-Hadaad, Hend Ahmed</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2Spec.Iss.</span>),
    <span class="NLM_cas:pages">106-116</span>CODEN:
                <span class="NLM_cas:coden">CBMADQ</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Tianjin Medical University Cancer Institute and Hospital</span>)
        </div><div class="casAbstract">Triple-neg. breast cancer (TNBC) is diagnosed more frequently in younger and premenopausal women and is highly prevalent in African American women.  TNBC is a term derived from tumors that are characterized by the absence of ER, PgR, and HER2.  So patients with TNBC do not benefit from hormonal or trastuzumab-based therapies.  TNBCs are biol. aggressive, although some reports suggest that they respond to chemotherapy better than other types of breast cancer, prognosis remains poor.  This is due to: shortened disease-free interval in the adjuvant and neoadjuvant setting and a more aggressive course in the metastatic setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoriUOaFeoi1bVg90H21EOLACvtfcHk0lj-oV_68c3c8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlslGjtr8%253D&md5=05e14e8e08ac1aafca78a730c6c7ba30</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWahba%26aufirst%3DH.%2BA.%26aulast%3DEl-Hadaad%26aufirst%3DH.%2BA.%26atitle%3DCurrent%2520approaches%2520in%2520treatment%2520of%2520triple-negative%2520breast%2520cancer%26jtitle%3DCancer%2520Biol.%2520Med.%26date%3D2015%26volume%3D12%26spage%3D106%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Innocenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Fee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span> <span> </span><span class="NLM_article-title">Expanding the scope of fused pyrimidines as kinase inhibitor scaffolds: synthesis and modification of pyrido[3,4-<i>d</i>]pyrimidines</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">893</span>– <span class="NLM_lpage">904</span>, <span class="refDoi"> DOI: 10.1039/C4OB02238F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1039%2FC4OB02238F" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=893-904&author=P.+Innocentiauthor=H.+Woodwardauthor=L.+O%E2%80%99Feeauthor=S.+Hoelder&title=Expanding+the+scope+of+fused+pyrimidines+as+kinase+inhibitor+scaffolds%3A+synthesis+and+modification+of+pyrido%5B3%2C4-d%5Dpyrimidines&doi=10.1039%2FC4OB02238F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2FC4OB02238F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4OB02238F%26sid%3Dliteratum%253Aachs%26aulast%3DInnocenti%26aufirst%3DP.%26aulast%3DWoodward%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Fee%26aufirst%3DL.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DExpanding%2520the%2520scope%2520of%2520fused%2520pyrimidines%2520as%2520kinase%2520inhibitor%2520scaffolds%253A%2520synthesis%2520and%2520modification%2520of%2520pyrido%255B3%252C4-d%255Dpyrimidines%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D893%26epage%3D904%26doi%3D10.1039%2FC4OB02238F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">VanderWel, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repine, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booth, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobrusin, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fry, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toogood, P. L.</span></span> <span> </span><span class="NLM_article-title">Pyrido[2,3-<i>d</i>]pyrimidin-7-ones as specific inhibitors of cyclin-dependent kinase 4</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">2371</span>– <span class="NLM_lpage">2387</span>, <span class="refDoi"> DOI: 10.1021/jm049355+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049355%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVGisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2371-2387&author=S.+N.+VanderWelauthor=P.+J.+Harveyauthor=D.+J.+McNamaraauthor=J.+T.+Repineauthor=P.+R.+Kellerauthor=J.+Quinauthor=R.+J.+Boothauthor=W.+L.+Elliottauthor=E.+M.+Dobrusinauthor=D.+W.+Fryauthor=P.+L.+Toogood&title=Pyrido%5B2%2C3-d%5Dpyrimidin-7-ones+as+specific+inhibitors+of+cyclin-dependent+kinase+4&doi=10.1021%2Fjm049355%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrido[2,3-d]pyrimidin-7-ones as Specific Inhibitors of Cyclin-Dependent Kinase 4</span></div><div class="casAuthors">VanderWel, Scott N.; Harvey, Patricia J.; McNamara, Dennis J.; Repine, Joseph T.; Keller, Paul R.; Quin, John, III; Booth, R. John; Elliott, William L.; Dobrusin, Ellen M.; Fry, David W.; Toogood, Peter L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2371-2387</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of the cell cycle kinase, cyclin-dependent kinase-4 (Cdk4), is expected to provide an effective method for the treatment of proliferative diseases such as cancer.  The pyrido[2,3-d]pyrimidin-7-one template has been identified previously as a privileged structure for the inhibition of ATP-dependent kinases, and good potency against Cdks has been reported for representative examples.  Obtaining selectivity for individual Cdk enzymes, particularly Cdk4, has been challenging.  A series of pyrido[2,3-d]pyrimidin-7-ones I (R1 = Me2CH, Et2CH, cyclopentyl; R2 = H, Me, Et, F3C; R3 = H, Me, F, Cl, COMe, MeO2C, etc.; X = HOCH, H2NCH, CH2N, CH2CH2, etc.) was synthesized and investigated as selective inhibitors of Cdk4.  The introduction of a Me substituent at the C-5 position of the pyrido[2,3-d]pyrimidin-7-one template is sufficient to confer excellent selectivity for Cdk4 vs other Cdks and representative tyrosine kinases.  Further optimization led to the identification of highly potent and selective inhibitors of Cdk4 that exhibit potent antiproliferative activity against human tumor cells in vitro.  The most selective Cdk4 inhibitors were evaluated for antitumor activity against MDA-MB-435 human breast carcinoma xenografts in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKNHZHOwd7c7Vg90H21EOLACvtfcHk0lj-oV_68c3c8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVGisLo%253D&md5=ef3c86bbdfaea0080d1103313d094ccd</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm049355%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049355%252B%26sid%3Dliteratum%253Aachs%26aulast%3DVanderWel%26aufirst%3DS.%2BN.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DMcNamara%26aufirst%3DD.%2BJ.%26aulast%3DRepine%26aufirst%3DJ.%2BT.%26aulast%3DKeller%26aufirst%3DP.%2BR.%26aulast%3DQuin%26aufirst%3DJ.%26aulast%3DBooth%26aufirst%3DR.%2BJ.%26aulast%3DElliott%26aufirst%3DW.%2BL.%26aulast%3DDobrusin%26aufirst%3DE.%2BM.%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DToogood%26aufirst%3DP.%2BL.%26atitle%3DPyrido%255B2%252C3-d%255Dpyrimidin-7-ones%2520as%2520specific%2520inhibitors%2520of%2520cyclin-dependent%2520kinase%25204%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2371%26epage%3D2387%26doi%3D10.1021%2Fjm049355%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toogood, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repine, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanderWel, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherry, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodfuehrer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barvian, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fry, D. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">2388</span>– <span class="NLM_lpage">2406</span>, <span class="refDoi"> DOI: 10.1021/jm049354h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049354h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVGisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2388-2406&author=P.+L.+Toogoodauthor=P.+J.+Harveyauthor=J.+T.+Repineauthor=D.+J.+Sheehanauthor=S.+N.+VanderWelauthor=H.+Zhouauthor=P.+R.+Kellerauthor=D.+J.+McNamaraauthor=D.+Sherryauthor=T.+Zhuauthor=J.+Brodfuehrerauthor=C.+Choiauthor=M.+R.+Barvianauthor=D.+W.+Fry&title=Discovery+of+a+potent+and+selective+inhibitor+of+cyclin-dependent+kinase+4%2F6&doi=10.1021%2Fjm049354h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective Inhibitor of Cyclin-Dependent Kinase 4/6</span></div><div class="casAuthors">Toogood, Peter L.; Harvey, Patricia J.; Repine, Joseph T.; Sheehan, Derek J.; VanderWel, Scott N.; Zhou, Hairong; Keller, Paul R.; McNamara, Dennis J.; Sherry, Debra; Zhu, Tong; Brodfuehrer, Joanne; Choi, Chung; Barvian, Mark R.; Fry, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2388-2406</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A pharmacol. approach to inhibition of cyclin-dependent kinases 4 and 6 (Cdk4/6) using highly selective small mol. inhibitors has the potential to provide novel cancer therapies for clin. use.  Achieving high levels of selectivity for Cdk4/6, vs. other ATP-dependent kinases, presents a significant challenge.  The pyrido[2,3-d]pyrimidin-7-one template provides an effective platform for the inhibition of a broad cross-section of kinases, including Cdks.  It is now demonstrated that the modification of pyrido[2,3-d]pyrimidin-7-ones to include a 2-aminopyridine side chain at the C2-position provides inhibitors with exquisite selectivity for Cdk4/6 in vitro.  This selectivity profile is recapitulated in cells where the most selective inhibitors create a G1 block at concns. up to 100-fold the IC50 for cell proliferation.  On the basis of its selectivity profile and pharmacokinetic profile, compd. I (PD 0332991) was identified as a drug candidate for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX577J5U0r97Vg90H21EOLACvtfcHk0lj-oV_68c3c8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVGisL0%253D&md5=23cbe58426ff1975695712db7c1b128a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm049354h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049354h%26sid%3Dliteratum%253Aachs%26aulast%3DToogood%26aufirst%3DP.%2BL.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DRepine%26aufirst%3DJ.%2BT.%26aulast%3DSheehan%26aufirst%3DD.%2BJ.%26aulast%3DVanderWel%26aufirst%3DS.%2BN.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DKeller%26aufirst%3DP.%2BR.%26aulast%3DMcNamara%26aufirst%3DD.%2BJ.%26aulast%3DSherry%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DBrodfuehrer%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DBarvian%26aufirst%3DM.%2BR.%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520cyclin-dependent%2520kinase%25204%252F6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2388%26epage%3D2406%26doi%3D10.1021%2Fjm049354h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aboagye, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balkwill, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balmain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruder, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Double, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farningham, D. A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glennie, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelland, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratford, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozer, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wedge, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span> <span> </span><span class="NLM_article-title">Guidelines for the welfare and use of animals in cancer research</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">1555</span>– <span class="NLM_lpage">1577</span>, <span class="refDoi"> DOI: 10.1038/sj.bjc.6605642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1038%2Fsj.bjc.6605642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=20502460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A280%3ADC%252BC3czmvFyhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=1555-1577&author=P.+Workmanauthor=E.+O.+Aboagyeauthor=F.+Balkwillauthor=A.+Balmainauthor=G.+Bruderauthor=D.+J.+Chaplinauthor=J.+A.+Doubleauthor=J.+Everittauthor=D.+A.+H.+Farninghamauthor=M.+J.+Glennieauthor=L.+R.+Kellandauthor=V.+Robinsonauthor=I.+J.+Stratfordauthor=G.+M.+Tozerauthor=S.+Watsonauthor=S.+R.+Wedgeauthor=S.+A.+Eccles&title=Guidelines+for+the+welfare+and+use+of+animals+in+cancer+research&doi=10.1038%2Fsj.bjc.6605642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Guidelines for the welfare and use of animals in cancer research</span></div><div class="casAuthors">Workman P; Aboagye E O; Balkwill F; Balmain A; Bruder G; Chaplin D J; Double J A; Everitt J; Farningham D A H; Glennie M J; Kelland L R; Robinson V; Stratford I J; Tozer G M; Watson S; Wedge S R; Eccles S A</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1555-77</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Animal experiments remain essential to understand the fundamental mechanisms underpinning malignancy and to discover improved methods to prevent, diagnose and treat cancer.  Excellent standards of animal care are fully consistent with the conduct of high quality cancer research.  Here we provide updated guidelines on the welfare and use of animals in cancer research.  All experiments should incorporate the 3Rs: replacement, reduction and refinement.  Focusing on animal welfare, we present recommendations on all aspects of cancer research, including: study design, statistics and pilot studies; choice of tumour models (e.g., genetically engineered, orthotopic and metastatic); therapy (including drugs and radiation); imaging (covering techniques, anaesthesia and restraint); humane endpoints (including tumour burden and site); and publication of best practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkVD7D529OLg5nADWVYHg1fW6udTcc2eYzk9NFhYu73bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czmvFyhsQ%253D%253D&md5=55f4c62e16fb1ebaa1f05d59caba3989</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605642%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DAboagye%26aufirst%3DE.%2BO.%26aulast%3DBalkwill%26aufirst%3DF.%26aulast%3DBalmain%26aufirst%3DA.%26aulast%3DBruder%26aufirst%3DG.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DDouble%26aufirst%3DJ.%2BA.%26aulast%3DEveritt%26aufirst%3DJ.%26aulast%3DFarningham%26aufirst%3DD.%2BA.%2BH.%26aulast%3DGlennie%26aufirst%3DM.%2BJ.%26aulast%3DKelland%26aufirst%3DL.%2BR.%26aulast%3DRobinson%26aufirst%3DV.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26aulast%3DWatson%26aufirst%3DS.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26atitle%3DGuidelines%2520for%2520the%2520welfare%2520and%2520use%2520of%2520animals%2520in%2520cancer%2520research%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2010%26volume%3D102%26spage%3D1555%26epage%3D1577%26doi%3D10.1038%2Fsj.bjc.6605642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faisal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, G. W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurden, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xavier, C. P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderhub, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innocenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Haven Brandon, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Fee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">vanMontfort, R. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linardopoulos, S.</span></span> <span> </span><span class="NLM_article-title">Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure <i>in vivo</i> MPS1 inhibition vs therapeutic efficacy</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">1166</span>– <span class="NLM_lpage">1176</span>, <span class="refDoi"> DOI: 10.1038/bjc.2017.75</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=10.1038%2Fbjc.2017.75" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=28334731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotVKht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2017&pages=1166-1176&author=A.+Faisalauthor=G.+W.+Y.+Makauthor=M.+D.+Gurdenauthor=C.+P.+R.+Xavierauthor=S.+J.+Anderhubauthor=P.+Innocentiauthor=I.+M.+Westwoodauthor=S.+Naudauthor=A.+Hayesauthor=G.+Boxauthor=M.+R.+Valentiauthor=A.+K.+De+Haven+Brandonauthor=L.+O%E2%80%99Feeauthor=J.+Schmittauthor=H.+L.+Woodwardauthor=R.+Burkeauthor=R.+L.+M.+vanMontfortauthor=J.+Blaggauthor=F.+I.+Raynaudauthor=S.+A.+Ecclesauthor=S.+Hoelderauthor=S.+Linardopoulos&title=Characterisation+of+CCT271850%2C+a+selective%2C+oral+and+potent+MPS1+inhibitor%2C+used+to+directly+measure+in+vivo+MPS1+inhibition+vs+therapeutic+efficacy&doi=10.1038%2Fbjc.2017.75"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure in vivo MPS1 inhibition vs therapeutic efficacy</span></div><div class="casAuthors">Faisal, Amir; Mak, Grace W. Y.; Gurden, Mark D.; Xavier, Cristina P. R.; Anderhub, Simon J.; Innocenti, Paolo; Westwood, Isaac M.; Naud, Sebastien; Hayes, Angela; Box, Gary; Valenti, Melanie R.; De Haven Brandon, Alexis K.; O'Fee, Lisa; Schmitt, Jessica; Woodward, Hannah L.; Burke, Rosemary; van Montfort, Rob L. M.; Blagg, Julian; Raynaud, Florence I.; Eccles, Suzanne A.; Hoelder, Swen; Linardopoulos, Spiros</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1166-1176</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: The main role of the cell cycle is to enable error-free DNA replication, chromosome segregation and cytokinesis.  One of the best characterized checkpoint pathways is the spindle assembly checkpoint, which prevents anaphase onset until the appropriate attachment and tension across kinetochores is achieved.  MPS1 kinase activity is essential for the activation of the spindle assembly checkpoint and has been shown to be deregulated in human tumors with chromosomal instability and aneuploidy.  Therefore, MPS1 inhibition represents an attractive strategy to target cancers.  Methods: To evaluate CCT271850 cellular potency, two specific antibodies that recognize the activation sites of MPS1 were used and its antiproliferative activity was detd. in 91 human cancer cell lines.  DLD1 cells with induced GFP-MPS1 and HCT116 cells were used in in vivo studies to directly measure MPS1 inhibition and efficacy of CCT271850 treatment.  Results: CCT271850 selectively and potently inhibits MPS1 kinase activity in biochem. and cellular assays and in in vivo models.  Mechanistically, tumor cells treated with CCT271850 acquire aberrant nos. of chromosomes and the majority of cells divide their chromosomes without proper alignment because of abrogation of the mitotic checkpoint, leading to cell death.  We demonstrated a moderate level of efficacy of CCT271850 as a single agent in a human colorectal carcinoma xenograft model.  Conclusions: CCT271850 is a potent, selective and orally bioavailable MPS1 kinase inhibitor.  On the basis of in vivo pharmacodynamic vs efficacy relationships, we predict that more than 80% inhibition of MPS1 activity for at least 24 h is required to achieve tumor stasis or regression by CCT271850.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodu8v7zdjvabVg90H21EOLACvtfcHk0ljbEWzPnONhew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotVKht74%253D&md5=656368a488e47677a8cb455de962371e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2017.75&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2017.75%26sid%3Dliteratum%253Aachs%26aulast%3DFaisal%26aufirst%3DA.%26aulast%3DMak%26aufirst%3DG.%2BW.%2BY.%26aulast%3DGurden%26aufirst%3DM.%2BD.%26aulast%3DXavier%26aufirst%3DC.%2BP.%2BR.%26aulast%3DAnderhub%26aufirst%3DS.%2BJ.%26aulast%3DInnocenti%26aufirst%3DP.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DNaud%26aufirst%3DS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DValenti%26aufirst%3DM.%2BR.%26aulast%3DDe%2BHaven%2BBrandon%26aufirst%3DA.%2BK.%26aulast%3DO%25E2%2580%2599Fee%26aufirst%3DL.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DWoodward%26aufirst%3DH.%2BL.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DvanMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DHoelder%26aufirst%3DS.%26aulast%3DLinardopoulos%26aufirst%3DS.%26atitle%3DCharacterisation%2520of%2520CCT271850%252C%2520a%2520selective%252C%2520oral%2520and%2520potent%2520MPS1%2520inhibitor%252C%2520used%2520to%2520directly%2520measure%2520in%2520vivo%2520MPS1%2520inhibition%2520vs%2520therapeutic%2520efficacy%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2017%26volume%3D116%26spage%3D1166%26epage%3D1176%26doi%3D10.1038%2Fbjc.2017.75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Milletti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storchi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sforna, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruciani, G.</span></span> <span> </span><span class="NLM_article-title">New and original pka prediction method using grid molecular interaction fields</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2172</span>– <span class="NLM_lpage">2181</span>, <span class="refDoi"> DOI: 10.1021/ci700018y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci700018y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSnsLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=2172-2181&author=F.+Millettiauthor=L.+Storchiauthor=G.+Sfornaauthor=G.+Cruciani&title=New+and+original+pka+prediction+method+using+grid+molecular+interaction+fields&doi=10.1021%2Fci700018y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">New and Original pKa Prediction Method Using Grid Molecular Interaction Fields</span></div><div class="casAuthors">Milletti, Francesca; Storchi, Loriano; Sforna, Gianluca; Cruciani, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2172-2181</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One of the most important physicochem. properties of a mol. is pKa.  It is known that two parameters imperative in ADME profiling, soly., and lipophilicity are governed by pKa, and receptor binding can be influenced by pKa.  Because most drugs are ionized in physiol. conditions, pKa is particularly relevant to medicinal chem.  Despite the numerous advances in high-throughput measurements, in silico detn. is still the fastest and cheapest way of obtaining pKa.  This paper presents a new original computational method for pKa prediction of org. compds.  Descriptors were generated using the program GRID, and these descriptors are based on mol. interaction fields precomputed on a set of mol. fragments.  The new method was developed, trained, and cross-validated by using a large and diverse data set of 24 617 pKa values.  This paper presents the results for a class of 421 acidic nitrogen compds. (RMSE = 0.41, r2 = 0.97, q2 = 0.87) and for a class of 947 six-membered N-heterocyclic bases (RMSE = 0.60, r2 = 0.93, q2 = 0.85).  For external validation 28 novel compds. were selected that covered nine different ionizable groups, and 39 pKa values could be exptl. detd. by spectral gradient anal. (SGA).  Comparison of exptl. pKa with calcd. pKa demonstrated that the predictive ability of the method is good (external set, r2 = 0.85, RMSE = 0.90).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzEk0uiS1E6rVg90H21EOLACvtfcHk0ljgTJ98_OUtBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSnsLrF&md5=f2b1dec853ccb0ef1a40540d234232fb</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fci700018y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700018y%26sid%3Dliteratum%253Aachs%26aulast%3DMilletti%26aufirst%3DF.%26aulast%3DStorchi%26aufirst%3DL.%26aulast%3DSforna%26aufirst%3DG.%26aulast%3DCruciani%26aufirst%3DG.%26atitle%3DNew%2520and%2520original%2520pka%2520prediction%2520method%2520using%2520grid%2520molecular%2520interaction%2520fields%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D2172%26epage%3D2181%26doi%3D10.1021%2Fci700018y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EH0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EH0','PDB','5EH0'); return false;">PDB: 5EH0</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1H08" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1H08','PDB','1H08'); return false;">PDB: 1H08</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6H3K" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6H3K','PDB','6H3K'); return false;">PDB: 6H3K</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i50"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00690">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_78306"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00690">10.1021/acs.jmedchem.8b00690</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00690/suppl_file/jm8b00690_si_001.csv">CSV</a>)</p></li><li><p class="inline">Experimental procedures and analytical data for all formamides (<b>10–13</b> and <b>29–33</b>) and corresponding intermediates, CYP, hERG activity, and P-gp efflux data as well as kinase selectivity profiling of <b>36</b>. Tables with standard deviations for all compounds as well as antiproliferative (GI<sub>50</sub>) data for several compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00690/suppl_file/jm8b00690_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00690/suppl_file/jm8b00690_si_001.csv">jm8b00690_si_001.csv (1.76 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00690/suppl_file/jm8b00690_si_002.pdf">jm8b00690_si_002.pdf (1.22 MB)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB ID code for <b>36</b> bound to MPS1 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6H3K">6H3K</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-18%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00690%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00690" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799292c691b3c76","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
